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INTRODUCTION TO PULSED DRUG RELEASE 
 
During the past decades much effort has been made on the development of dosage 
forms for sustained drug release, providing a constant release rate and concentration in the 
bloodstream. Pulsed drug release can be defined as the rapid and transient release of a drug 
after a lag-phase with no or little drug being released. 1 Pulsed drug release could be of 
interest e.g. to prevent drug tolerance (as in the case of nitrate therapy where a sustained 
therapy leads to the rapid development of tolerance), to satisfy circadian requirements (which 
can modulate the pharmacokinetic and pharmacodynamic responses, as in the case of 
attaining night time theophylline levels in anti-asthmatic therapy) and to achieve ‘on demand’ 
responses (as in insulin therapy).  
Drug delivery scientists have worked on several concepts holding promise to 
establish pulsed drug release profiles. One way to classify the pulsed drug delivery systems 
under development is based on the physicochemical and biological principles that trigger 
their release. In ‘programmed’ delivery systems the release is completely governed by an 
inner mechanism of the device, i.e. the lag time prior to the drug release is controlled 
primarily by the delivery system. In ‘triggered’ delivery systems the release is governed by 
changes in the physiological environment of the device (‘biologically triggered systems’) or by 
external stimuli (like the application of e.g. an electromagnetic field, ultrasound or laser light).  
  
 
IMPLANTABLE MICROCHIPS FOR PULSED DRUG RELEASE  
 
Several approaches to achieve pulsed drug release have already been presented. 
E.g. Santini et al. reported on the fabrication of implantable microchips for controlled release 
of therapeutics. 2 The microchips consist of several micro-reservoirs, containing the 
therapeutics, embedded in a matrix. The drug release from any desired micro-reservoir can 
be triggered by applying an electric current to the seal of the corresponding micro-reservoir, 
inducing the dissolution of the seal leading to release of drug molecules. In another approach 
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biodegradable polymers, such as poly(lactic acid) (PLA) and poly(lactic-co-glycolic acid) 
(PLGA), were used to fabricate the seals of the micro-reservoirs. 3 By tailoring the 
degradation rate of the seal material it was possible to tailor the exact moment at which the 
drug molecules were released from a specific micro reservoir, creating a steep release 
profile. 
 
 
EXPLODING MICROCAPSULES FOR PULSED DRUG RELEASE 
  
Microcapsules, releasing their content in response to an internal or external trigger, 
are of great interest in the field of pulsed drug delivery. Due to their micrometer dimensions 
they can be administered by injection, offering considerable advantages towards patient 
compliance as they are less invasive than implants. Recently, the Sukhorukov 4, 5 and 
Caruso6, 7 research groups reported on ‘exploding’ microcapsules. Polyelectrolyte 
microcapsules containing gold nanoparticles were fabricated using the layer-by-layer (LbL) 
technique. Therefore a sacrificial colloidal template was coated with several polyelectrolyte 
layers of opposite charge and also one layer of gold nanoparticles, followed by the 
dissolution of the template resulting in the formation of hollow capsules. Afterwards the 
capsules could be filled with macromolecules by reversibly changing the permeability of the 
LbL membrane. Irradiation of the microcapsules with IR-light induced a local heating of the 
gold nanoparticles causing a disruption of the LbL membrane and thus release of 
encapsulated molecules. As IR-light is able to penetrate the skin over several millimetres, 
such microcapsules, once injected subcutaneously, could be interesting for pulsed drug 
delivery. 
 
INTRACELLULAR PULSED DRUG RELEASE 
  
On the other hand, instead of pre-programmed pulsed drug delivery, one could also 
aim to develop drug delivery systems able to release their payload after a specific physico-
chemical trigger. Especially triggers which can be evoked by the human body itself are of 
interest. E.g. to deliver therapeutic molecules, such as peptides and nucleic acids, to an 
intracellular target it could be interesting to make use of physicochemical differences 
between the extra- and intracellular medium. It is well known that the pH in the 
endo/lysosomes is up to two units lower than the extracellular pH (i.e. pH 7.4). Recently Lynn 
et al. reported on a novel family of pH-sensitive degradable polycations (so called poly-β-
aminoesters). 8 These polymers exhibit some unique features as they appear to be only 
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soluble at a pH below 6.5. Poly-β-aminoester based micro- or nanoparticles rapidly dissolve 
when they are transferred from a pH 7.4 to a slightly acidic pH. 9 These characteristics are 
highly interesting as it would allow such microparticles to release their drug content upon 
cellular internalisation. DNA and anti-tumour agents have been encapsulated in such 
microparticles and successfully used for cellular delivery in vitro. 
 
 
PULSED DRUG RELEASE – HOPE OR HYPE? 
 
“Precisely timed drug delivery may maximize therapeutic efficacy, may minimize dose 
frequency and may reduce toxicity by avoiding side effects and drug tolerance”, an often 
cited slogan. Will it remain hype or will it become reality?  
It is outspoken claimed by the World Health Organization and research funding 
foundations (like e.g. the Bill and Melinda Gates Foundation) that ‘single-shot’ vaccines, 
where the initial and booster doses are contained in one delivery system, could improve 
vaccination coverage by reducing the number of vaccination sessions required to generate 
immunity. Single-shot vaccination would be a major step forward not only in delivering 
established vaccines but also future vaccines. As an example, it is expected that women will 
need three to four antigen doses, spread over a number of months, to become well protected 
against human pappiloma virus induced cervical-cancer. Thus both the developing countries 
as well as the western world could benefit from single-shot vaccines. To develop single-shot 
vaccines many pre-clinical studies, (often based on poly-lactic acid /poly-glycolic acid which 
release the antigen) undertaken in recent years, have proven that biodegradable 
microspheres in a sustained (i.e. not pulsed) way are promising in generating immunity. 10 
Clinical testing would be a next step, however, the financial resources available today seem 
to be a major bottleneck for clinical research on single-shot vaccination. Also the major 
question whether ‘pulsing single-shot vaccines’ should be preferred above ‘slowly releasing 
single-shot vaccines’ remains currently unanswered. Considering the impact single-shot 
vaccines could have on human health we strongly encourage pharmaceutical and clinical 
researchers to focus on pulsed delivery of antigens. Both the implantable microchips as well 
as the exploding microcapsules described above should be evaluated for this purpose.  
In the last decade material scientists already have shown to be able to fabricate new 
materials with unique properties that respond to biological triggers, at least in vitro and in 
vivo. Biocompatible glucose sensors can open opportunities as triggered devices to guide 
insulin release from implanted subcutaneous supplies. 11 It is important to notice that the 
major part of the pulsed drug delivery devices reported are prototypes performing well in 
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vitro, however no data are available on their performance in vivo. Therefore it remains a 
huge challenge to cope with the influences of a biological environment on the integrity of the 
drug delivery devices and on their drug release profile. Also, are fluctuations in temperature, 
pH… under physiological or pathophysiological conditions large enough to meaningfully 
influence the drug release?  
The rather limited progress in in vivo pulsed delivery of therapeutic agents is also 
partially due to limited knowledge on which drugs and indications would benefit from pulsatile 
or temporally modulated release. Quite a lot of challenges remain with this regard. Many 
diseases display symptoms and onset characteristics that are randomly distributed within 24 
hours: e.g. coronary infarction and angina pectoris (activity related), asthmatic attacks (early 
morning) and peptic ulcer pain (night). Data, primarily concerned with the 
chronopharmacokinetics of propranolol, organic nitrates, nifedipine, antiasthmatics and 
histamine H2-blockers can be taken as examples. 12, 13 Pulsed drug delivery should make 
glucocorticoid replacement therapy as physiological as possible, the normal pattern of 
secretion including a diurnal rhythm and a pulsatile ultradiurnal rhythm. It may enable 
splitting the daily delivered dose and temper the long term side effects like adrenal 
suppression and lowered bone mineral density. 14  
Even with relatively small and well known molecules indirect approaches can be 
hypothesised to pathological conditions. It has been clearly demonstrated hat 
benzodiazepine administration affects the activity of the hypothalamus-pituitary-adrenal axis 
(HPA) with a variety of effects at both the central and peripheral level. An inhibitory effect of 
diazepam on the adrenocorticotropic hormones (ACTH) has been reported. Alprazolam 
possesses the most remarkable inhibitory effect on the HPA axis, being 40 times more 
potent than diazepam. This finding could enable programmed release in case of panic 
provoked by central HPA axis hyperactivation. 15 
As benzodiazepines are concerned, pulsed drug delivery of diazepam can render 
service in case of addiction by releasing appropriate doses diminishing in time. It seems that 
the consequences of circumstantial change of sleep and wakefulness by shift work are 
largely underestimated. Disrupted nocturnal production of melatonin and reproductive 
hormones are of relevance for breast cancer ethiology. Studies completed to date have 
found an increased risk of breast cancer associated with indicators of exposure to light-at-
night and night shift work. 16 More insight in the neurophiology of sleep and wakefulness may 
enable to install a ‘programmed’ sleep pattern by releasing agents proper to different sleep 
phases. 17  
It should be encouraged to challenge more the pharmacokinetic paradigm that ‘flatter 
is better’: what drugs and/or therapeutic indications will benefit indeed from temperature, pH, 
ionic strength… induced release? Further pharmaceutical research in pulsed drug delivery 
7
INTRODUCTION TO PULSED DRUG RELEASE 
 
 
 
should be also supported by biologists who should try to obtain better insights into circadian 
rhythms. On the other hand, assuming that we would know how the optimal ‘delivery 
equation’ looks like for a certain drug, as material scientists we wonder whether we will ever 
be able to design delivery systems, based on biocompatible building blocks as this is a 
primary requirement to reach clinical phase testing, which truly meet the (highly likely 
complicated) delivery characteristics. Considering these criticisms, we believe that in the 
coming years ‘pulsed drug delivery scientists’ should define (in a trans-disciplinary approach) 
which type of drugs/diseases will be the focus in pulsed drug delivery research with the hope 
that within the next decade injectable pulsed drug delivery system will become available to 
(hopefully a large group of) patients.  
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Upon administration into the body many (biotechnological) therapeutics, such as e.g. 
proteins and peptides, face a threatening environment and become readily degraded when 
not encapsulated in a suitable pharmaceutical carrier. Besides protecting the drug from 
degradation, the carrier should deliver it at the desired target site and/or at the desired 
moment. Generally speaking, this thesis deals with the design of vehicles for pharmaceutical 
purposes. The vehicles reported in this thesis are prepared by the ‘layer-by-layer’ (LbL) 
technique. The LbL technique is based on the sequential adsorption of charged 
polyelectrolytes onto an oppositely charged surface. When this technique is applied on a 
colloidal template one can encapsulate this template. It is even possible to fabricate ‘hollow 
capsules’ after dissolution of the template. 
Several types of so called ‘polyelectrolyte microcapsules’, each able to release their 
content after a specific internal or external stimulus, are presented in this thesis. Two 
categories of polyelectrolyte microcapsules were investigated. The first category of 
polyelectrolyte microcapsules releases their content upon an internal trigger inside the 
microcapsules. This type of capsules was denoted as ‘self-exploding microcapsules’. The 
second category of microcapsules has specific properties in the LbL membrane, making 
them sensitive to specific physicochemical stimuli. This stimuli responsive behaviour is 
achieved by incorporation of specific moieties, such as chemical groups, degradable 
polymers, nanoparticles, etc … within the LbL membrane. 
CHAPTER 1 overviews the layer-by-layer technique and describes how polyelectrolyte 
microcapsules are fabricated by LbL coating of a sacrificial template. We particularly review 
on stimuli responsive polyelectrolyte microcapsules which decompose and release their 
content after a specific physicochemical trigger. CHAPTER 1 also describes how these 
capsules may be used for biomedical/pharmaceutical applications and compares the 
potential of these microcapsules to other drug delivery systems under investigation. 
CHAPTER 2 – 5 report on self-exploding microcapsules. CHAPTER 2 describes that it is 
possible to obtain self-exploding microcapsules by surrounding a biodegradable microgel 
core with a semi-permeable membrane based on synthetic polyelectrolytes. CHAPTER 3 
reports in detail on the physicochemical properties of the self-exploding microcapsules.  
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In CHAPTER 4 we use bio-polyelectrolytes, instead of synthetic polymers, to coat the 
microgels and show that the ‘exploding behaviour’ of the microcapsules strongly depends on 
the type of bio-polyelectrolytes the membrane consists of. It is shown that choosing suitable 
bio-polyelectrolyte microcapsules allows making self-exploding microcapsules which explode 
upon incubation under physiological conditions. In CHAPTER 5 an alternative technique for the 
coating of the microgels is reported. By adsorbing charged lipid vesicles onto the surface of 
oppositely charged microgels it is possible to surround the microgels with a continuous lipid 
coating, also leading to self-exploding microcapsules.  
CHAPTER 6 describes the fabrication of monodisperse microgels using a microfluidic 
emulsification device. The use of monodisperse microgels, compared to polydisperse 
microgels fabricated by ordinary emulsification, should contribute to a more uniform 
behaviour of a large population of self-exploding microcapsules. 
CHAPTER 7 – 10 report on hollow polyelectrolyte microcapsules able to release their 
content due to an external trigger. CHAPTER 7 describes the fabrication of polyelectrolyte 
microcapsules responsive to glucose using a new phenylboronic acid containing polycation 
whose charge changes upon binding with glucose. Polyelectrolyte microcapsules containing 
this polycation decompose when glucose is present in the surrounding medium. CHAPTER 8 
reports on the use of degradable polyelectrolytes to fabricate polyelectrolyte microcapsules 
and show that after intracellular uptake, such microcapsules become digested by the cells.  
CHAPTER 9 & 10 deal with the fabrication of hybrid gold nanoparticle/polyelectrolyte 
microcapsules. It is proven that such capsules can be decomposed by a variety of 
physicochemical triggers such as a change in pH, IR-laser light and ultrasound energy. 
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ABSTRACT 
 
Polyelectrolyte microcapsules have recently been introduced as new microscopic vehicles 
which could have high potential in the biomedical field. In this chapter we give an introduction 
on the layer-by-layer (LbL) technique which is used to fabricate these polyelectrolyte 
microcapsules as well as on the different triggers that have been exploited to obtain drug 
release from these microcapsules. Furthermore, other delivery systems that use the same 
trigger for drug delivery are compared and critically discussed with regard to their biomedical 
relevance. 
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Chapter 1 
Release Mechanisms for 
Polyelectrolyte Microcapsules 
 
 
INTRODUCTION 
 
The field of drug delivery focuses on the development of suitable carriers for 
therapeutic molecules.1 The recent availability of many biotechnological therapeutics, such 
as peptides, proteins and oligonucleotides has challenged and thus stimulated the advanced 
drug delivery research field as such therapeutics depend on suitable carriers to protect them 
from extracellular enzymes and to deliver them to the target cells. During the past decades a 
large variety of micro- and nanocarriers have been developed to serve this purpose. 
Liposomes were amongst the first nanocarriers studied for the delivery of a large variety of 
both low and high molecular weight therapeutics.2 
 Since the beginning of the nineties controlled radical polymerisation techniques 3, 4 
such as atom transfer radical polymerisation (ATRP) and nitroxide mediated polymerisation 
(NMP) have offered new tools to polymer chemists for the design of well defined polymeric 
architectures 3 such as block copolymer micelles and polymersomes. 5 The latter 
supramolecular structures can be seen as the synthetic analogue of liposomes and have, to 
a certain extent, also been explored for the encapsulation of therapeutics. The major 
advantage of these synthetic structures is that their properties can be tailored by varying their 
chemical composition. This allows the design of vesicles which respond to specific stimuli 
(such as pH, redox-potential, magnetic field etc.) which may trigger them to release their 
content at the desired site and time. However, there are several drawbacks to these vesicles. 
They are not yet commercially available and their fabrication requires complex chemical 
syntheses and purification making them expensive to fabricate and hardly accessible to a 
broad public in the biomedical field  
 A few years ago, a novel type of vesicles, called polyelectrolyte microcapsules, were 
introduced.6, 7 They are fabricated using the Layer-by-Layer (LbL) technique, i.e. the self 
assembly of charged species onto an oppositely charged sacrificial colloidal substrate 
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followed by the dissolution of this substrate. Possible advantages of polyelectrolyte 
microcapsules are the absence of hazardous procedures and the use of simple building 
blocks along with the possibility to introduce a high degree of multifunctionality within their 
shell. The promising expectations of polyelectrolyte microcapsules for biomedical 
applications have evoked a synergetic effect between scientists from different fields such as 
chemists, material scientists, pharmacists, biologists and even theoretical and experimental 
physicists. 
 While other reviews have reported on the physicochemical properties,8, 9 
permeability,10 use as microreactor11  or biofunctionalisation 12 of polyelectrolyte 
microcapsules, this review aims to outline the efforts made towards the development of 
polyelectrolyte microcapsules which are ‘intelligent’ in the sense that they release their 
content as a consequence of external or internal stimuli. We especially tried to find out the 
strengths and weaknesses of intelligent polyelectrolyte microcapsules versus other types of 
stimuli-sensitive delivery systems and try to determine what specific opportunities there are 
for polyelectrolyte microcapsules in the field of drug delivery. The discussion brought in this 
chapter should stimulate scientist from multidisciplinary fields to focus on the development of 
polyelectrolyte microcapsules which could offer a solution to persisting needs in drug 
delivery. 
 
 
THE LAYER-BY-LAYER TECHNIQUE 
 
 The Layer-by-Layer (LbL) technique was introduced in the beginning of the nineties 
by Gero Decher. 13 Originally this technique was based on the sequential adsorption of 
oppositely charged polymers (i.e. polyelectrolytes) on a charged planar substrate. Upon 
adsorption of a polyelectrolyte layer, charge overcompensation takes place, leading to a 
reversal of the surface charge, promoting the adsorption of a next, oppositely charged, 
polyelectrolyte. Figure 1 is a schematic illustration of the LbL process. A charged substrate, 
e.g. a silicon wafer, is immersed into an aqueous solution of an oppositely charged 
polyelectrolyte. After a certain adsorption time the substrate is removed and washed with 
water in order to remove excess polyelectrolyte. In the next step the substrate is immersed 
into the second polyelectrolyte solution which has a charge opposite to the first 
polyelectrolyte. This second polyelectrolyte adsorbs onto the layer of the first polyelectrolyte 
which reverses the surface charge. Again a washing step is performed and the whole 
procedure can be repeated as many times as one desires.  In this way one can easily 
18
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prepare multilayered films with tuneable physico-chemical properties as both the number of 
layers as well as their composition can easily be varied. 
 
 
Figure 1. (A) Schematic representation of the deposition of a polyelectrolyte film on a slide. Steps 1 and 3 
represent the adsorption of respectively a polyanion and polycation, steps 2 and 4 are washing steps. (B) 
Simplified molecular picture of the first two adsorption steps, depicting film deposition starting with a positively 
charged substrate. Counterions are omitted for clarity. The polyion conformation and layer interpenetration are an 
idealization of the surface charge reversal with each adsorption step. (C) Chemical structure of poly(styrene 
sulfonate) (PSS) (left) and poly(allylamine hydrochloride) (PAH) (right), often used polyions to build LbL films. 
  
Several techniques have been used to characterize the multilayer build-up on planar 
surfaces. Amongst them UV-VIS adsorption, 14 quartz crystal microbalance (QCM) 15, 16 and 
ellipsometry 17 are the most widespread and allow one to determine both the mass and 
thickness increment upon adsorption of a single polyelectrolyte layer. The internal structure 
of the polyelectrolyte films (whether it is ordered or rather ‘fuzzy’) can be investigated by X-
ray techniques 18 while their surface morphology can be adequately analyzed by atomic force 
microscopy (AFM). 19  
 Currently, a large number of components, other than charged polymers, have been 
used to build multilayered films. DNA, 20 proteins, 21, 22 nanoparticles, 23 lipids, 24 viruses 25 
etc. have been included in the multilayers yielding to thin films with tailor made properties. 
Besides electrostatic, other interactions such as H-bonds, 26, 27 covalent bonds, 28, 29 
biospecific interactions, 30, 31 stereocomplex formation 32, 33 etc… have also been used in 
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order to accomplish a layer-by-layer build-up. Additionally, pH 34, 35, temperature, 36, 37 
glucose 38 and biotin 39 responsive LbL films have been made by varying the chemical nature 
of the polyelectrolyte film. 
 Most of the applications cited above involve the design of planar films. One of the 
most eye-catching applications of the LbL technology involves polyelectrolyte microcapsules 
fabricated by LbL coating of colloidal templates. 7 The potential use of LbL microcapsules as 
drug carriers has extended LbL research in the field of drug delivery 11,40 The following 
paragraphs give additional information on these microcapsules.  
 
 
POLYELECTROLYTE MICROCAPSULES  
 
Fabrication of polyelectrolyte microcapsules 
  
Polyelectrolyte microcapsules, introduced in 1998, are obtained by LbL coating of a 
colloidal substrate followed by the dissolution of this template as schematically presented in 
Figure 2. 6, 7, 41 For the fabrication of hollow polyelectrolyte microcapsules poly(styrene 
sulfonate) / poly(allylamine hydrochloride) (PSS/PAH) is a very popular polyelectrolyte pair 
as PSS/PAH multilayer films deposited on planar substrates have been well studied. Also, 
the preparation of PSS/PAH microcapsules is reproducible and does not suffer from capsule 
aggregation or capsule decomposition upon removal of the core template, as often observed 
in the case of microcapsules fabricated from biopolymers, having a lower charge density. 
The physicochemical 10 and mechanical 42, 43 properties of PSS/PAH microcapsules have 
been investigated by several groups. Initially hollow polyelectrolyte microcapsules were 
made using organic templates (like polystyrene (PS) or cross-linked melamine formaldehyde 
(MF) microparticles) which were dissolved after deposition of the LbL coating using both 
organic solvents and acidic solutions (0.1 M HCl). However, as discussed below, a main 
issue during the core removal is the integrity of the capsule wall. 44-46 It is known that organic 
solvents create pores in polyelectrolyte multilayers allowing the polystyrene to diffuse 
outwardly from the microcapsules. 47 However, removal of MF-templates is more difficult as it 
has been reported that MF oligomers stay complexed to the capsule wall and/or in the 
capsule interior, even after prolonged incubation in an acidic environment. 44, 45, 48, 49 
Therefore MF microparticles became less frequently used as templates, because MF 
oligomers remaining in the capsule wall lead to a rather undefined structure of the 
polyelectrolyte microcapsules and may also be toxic. Although the removal of a PS-core is 
easier, the fast dissolution of PS in organic solvents creates an osmotic pressure which may 
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destroy the polyelectrolyte shell. 47 To overcome this inconvenience inorganic carbonates, 
such as calcium carbonate (CaCO3), 50-54 manganese carbonate (MnCO3)  and cadmium 
carbonate (CdCO3) 50, 55 have recently been introduced as a template for the fabrication of 
hollow polyelectrolyte microcapsules. These microparticles are easily made by mixing 
calcium chloride and sodium carbonate and become easily dissolved by EDTA (when CaCO3 
is used) or by a low pH (in the case of MnCO3 and CdCO3). The major advantage of 
inorganic templates is the low molecular weight of the ions. Polyelectrolyte shells are, 
generally speaking, known to be permeable to molecules with a molecular weight below 
5 kDa 56 and should therefore not undergo an osmotic stress during the dissolution of the 
inorganic templates. 
  
 
Figure 2. Schematic illustration showing the preparation of ‘hollow’ polyelectrolyte microcapsules. The initial 
steps (a through d) involve stepwise film formation by repeated exposure of the colloids to polyelectrolytes of 
alternating charge. Between each step the excess polyelectrolytes are removed before the next layer is 
deposited. When the desired number of polyelectrolyte layers is obtained the core is decomposed (e) resulting in 
a suspension of ‘hollow’ polyelectrolyte microcapsules (f).  
 
Loading of polyelectrolyte microcapsules 
 
 CaCO3 microparticles (Figure 3) have proved to be excellent sacrificial templates not 
only for the fabrication of hollow polyelectrolyte microcapsules but also for making ‘filled’ 
polyelectrolyte microcapsules since CaCO3 microparticles can be easily loaded with 
macromolecules (e.g. proteins) during 51 or after their preparation. On top, the mild 
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dissolution conditions do not destroy the encapsulated macromolecules. Also silica has been 
used as core for the fabrication of hollow polyelectrolyte microcapsules. 57 58 This approach 
has advantages as monodisperse non-porous silica particles are commercially available 
allowing the preparation of monodisperse polyelectrolyte microcapsules. However, the 
hydrofluoric acid solution, required to dissolve the silica core, requires extreme caution when 
handled. This possibility of encapsulating macromolecules is a great advantage over 
microcapsules made using PS or MF-templates. Indeed, the latter have to be loaded 
afterwards by varying the solvent polarity, 59 salt concentration or pH 60 of the medium in 
order to reversibly create pores to allow the inward diffusion of macromolecules. 
Subsequently the pores are closed by dispersing the microcapsules in their original medium 
as shown in Figure 4. A variation on this route is filling the microcapsules with 
macromolecules followed by a cross-linking of the shell leading to the entrapment of the 
macromolecules. 61 It is very likely that the conditions used to ‘post-load’ polyelectrolyte 
microcapsules will affect the integrity of many therapeutic macromolecules like peptides and 
proteins. The Caruso group recently reported on the fabrication of mesoporous silica 
particles which could easily be filled with proteins in their pores and subsequently used as 
template for the fabrication of protein filled microcapsules. 62 These pre-loading procedures 
should offer the same advantages as in case of coprecipitated CaCO3.   
 
 
Figure 3. SEM images of CaCO3 microparticles: (A) in overview, (B) single particle, and (C) broken particle.  
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Macromolecular drugs or nanoparticles, 6 lipids, 63 dendrimers, 64-66 enzymes, 67 
DNA, 68 and empty viruses 69 can also be incorporated in the polyelectrolyte multilayer wall. 
Finally, polyelectrolyte microcapsules may be loaded with charged molecules by electrostatic 
interactions with an oppositely charged matrix present inside the polyelectrolyte 
microcapsules. 64, 70, 71 Clearly, for this purpose the charged molecules should be able to 
diffuse through the LbL shell. This type of ‘post-loading’ has been used to encapsulate 
negatively charged species in polyelectrolyte microcapsules derived from MF templates, 
through interaction with MF remnants. 48, 49 Positively charged species have been 
encapsulated by using an alginate 71 or PSS 70 matrix inside the microcapsules. 
 
 
Figure 4. Loading of (green) fluorescently labelled urease in ‘hollow’ polyelectrolyte microcapsules.  
 
 
Drug delivery applications of polyelectrolyte microcapsules 
 
 Polyelectrolyte microcapsules may find applications in very distinct fields. They may 
be used as microreactors for the synthesis 11 or separation 72 of materials or they may act as 
sensors. 73-75 For a couple of years there has been serious interest in exploring their potential 
as drug delivery vehicles. 40 In the field of drug delivery there is an urgent need for time and 
space controlled drug delivery systems. Therefore, the LbL technique has recently been 
applied to prepare stimuli responsive polyelectrolyte microcapsules for controlled drug 
delivery.  The following paragraphs review stimuli that have been exploited to induce the 
release from polyelectrolyte microcapsules.  
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pH-responsive polyelectrolyte microcapsules 
 
 Generally speaking, polyelectrolyte microcapsules composed of weak polyelectrolytes 
are responsive to the pH of the environment. PAH, one of the most popular polyelectrolytes 
for the fabrication of hollow polyelectrolyte microcapsules is a weak polyelectrolyte (pKa of 
8.7 in salt free solution). When complexed to PSS the apparent pKa changes to 10.7 as 
described by Petrov et al. 76 When the environmental pH becomes higher (in the case of a 
polybase) or lower (in the case of a polyacid) than the pKa, the polyelectrolytes become 
uncharged, which in turn, disassembles the microcapsules.  
 
 
Figure 5. AFM images of PSS/PAH based polyelectrolyte microcapsules treated with pH 3.5 (left) and pH 12 
(right) buffers before drying. The microcapsules were prepared on MF particles. The porous structure of the 
polyelectrolyte shell treated with the acidic solution is clearly visible.  
 
 Rubner et al. described the influence of pH on the charge density and morphology of 
PAH based planar multilayers. 77 Using AFM they observed that pore formation occurs when 
PAH containing multilayers are placed in an acidic environment, whereas the multilayers 
exhibit a smooth surface at a higher pH. Also, pore formation seemed to be a reversible 
process as the pores disappeared when the pH was increased. Antipov et al. made similar 
observations on PSS/PAH-based polyelectrolyte microcapsules. 78 In Figure 5 one can 
clearly see pores in the polyelectrolyte microcapsules treated with an acidic solution (left 
image), whereas the shell of microcapsules treated with an alkaline solution is intact (right 
image). The pH dependent integrity of the shell makes the permeability of the microcapsules 
to high molecular weight substances also pH dependent. As shown in Figure 6, the 
microcapsules are permeable in the acidic region whereas they are impermeable in the 
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alkaline region. Using this reversible pore formation Sukhorukov et al. filled PSS/PAH 
polyelectrolyte microcapsules with FITC-dextrans: dextrans were allowed to diffuse in the 
microcapsules at low pH while they became entrapped in the microcapsules by increasing 
the pH. 60 
 The pH dependent behaviour of polyelectrolyte microcapsules containing one or two 
weak polyelectrolytes has been also described by Déjugnat et al. 47 for PSS/PAH 
microcapsules and by Mauser et al. 79 for PMA/PAH (PMA: poly(methacrylic acid)) 
microcapsules. Both authors reported swelling of the microcapsules when the pH was shifted 
towards the pKa of one of the polyelectrolytes. PSS/PAH microcapsules started to swell when 
the pH was above 11 and disassembled when the pH was above 12. Concerning PMA/PAH 
microcapsules, swelling, followed by dissolution of the microcapsules, could be observed 
both at low and high pH, thus resulting in a dual pH-responsive behaviour of PMA/PAH 
microcapsules. The permeability of such dual responsive microcapsules was studied by 
Shutava et al. 80 for microcapsules based on tannic acid and PAH: the microcapsules 
seemed impermeable to FITC-dextrans at neutral pH but became permeable at both low and 
high pH. 
 The reversible pH dependent swelling of PSS/PAH microcapsules has been used by 
Déjugnat et al. 81 for the encapsulation of high molecular weight compounds such as 
rhodamine-labelled PSS and FITC-dextrans. By shortly exposing the microcapsules to a pH 
above 11 they swell dramatically and become largely permeable to high molecular weight 
compounds. A rapid lowering of the pH below 11 shrinks the microcapsules, returns them to 
their closed state, which entraps the molecules. Similarly, release of high molecular weight 
compounds can be obtained from the filled microcapsules by transferring them from neutral 
pH to a pH above 11.  
 Pharmaceutical applications of pH-responsive polyelectrolyte microcapsules may be 
the delivery of entrapped drugs at locations with a pH lower than that of serum (i.e. 7.4). A 
lower pH is found for example in the stomach, 82 vagina, 83 extracellular matrix of 
tumours, 84, 85 inflammatory and ischemic regions, intracellular vesicles like endosomes, 
lysosomes and secretory granules.  Importantly, except in the stomach, the pH in these 
tissues and cellular organelles is only slightly lower than 7.4. It will therefore be a challenge 
to design polyelectrolyte microcapsules that are stable in the blood but release their payload 
at a pH of e.g. ~6.8. None of the present pH-responsive polyelectrolyte microcapsules fulfil 
this requirement. This is in contrast with the well studied pH-responsive microgels, 86-92 
fabricated from weakly acidic or basic polymers, which swell at lower pH and release 
encapsulated molecules. Other hydrogels, like the commercially available pH-sensitive SQZ 
GelTM (Macromed Inc, USA), shrink upon lowering the pH and squeeze out the drug 
molecules. 93 The pH at which these hydrogels start to swell or shrink has been fine-tuned to 
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physiologically relevant pH’s by playing around with the hydrophobicity of the hydrogel. 94, 95 
Apart from microgels that show a pH dependent swelling,  also microgels 96-99 and liposomes 
100, 101 which start to degrade or to dissolve at a pH lower than 7.4 have been proposed as a 
pH sensitive delivery system. Most of the pH-responsive hydrogels are prepared by radical 
crosslinking of derivatives of polyacrylamide, vinylpyridine, 102 vinyl imidazole 103 and amino 
acids. 93 This is a major drawback as the radical crosslinking may affect the integrity of the 
encapsulated drugs like proteins or DNA. Therefore, physically cross-linked pH sensitive 
hydrogels have been recently described. 104, 105 Besides pH sensitive microgels and 
liposomes, pH responsive polymeric micelles have also gained attention as an extra- or 
intracellular drug delivery system, especially in the treatment of cancer. 106-108 Excellent 
reviews on pH-sensitive micelles have been recently published. 109, 110 Important to note is 
that intracellular drug delivery by pH sensitive polyelectrolyte microcapsules will probably be 
limited to phagocytes and cancerous cells as mostly those cells are able to internalize 
micrometer-sized particles, being the size range of most polyelectrolyte microcapsules 
studied today. 
 
 
Figure 6. Open (a, c) at pH 3.5 and closed (b, d) at pH 10 states of polyelectrolyte shells prepared on MF 
particles (a, b) and CdCO3 crystals (c, d).  
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Figure 7. Confocal microscopy images showing microcapsules consisting of 8 layers PSS/PAH (a) being 
impermeable to fluorescently labelled PAH (Mw~70kDa) in the absence of salt, (b) being impermeable to 
fluorescently labelled PAH in the presence of 10-2 M NaCl, (c) coloured with rhodamine 6G and (d) filled with 
fluorescently labelled PAH after removal of the excess PAH following a washing/centrifugation step of the 
microcapsules in image (b).  
 
 
Salt responsive polyelectrolyte microcapsules 
 
 The first report on polyelectrolyte microcapsules decomposable by salts was made by 
Caruso et al. 68 They fabricated polyelectrolyte microcapsules using DNA/spermidine. It is 
known that DNA-spermidine interactions are reduced at higher ionic strength.  When the 
DNA/spermidine microcapsules were immersed in a solution containing 5 M of salt, the 
multilayers completely dissolved leading to the destruction of the microcapsules. Ibarz et al. 
reported that the permeability of hollow PSS/PAH polyelectrolyte microcapsules, templated 
on MF cores, for high molecular weight compounds, sharply improved when the salt 
concentration exceeded 10-2 M. The higher permeability was not due to the formation of 
pores, 111 this is in contrast to the pH induced pore formation in PSS/PAH microcapsules as 
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reported above. Föster resonance energy transfer between rhodamine and fluorescein 
labelled PAH revealed structural changes within the polyelectrolyte multilayers. A sharp 
decrease in FRET (indicating a longer distance between the polyelectrolyte layers) was 
observed around a 10-2 M salt concentration, which does correspond with the higher 
permeability of the capsule wall. The salt induced permeability of the microcapsules was 
explained by a shielding of the charges on the polyelectrolytes that lowers the interactions 
between the oppositely charged polyelectrolytes and facilitates the diffusion of 
macromolecular substances through the multilayers. 
 The reversible switching of the permeability of polyelectrolyte microcapsules through 
variation of the salt concentration has also been used to encapsulate high molecular weight 
compounds. 111 (Figure 7) At higher salt concentration the PSS/PAH capsule are open to 
macromolecules with a molecular weight of up to 70 kDa while at lower salt concentration the 
wall closes. Antipov et al. reported similar findings on PSS/PAH microcapsules fabricated on 
inorganic CdCO3 crystals as sacrificial template. 78  
Although some salt responsive drug delivery systems have been proposed, 112-115 salt 
responsive polyelectrolyte microcapsules will probably have no application in drug delivery 
as ionic strength variations in the human body do not exist. However, the intra- versus 
extracellular concentration of a number of ions differs significantly. For example, the 
concentration of sodium, calcium and potassium inside cells (respectively ~11 mM, ~230 nM, 
~115 mM) is significantly different from the concentration in serum (respectively ~140 mM, 
~2mM, ~4.5 mM). 116-118 Additionally, the intracellular concentration of calcium significantly 
varies from cell organelle to cell organelle, with the highest calcium concentrations in the 
mitochondria and sarcoplasmic reticulum. Microgels that swell/shrink upon sensing a specific 
ion may be suitable to deliver drugs in the cytosol or in certain cell organelles. As an 
example, polyacrylate hydrogels were described by Horkay et al. 119, 120 which significantly 
swell when the calcium concentration in the environment becomes lower than 1 mM (note 
that the intracellular concentration is ~230 nM). Also, diseases exist which are characterized 
by a non-physiological plasma concentration of one or more ions. For example, a low 
calcium concentration in serum has been exploited as a trigger for the delivery of oestradiol 
in the treatment of osteoporosis. 121 However, the relevance of this system is limited as it is 
well-known that osteoporosis is not always characterized by low calcium levels in the serum. 
 
Light-responsive microcapsules 
 
 The first report on optically sensitive polyelectrolyte microcapsules was made by Tao 
et al. 122 They reported on the use of the azo dye Congo red as a constituent of 
polyelectrolyte multilayers. Irradiation of such polyelectrolyte microcapsules with visible light 
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(for 120 min) slightly distorted the polyelectrolyte multilayers, enhancing their permeability for 
fluorescently labelled dextrans with a molecular weight of up to 464 kDa. Both the long 
irradiation time and the use of visible light (which does not sufficiently penetrate the skin) 
limit, however, the in vivo use of light responsive polyelectrolyte microcapsules for drug 
delivery. 
 
 
Figure 8. Confocal microscope images demonstrating remote release of encapsulated rhodamine-labelled PSS 
polymers from a polyelectrolyte multilayer capsule containing gold sulphide core/gold shell nanoparticles in its 
walls. Fluorescence intensity profiles along the line through the capsule show that it is filled with fluorescent 
polymers before (a) and empty after (b) laser illumination. After the release of encapsulated polymers, the leftover 
fluorescent intensity is observed only in the walls of the capsule, (b). Insets show black and white transmission 
microscope images of the same capsule. Incident intensity of laser diode operating at 830 nm was set at 50 mW. 
 
 Near infrared (IR) laser light is interesting for drug delivery applications as most 
tissues show negligible adsorption in the 800-1200 nm region, making IR-laser light attractive 
for inducing structural changes in drug containing microcapsules injected in tissues located 
at the surface of the body. IR-light sensitive polyelectrolyte microcapsules have been 
fabricated by incorporating gold nanoparticles in their PSS/PAH polyelectrolyte shell. 123-125 
Upon irradiation with IR-light (short pulses of < 10 ns) the gold nanoparticles absorb the 
energy and transform it into heat, which locally disturbs the integrity of the polyelectrolyte 
microcapsules. The Caruso group was the first to demonstrate the release of encapsulated 
biomacromolecules upon IR irradiation of polyelectrolyte microcapsules functionalised with 
gold nanopartciles. 124 Also Skirtach et al. reported recently on near IR sensitive 
polyelectrolyte microcapsules. 125, 126 Figure 8a shows confocal and transmission images of a 
PSS/PAH capsule, doped with gold nanoparticles, which is filled with rhodamine-labelled 
PSS. Upon irradiation with IR-laser light (Figure 8b) the capsule breaks open, as can be 
seen from the strongly deformed structure, leading to the release of the encapsulated 
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material. Figure 9 shows SEM images of microcapsules (a) before irradiation, (b) after 
irradiation at moderate intensity and (c) after irradiation at high intensity. They clearly 
demonstrate the drastic impact of IR-light on the morphology of the microcapsules.  
 
 
Figure 9. Irradiation of the microcapsules with multiple laser pulses. SEM images of the microcapsules: a) before 
irradiation; b) after moderate radiant exposure (30 mJ/cm²); and c) after radiant exposure of 50 mJ/cm² and 
higher. The insets are the corresponding TEM images. 
 
‘Photo-controlled’ release of drugs remains an attractive approach as it should allow 
controlling the delivery in time and space. Therefore, IR-sensitive polyelectrolyte 
microcapsules may be useful for controlled drug release, because after subcutaneous 
injection the release of encapsulated material may be triggered by local irradiation of the skin 
with IR-light. Besides IR-sensitive polyelectrolyte microcapsules, also photo-sensitive 
liposomes and photo-sensitive polymer micelles are under development. 127, 128 Light-
triggered release of drugs from liposomes is due to a light induced destabilization of the lipid 
bilayer that can occur via (1) light sensitized production of reactive species (such as singlet 
oxygen) that cause fragmentation of the lipids in the liposomes, 129, 130 (2) photo-
polymerization 131 or (3) photo-isomerization of the lipids. 132 Additionally, local heating upon 
30
CHAPTER 1 – RELEASE MECHANISMS FOR POLYELECTROLYTE MICROCAPSULES 
  
irradiation of gold nanoparticles incorporated in the liposomes may also induce drug 
release. 133, 134 In case of polymer micelles the release is due to a photo-chemical reaction 
that alters the hydrophobicity of the micelle-forming polymers, leading to the release of 
encapsulated material. 135, 136 However, most of the photo-sensitive liposomes and micelles 
are responsive to the shorter wavelengths which limits their application in vivo. Indeed, UV-
light may damage cells and shows a limited penetration depth (<0.5 mm) in tissues. 
Therefore, we believe that research on light-sensitive delivery systems should focus on IR-
light sensitive systems because IR-light is less harmful and has a much deeper penetration 
depth in tissues (e.g. 8 mm in the liver at a wavelength of 1070 nm). 137  
 
Magnetic field responsive microcapsules 
 
 Lu et al. reported on hollow PSS/PAH-based microcapsules (using MnCO3 as 
sacrificial template) which are addressable by a magnetic field due to the incorporation of 
one layer of positively charged gold coated cobalt nanoparticles (Co@Au) into the 
polyelectrolyte shell of the microcapsules. 138 Microcapsules with a rather thick wall 
(approximately 250 nm) were observed by AFM. The thick walls are probably due to the 
aggregation of Co@Au nanoparticles. Upon applying an oscillating magnetic field, the 
ferromagnetic Co@Au nanoparticles twist, which disturbs the structure of the polyelectrolyte 
multilayers and, consequently, allows the diffusion of macromolecules through the capsule 
wall (Figure 10). Furthermore it was shown that only microcapsules having one layer of 
Co@Au nanoparticles could switch their permeability upon application of a magnetic field, 
whereas microcapsules having multiple Co@Au nanoparticles layers remained impermeable 
upon applying a magnetic field. The magnetically induced permeability could be of interest 
for drug loading and release from polyelectrolyte microcapsules . However, one should note 
that the long exposure time (30 min) and strong magnetic field (1200 Oe, 150 Hz) required to 
permeabilize the Co@Au microcapsules described above led to a 30°C increase in 
temperature of the capsule suspension which is, highly likely, problematic for the loading of 
thermosensitive drugs (like e.g. proteins) in the microcapsules. Clearly, magnetically induced 
drug release from microcapsules injected in the body would be also problematic. 
Some other magnetic-responsive delivery systems have been reported as well. The 
group of Langer et al. embedded magnetic beads together with insulin in a 
ethylenevinylacetate copolymer matrix and demonstrated, after implantation of the matrix in 
diabetic rats, that the blood glucose levels drastically decreased each time an external 
oscillating magnetic field was applied. 139, 140 Couvreur et al. made alginate spheres 
containing insulin and ferrite microparticles and showed a 50-fold increase in insulin release 
in the presence of an oscillating magnetic field. 141 It was believed that the vibrating magnetic 
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particles induced openings in the polymer matrix facilitating the release of insulin. Currently 
there is a renewed interest in magnetically controlled drug delivery systems. Babincova et al. 
developed doxorubicin loaded magnetoliposomes which are first targeted into tumours by a 
static magnetic field and, consequently, massively release the doxorubicin upon application 
of an oscillating magnetic field. 142 The release occurs due to a local increase in temperature 
(up to 42°C) which ‘melts’ the liposomes. 
 
 
Figure 10.  Assembly and magnetically permeabilization of the polyelectrolyte microcapsules by oscillating 
magnetic field (1200 Oe, 150 Hz) for 30 min. The molecular weight of the FITC-dextran was 2000 kDa. 
 
 
Glucose-responsive polyelectrolyte microcapsules 
 
 Glucose responsive microcapsules, encapsulating insulin, could be promising for the 
treatment of diabetes mellitus patients as the insulin would only be released when the 
glucose concentration in the blood exceeds a physiological value. 
 Mc Shane et al. fabricated polyelectrolyte microcapsules containing glucose oxidase 
within the multilayers. 74 They expected the microcapsules to be glucose sensitive because 
the glucuronic acid, occurring from the oxidation of glucose by the immobilized glucose 
oxidase, would drop the pH at the surface of the microcapsules and hence modify its 
permeability. However, glucose did not disassemble the microcapsules, nor did the authors 
report on any possible change in permeability of the microcapsules. Other glucose-sensitive 
delivery systems for insulin have been described. Indeed, pH-sensitive hydrogels loaded with 
insulin, glucose oxidase and catalase have been well-studied. In these hydrogels glucose 
oxidase also generates glucuronic acid when glucose enters the hydrogels. This lowers the 
pH which  swells 143 or shrinks 144 the hydrogel and which leads to the release of insulin. The 
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function of catalase in these hydrogels is to convert the aggressive hydrogen peroxide, 
occurring from the enzymatic conversion of glucose, to oxygen and water. Unfortunately 
these systems have important shortcomings. Firstly, they lack a reproducible and rapid 
response on a long-term basis. Secondly, these hydrogels are often neither biocompatible 
nor biodegradable. Also, many of the reported systems are only glucose-responsive at very 
high (4 to 36 mg/ml) 145 (clinically irrelevant) glucose concentrations. Indeed, in a healthy 
person the blood glucose concentration is around 1 mg/ml, whereas glucose levels above 
2 mg/ml are already common in diabetic patients. Therefore, glucose-responsive delivery 
systems should ideally start to release insulin as soon as the glucose level reaches about 
2 mg/ml.  
 
Degradable polyelectrolyte microcapsules 
  
For many biomedical applications, especially for drug delivery, biodegradable 
polyelectrolyte microcapsules would be preferred to non-degradable ones. Several reports 
on degradable LbL films deposited on planar substrates have been published. Lynn et al. 
reported on degradable polycations (poly-β-aminoesters) 98 to make LbL films for the 
controlled release of small drug molecules 146 and DNA. 147 Serizawa et al. 148 and Picart et 
al. 149 reported on enzymatically degradable polysaccharide-based polyelectrolyte films, 
which seemed to be degradable in the mouths of rats. Biodegradable polyelectrolyte films 
could be of interest for the surface modification of implants by rendering them more 
biocompatible or by making them drug eluting by the incorporation of drug molecules within 
the multilayers.  
 The first paper on degradable polyelectrolyte microcapsules was published by 
Mohwald et al. 150 Polyelectrolyte microcapsules were covered with a lipid bilayer rendering 
them impermeable to low molecular weight compounds such as carboxyfluorescein. When 
phospholipase A2 was added, the lipid bilayer degraded resulting in the formation of pores 
rendering the microcapsules permeable to carboxyfluorescein. Several papers reported on 
the use of biopolymers such as polypeptides, 151 polysaccharides 152 and DNA. 153 Although 
the authors did not report on the degradation of these microcapsules, highly likely they will 
degrade  in vivo .  
 
Redox responsive microcapsules 
 
 It is well-known that the colon and the cytosol of cells have a more reducing 
environment compared to other locations in the body. This has been exploited for colon 
33
CHAPTER 1 – RELEASE MECHANISMS FOR POLYELECTROLYTE MICROCAPSULES 
  
specific delivery of drugs using hydrogels that contain azo-bounds which are reductive-
sensitive. 154 Also redox-sensitive polymers containing a disulfide linkage in their backbone 
have been synthesized. 155 The high redox-potential inside cells has recently been used as a 
trigger to enhance the intracellular release of plasmid DNA, antisense oligonucleotides, or 
small interfering (si) RNAs from pharmaceutical carriers containing disulfide linkages. 156  
 Polyelectrolyte microcapsules that are redox-sensitive have recently been reported by 
Haynie et al. They were fabricated from anionic and cationic polypeptides containing cysteine 
groups. 151 Upon cross-linking of the cysteine’s thiol groups (leading to disulfide bonds) 
microcapsules were found to be stable at both neutral and acidic pH. However, after 
reducing the disulfide bonds, the microcapsules disassembled at a pH lower than the pKa of 
the anionic polypeptides as the multilayers were then no longer stabilized by electrostatic or 
covalent bonds. Although a redox triggered deconstruction of polyelectrolyte microcapsules 
is highly suitable for in vivo applications, the system reported by the Haynie groups requires 
an acidic pH to disassemble the microcapsules. At pH 7.4 the microcapsules will remain 
stabilized through the electrostatic interactions between the cationic and anionic polypeptides 
as both are charged.  
 The Caruso group recently fabricated microcapsules with a shell composed of 
multiple layers of thiol-modified polymers, bound to each other through hydrogen bonds and 
which can be cross-linked via disulfide bridges. 157 As described in the introduction of this 
chapter it is possible to make multilayers based on interactions other than electrostatic 
interactions. Hydrogen-bound multilayers deposited on flat substrates have been well-
studied. However, polyelectrolyte microcapsules fabricated from hydrogen-bound multilayers 
are less investigated. The attractiveness of hydrogen-bound multilayers lies in the fact that 
some of them can be deconstructed under physiological conditions. For example hydrogen-
bound multilayers containing poly(methacrylic acid) (PMA) as a proton donor are fabricated 
at low pH in order to have the PMA in its uncharged form, whereas at pH 7.4 the PMA 
becomes charged and repulsion between the PMA chains will occur, disassembling the 
multilayer film. Multilayered microcapsules based on hydrogen bond interactions between 
PMA and poly(vinylpyrrolidone) (PVPON) were fabricated on protein filled mesoporous silica 
(note that silica can be dissolved in a hydrogen fluoride (HF) solution). 157 Cross-linking 
through disulfide bonding was accomplished using PMA functionalized with cysteinamine 
moieties. Microcapsules cross-linked through disulfide bonds were found to be stable under 
physiological conditions. However, when the disulfide bonds were reduced, the 
microcapsules disassembled readily and released their content.  
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CONCLUSIONS AND OUTLOOK  
 
 Drug delivery systems that can release their payload in response to internal or 
external triggers may offer great advantages. The potential of the LbL technique to make 
(bio)responsive drug delivery systems has recently been discovered. We have reviewed 
such (bio)responsive polyelectrolyte microcapsules  and  compared them with  other types of 
(bio) responsive drug delivery systems which are under development.  
 In our opinion, currently only the IR-sensitive and the biodegradable polyelectrolyte 
microcapsules seem realistic for in vivo drug delivery. Unfortunately, detailed in vivo data on 
such microcapsules are lacking. Indeed, most of the so far studied polyelectrolyte 
microcapsules only respond to extreme stimuli that do not occur or cannot be applied in vivo. 
One should realize that the physiological processes during which release of drugs from the 
polyelectrolyte microcapsules should occur create only subtle physicochemical changes in 
the human body. Consequently, polyelectrolyte microcapsules which are sensitive to such 
subtle changes are required. A clear challenge is to synthesize polyelectrolytes that allow the 
design of polyelectrolyte microcapsules sensitive to small (and physiologically) relevant 
changes of pH, salt concentration, glucose concentration and redox potential. For example, it 
would be of interest to build polyelectrolyte microcapsules which could escape from 
endosomes at the time acidification starts in the endosomes. Subsequently they should 
release their payload in the cytosol or nucleus in response to the high reductive environment 
of the cytosol or in response to nucleus specific enzymes.   
 Another important issue in capsule science is promoting cellular uptake, specific 
targeting or just avoiding uptake or adsorption on the microcapsules. It is well known that 
aspecific adsorption to particles for intravenous injection should be avoided in order to avoid 
the formation of large aggregates or to avoid uptake by fagocyting cells from the immune 
system. The issue of biofunctionalisation has been addressed by several groups. Shielding 
of polyelectrolyte microcapsules from non-specific adsorption has been performed by 
pegylation of the capsule surface using a polyelectrolyte grafted with polyethylene glycol 
(PEG) side chains. 158 Targeting of microcapsules using an external magnetic field to 
concentrate the microcapsules at a certain location has been demonstrated by Zebli et al. 
using microcapsules functionalised with magnetic particles. 159 The Donath group has 
provided microcapsules with virus functionalities by incorporating rubella like particles in the 
polyelectrolyte shell. 69, 160 Such microcapsules could hold promise to enhance endosomal 
uptake/escape or promote the delivery of encapsulated material to the cell nucleus. Lipid 
coating of microcapsules was first demonstrated by Moya et al. 63 Recently the Caruso group 
coupled antibodies to microcapsules covered with lipid bilayers and showed that those 
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antibodies could bind the secondary antibodies. 12 This approach is promising towards the 
selective uptake of microcapsules by specific cell types. 
 Until now the pharmaceutical technological   aspects of polyelectrolyte microcapsules 
have not thoroughly been studied. Capsule formulations, stable for extended periods, should 
be developed using freeze-drying or other conservation techniques. With respect to clinical 
applications, sterilisation and up scaling will become important issues. Finally, the 
toxicological and immunological aspects of the microcapsules should be explored into detail. 
This issue has briefly been addressed in one paper indicating no significant effect on cell 
viability at low capsule concentration. 161 It remains however important to further concentrate 
on this topic and to evaluate the toxicity of the microcapsules in vivo. 
 Clearly, polyelectrolyte microcapsules are an intriguing new type of vesicle which may 
offer potential for biomedical applications. Also, the science of layer-by-layer assembly is 
gaining interest from scientists in a broad field which is a very interesting evolution. This 
multidisciplinary approach is the prerequisite to find effective applications for polyelectrolyte 
microcapsules. It is very important that people with different backgrounds combine their 
efforts in order to come up with new applications for these microcapsules in medicine. 
Finally, keeping in mind that other concepts and devices do exist, the major challenge for 
polyelectrolyte microcapsules research is also to determine precisely for which applications 
they offer distinct advantages, compared to other vesicles.  
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ABSTRACT 
 
In this chapter we describe the design of self-exploding microcapsules by layer-by-
layer (LbL) coating of degradable dextran-hydroxyethyl methacrylate (dex-HEMA) microgels 
with the polyelectrolytes poly(allylamine hydrochloride) (PAH) and sodium 
polystyrenesulfonate (PSS). When the microgel core degrades, the swelling pressure 
increases and at a critical value of the swelling pressure the surrounding membrane will 
suddenly rupture. This type of microcapsules could be very promising for pulsed drug 
delivery. 
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SELF-EXPLODING  
MICROCAPSULES 
 
 
INTRODUCTION 
 
Pharmaceutical research strives to design systems that deliver drugs according to 
therapeutic needs. For example, to avoid multiple dosing, scientists have designed controlled 
drug delivery tablets, pumps, implants, and patches that provide a continuous drug release 
over a prolonged period of time. However, there are many applications in medicine where a 
non-uniform release profile could be more beneficial. 1-4 For example, for bioactive agents 
such as hormones, many have suggested that pulsed release may offer advantages over 
continuous release. 5-7 A pulsed release pattern could also be advantageous for drugs that 
develop biological tolerance when they are constantly present at their target site. 
Additionally, a device that could release an initial dose and a booster dose of a vaccine at 
different times after a single injection (‘single-shot vaccination’) would be promising as it 
would reduce the number of injections required to generate immunity. 8 
To achieve pulsed delivery we try to design ‘self-exploding microcapsules’. As 
Figure 1 shows, we envision (bio)degradable microgels surrounded by a membrane that is 
permeable to water but impermeable to both the microgels’ degradation products and the 
entrapped drugs. As the microgels degrade their swelling pressure will increase which should 
rupture the membrane. Rupture is followed by a sudden release of the entrapped drug. The 
release time of the drug will therefore be governed by the degradation kinetics of the 
microgels, as this will determine the increase in swelling pressure and thus the time of 
explosion of the microcapsules. This chapter aims to investigate whether we can 
experimentally achieve such self-exploding microcapsules. Microcapsules which rupture 
upon applying an external trigger such as an electric field, 9, 10 IR light, 11-15 pH 16, 17  etc, have 
been reported before. However, the requirement of an external trigger greatly limits the in 
vivo applicability. To the best of our knowledge self-exploding microcapsules, in which an 
internal mechanism governs the explosion, have never been reported.  
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Figure 1. Schematic representation of self-exploding microcapsules. (I) Before degradation the polymer chains 
in the microgels are connected in a three-dimensional network by chemical cross-links (). The yellow discs 
represent the encapsulated drugs. The microgels are surrounded by a polyelectrolyte membrane. (II) The 
microgels degrade by hydrolysis of the cross-linkers. As degradation proceeds, the cross-link density decreases 
and free polymer chains occur. (III) At the end of the degradation process, the core of the microcapsules has 
become a polymer solution and the corresponding swelling pressure causes the membrane to rupture. 
 
 
MATERIALS AND METHODS 
  
Materials.  
 
 1,1’-carbonyldiimidazole (CDI), 2-hydroxyethyl methacrylate (HEMA), N,N,N’,N’-
tetramethylenediamine (TEMED), 4-N,N-dimethylaminopyridyne (DMAP), dimethyl sulfoxide 
(DMSO), magnesium sulfate (MgSO4), hydroquinone monomethyl ether, dimethyl aminoethyl 
methacrylate (DMAEMA), tetramethyl rhodamine B isothiocyanate (TRITC), PSS (Mw~70 
kDa),  PAH (Mw~70 kDa), dextran (Mw~19 kDa) and FD (Mw~4kDa, 20 kDa and 150 kDa) 
were purchased from Sigma-Aldrich-Fluka. Dichloromethane (CH2Cl2), Potassium 
peroxodisulfate (KPS) and polyethylene glycol (PEG; Mw~20 kDa) were purchased from 
Merck. Dextran (Mw~19 kDa) was obtained from Fluka. TRITC labeled PAH was prepared as 
reported in literature. 18 
 
Synthesis of dex-HEMA 
  
 Dex-HEMA with a degree of substitution (DS; the number of HEMA groups per 100 
glucopyranose units in dextran) of 2.5 was synthesized in a two step reaction according to 
literature. 19, 20 The reaction scheme is shown in Figure 2. Flasks, stoppers, stirring bars and 
dextran were dried overnight under vacuum at 40 °C. In a the first step, CDI (2.43 g; 
15 mmol) was dissolved in 25 ml CH2Cl2 and stirred under a nitrogen atmosphere. HEMA 
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(1.3 g; 10 mmol) was added drop wise and stirred for 1 h under a nitrogen atmosphere. The 
CH2Cl2 phase is extracted twice with water and MgSO4 is added to dry the CH2Cl2 phase. 
The MgSO4 is filtered and a spatula tip hydroquinone monomethyl ether is added to prevent 
spontaneous polymerisation. The CH2Cl2 is evaporated yielding carbonylimidazole activated 
HEMA (HEMA-CI). The purity of the HEMA-CI is investigated by 1H-NMR in CDCl3.  
 In the second step, dextran (50 g) and DMAP (10 g) are dissolved in 500 ml DMSO 
and stirred until completely dissolved. HEMA-CI was added to the reaction mixture taking 
into account the purity of the HEMA-CI and conversion efficiency of the reaction as 
previously reported. 19, 20 The reaction mixture is stirred for 4 days at room temperature under 
a nitrogen atmosphere and subsequently put in dialysis bags with an Mw cut-off of 14 kDa. 
After 5 days of dialysis against pure water the solution is freeze dried and dex-HEMA is 
obtained as a white fluffy product. The DS of the dex-HEMA is determined by 1H-NMR in 
D2O. 
 
 
Figure 2. Reaction scheme for the synthesis of dex-HEMA. 
 
Preparation of dex-HEMA-DMAEMA microgels.  
 
 Dex-HEMA-DMAEMA microgels with initial water content of 70% (w/w) were 
prepared according to Franssen et al. 21 In detail, 71 mg dex-HEMA, 20 µl FITC-dextran 
solution (50 mg/ml) and 35 µl DMAEMA were dissolved in 1.577 ml water and subsequently 
emulsified with a 3.35 ml 24 % (v/v) aqueous PEG solution. Radical polymerisation of the 
aqueous dex-HEMA emulsion droplets was initiated by adding TEMED (100 µl pH 
neutralized with 4 N HCl) and KPS (9 mg). The reaction was carried out at room temperature 
for 1h. Afterwards the obtained microgels were washed three times with pure water to 
remove PEG, KPS and TEMED. Finally the microgels were suspended in 5 ml and stored 
at -20 °C. 
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LbL coating of the dex-HEMA microgels.  
 
 500 µl (15 mg/ml) microgels were dispersed in 1 ml polyelectrolyte solution (2 mg/ml 
in 0.5 M NaCl) and shaken for 15 min. The excess polyelectrolyte was removed by 2 
centrifugation steps. This procedure was repeated until 3 polyelectrolyte bilayers were 
obtained. 
 
Confocal laser scanning microscopy (CLSM).  
 
 CLSM experiments were performed using a MRC1024 Bio-Rad scanning system 
equipped with a 60x water immersion objective. Permeability experiments were performed in 
96 well plates by mixing a 50 µl FD (1 mg/ml) solution with 50 µl microgel dispersion, both in 
0.1 M carbonate buffer at pH 9 or in a 0.1 M phosphate buffer at pH 7. FRAP experiments 
were performed by bleaching a circular region inside the microcapsules. The fluorescence 
recovery was quantified by calculating the ratio of the fluorescence intensity of the recovering 
region to the fluorescence intensity of a non-bleached region in the same capsule. 
 
 
Figure 3. Reaction mechanisms for the hydrolysis and polymerisation of dex-HEMA.  
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RESULTS AND DISCUSSION 
 
Dex-HEMA was synthesized as reported in literature by a two step reaction. In a first 
step HEMA was activated by reaction with carbonyldiimidazole. Secondly the activated 
HEMA was conjugated to dextran yielding dex-HEMA, bearing methacrylate groups 
connected  to the dextran backbone by a carbonate ester bond. Biodegradable dextran 
based microgels, with an average diameter of 7 µm, were prepared from dextran-
hydroxyethyl methacrylate (dex-HEMA) as described by the Hennink group. 7 Radical 
polymerisation was performed at ambient conditions using the KPS/TEMED initiator/catalyst 
system. Figure 3 shows the reaction mechanism of the dex-HEMA polymerisation. The 
obtained three dimensional structure is schematically represented in Figure 4. Because the 
methacrylate groups are connected to the dextran backbone by a carbonate ester, the 
degradation of the microgels occurs by hydrolysis of the cross-links, yielding both the original 
dextran chains and HEMA oligomers as degradation products. 19, 20 The reaction mechanism 
of the hydrolysis of the carbonate ester in dex-HEMA is shown in Figure 3. The degradation 
of dex-HEMA gels can be tailored from days to months by changing the cross-link density 19, 
20 To obtain positively charged microgels we copolymerized dex-HEMA with dimethyl 
aminoethyl methacrylate (DMAEMA; pKa 8.3). 22 These microgels are hereafter referred to as 
dex-HEMA-DMAEMA microgels.  
 
 
Figure 4. Schematic representation of the polymerization of dex-HEMA (step A), leading to the formation of intra- 
and intermolecular cross-links which form the three dimensional hydrogel network, and (step B) the hydrolysis of 
the dex-HEMA hydrogels leading to the formation of dextran chains and oligomethacrylates as degradation 
products. 
 
The dex-HEMA-DMAEMA microgels were coated with polyelectrolytes using the 
Layer-by-Layer (LbL) technology. 23-25 Briefly, this technique is based on the sequential 
adsorption of oppositely charged polyelectrolytes on a charged substrate. The major 
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advantage of this technique is that the properties of the obtained membrane can be created 
to within nanometers. To the best of our knowledge LbL coating of micron sized hydrogel 
particles has not been reported yet. Sodium polystyrenesulfonate (PSS) (Figure 5C) served 
as polyanion while polyallylamine hydrochloride (PAH) (Figure 5B) served as polycation. 
This polyelectrolyte pair has been thoroughly studied and has proved to be ideally suited to 
coat colloids. 26-28 The adsorption procedure was monitored by measuring the electrophoretic 
mobility after each adsorption step. The initial ζ-potential of the dex-HEMA-DMAEMA 
microgels was +29 mV and oscillated steadily between -50 mV and +50 mV upon alternating 
adsorption of PSS and PAH, well in agreement with published data on PSS/PAH coating of 
other types of particles. 28 To visualize the coating, rhodamine-labeled PAH (PAHTRITC) was 
used. Figure 5A shows a confocal laser scanning microscopy (CLSM) image of (PSS/PAH)3-
coated dex-HEMA-DMAEMA microgels; a clear fluorescent ring can be observed, which 
indicates the formation of a polyelectrolyte membrane surrounding the microgels.  
 
 
Figure 5. (A) CLSM image of (PSS/PAH)3-coated dex-HEMA-DMAEMA-microgels. PAH was fluorescently 
labeled with TRITC. Molecular structure of poly(allylamine hydrochloride) (B) and poly(styrene sulfonate) (C), 
both in their charged form. 
 
As outlined above, to obtain self-exploding microcapsules the membrane should be 
impermeable to the degradation products of the microgels. As the microgels degrade by 
hydrolysis of the HEMA-crosslinks, the major degradation product is dextran (being the 
chains used to synthesize the dex-HEMA which had an average molecular weight of 19 
kDa). By CSLM we investigated the permeability of the (PSS/PAH)3 coating to FITC-dextrans 
(FD) of various molecular weights (4 kDa and 20 kDa) at respectively pH 7 and 9. Uncoated 
and (PSS/PAH)3-coated dex-HEMA-DMAEMA microgels were immersed in FD-solutions. 
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Chart 1 shows that the uncoated dex-HEMA-DMAEMA microgels were permeable to both FD 
4 kDa and 20 kDa, independent of the pH. The permeability of the (PSS/PAH)3-coated dex-
HEMA-DMAEMA microgels was however pH dependent: at pH 7 the coated microgels were 
permeable to both 4 kDa and 20 kDa FD’s while at pH 9 they were impermeable. Similar 
findings on the pH dependent permeability of (PSS/PAH)3 coatings were reported by Antipov 
et al. 29 These permeability observations allowed us to suggest that at pH 9 the 
polyelectrolyte membrane should be impermeable to the degradation products of the 
microgels, being dextrans chains of 19 kDa. This should allow a build-up of the osmotic 
pressure upon degradation of the gel in the microcapsules. To the contrary, at pH 7 the 
(PSS/PAH)3 coating is expected to be permeable to the degradation products and, 
consequently, a rise in osmotic pressure is not expected. 
 
Chart 1. Permeability of uncoated and (PSS/PAH)3-coated dex-HEMA-DMAEMA microgels to FD’s. Images A 
and B illustrate the (PSS/PAH)3-coated microgels immersed in a 20kDa FD solution at pH 7 (A) and pH9 (B). 
 
 
To verify this we studied the behavior of uncoated and (PSS/PAH)3-coated dex-
HEMA-DMAEMA microgels during degradation. Both microgel types were incubated at 37 °C 
at pH 7 as well as pH 9. Microscopy experiments on uncoated microgels revealed that at pH 
7 the microgels were completely degraded after 5 days while at pH 9, they were completely 
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degraded in one day, due to accelerated hydrolysis at an alkaline pH. Figure 6A shows a 
CSLM image of (PSS/PAH)3-coated dex-HEMA-DMAEMA microgels 5 days after 
degradation at pH 7. To prove that at pH 7 degradation of the microgels had indeed occurred 
we studied the mobility of encapsulated 150 kDa FD by fluorescence recovery after 
photobleaching (FRAP) before and after incubating the (PSS/PAH)3-coated dex-HEMA-
 
Figure 6. (A) CLSM image of (PSS/PAH)3-coated dex-HEMA-DMAEMA microgels 5 days after degradation at 
pH 7. 150 kDa FD were encapsulated in the microgels.(B) Fluorescence recovery curves after bleaching a 
spot inside the microcapsules. The red curve corresponds with non-degraded microcapsules (lower images) 
while the black curve corresponds with microcapsules degraded at pH 7 (upper images).(C) CLSM image of 
(PSS/PAH)3-coated dex-HEMA-DMAEMA microgels 1 day after degradation at pH 9. Only remnants of broken 
microcapsules are present. 
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DMAEMA microgels for 10 days in buffer at pH 7. Figure 6B clearly shows that in non-
degraded microgels the fluorescence does not really recover after the bleaching step 
indicating that the FD chains are (sterically) immobilized in the microgel network. In 
(PSS/PAH)3-coated dex-HEMA-DMAEMA microgels incubated for 10 days at pH 7 the 
fluorescence significantly recovers, indicating that the FD chains became mobile due to 
degradation of the network in the microgels. Nevertheless the microgels were degraded, and 
clearly explosion did not occur. 
 
 
Figure 7. Snapshots of (A) (PSS/PAH)3-coated dex-HEMA-DMAEMA microgels during the rupturing of the 
membrane and (B) uncoated dex-HEMA-DMAEMA microgels. The time interval between the snapshots is 15 min.  
 
Consequently we studied the behavior of the (PSS/PAH)3-coated dex-HEMA-
DMAEMA microgels at pH 9. As shown in Figure 6C, only remnants of broken polyelectrolyte 
shells were visible after degradation of the dex-HEMA-DMAEMA microgels. To prove the 
self-explosion of the particles we tried to witness the rupturing of the membrane. In this 
experiment (PSS/PAH)3-coated dex-HEMA-DMAEMA microgels with encapsulated 150 kDa 
FD were placed at 80°C for 4 minutes (to accelerate the degradation) in buffer at pH 9. The 
particles were subsequently put under the CLSM (at 40 °C) and followed over time. 
Figure 4A shows four snapshots of the particles taken after respectively 60, 75, 90 and 105 
min: rupturing of the coating occurs and the encapsulated 150 kDa FD is suddenly released 
from the particles (Figure 7A). 30 Due to Laplace’s law larger microcapsules explode earlier 
than smaller microcapsules. However, the time-interval during which all the microcapsules 
ruptured is less than 10% of the total time required for the degradation of the microgel core. 
As a negative control we also followed the behavior of non-coated dex-HEMA-DMAEMA 
microgels. As shown in Figure 7B the microgels dissolve gradually in the alkaline solution. 30  
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As outlined above, when completely degraded a dex-HEMA gel turns into a solution 
of dextran and HEMA oligomers. In case the LbL membrane is permeable to the HEMA 
oligomers one can assume that, when the dex-HEMA-DMAEMA microgel is totally degraded, 
the swelling pressure of the microcapsule becomes the osmotic pressure of the 
corresponding dextran solution which is estimated to be 150 kPa for the dex-HEMA-
DMAEMA microgels used in this study.  31 Therefore, assuming a particle mean diameter of 
7 µm and using Laplace’s law (τ=Δπ r/2; where τ is the the tensile strength [N/m], Δπ the 
osmotic pressure gradient [N/m²] and r the radius [m], an upper limit of the tensile strength of 
the (PSS/PAH)3 membrane is estimated to be 0.26 N/m. The osmotic pressure of 150 kPa 
which is able to rupture the microcapsules is in accordance with the reported data on the 
osmotic pressure required to induce severe deformations in hollow polyelectrolyte 
microcapsules. 32, 33 
 
 
CONCLUSIONS 
 
In conclusion, this study shows that charged dex-HEMA microgels can be coated with 
polyelectrolytes using electrostatic interactions: CSLM and zeta-potential measurements 
proved that sequential adsorption of PSS and PAH at the surface of the dex-HEMA-
DMAEMA microgels could be achieved. We observed that the permeability of the 
(PSS/PAH)3 coating was pH dependent: while it was permeable to 20 kDa FITC-dextran at 
pH 7 it was impermeable at pH 9. Consequently, as the major degradation product of dex-
HEMA-DMAEMA microgels is dextran of 19 kDa we expected that at pH 9 the (PSS/PAH)3 
coating should be impermeable to the degradation products. This should increase the (inner) 
swelling pressure of the microcapsules upon degradation of the entrapped gel, which could 
lead to a rupturing of the surrounding membrane. Indeed, a sudden rupturing of the coating 
due to the degrading gel could be experimentally confirmed. In this way self-exploding 
microcapsules are obtained as they explode without the need of an external trigger: the time 
of explosion being completely governed by the degradation kinetics of the entrapped gel 
which governs how the swelling pressure of the microcapsules increases as a function of 
time.        
The dextran-based microgels described above are promising for biomedical 
applications based upon reports that dex-HEMA is biocompatible 34, 35 and because proteins 
can be easily incorporated inside dex-HEMA microgels with encapsulation efficiencies up to 
90 %. 36 Our on-going research is focusing on the development of monodisperse microgels 
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which should significantly enhance the simultaneous explosion of the microcapsules and we 
will further evaluate the potential of the self-exploding microcapsules for pulsed drug delivery. 
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ABSTRACT 
 
In the previous chapter we reported on ‘self-rupturing’ microcapsules which consist of 
a biodegradable dextran-based microgel surrounded by a polyelectrolyte membrane. 
Degradation of the microgel increases the swelling pressure in the microcapsules which, 
when sufficiently high, ruptures the surrounding polyelectrolyte membrane, applied by layer-
by-layer (LbL) technology on the microgels’ surface. In this chapter we characterize in detail 
the morphology and permeability of the LbL coatings surrounding the dextran microgels and 
investigate how they behave during degradation of the microcapsules. We show that by fine-
tuning the properties of both the microgel core and the LbL membrane a ‘pulsed release’ 
from the self-rupturing microcapsules can be obtained. Compared to ‘sustained’ release, 
‘pulsed’ delivery could be an advantage for the delivery of certain drugs.    
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INTRODUCTION 
 
Due to the ever increasing amount of biopharmaceuticals there is a growing need for 
advanced drug delivery systems. 1 Instead of sustained drug release, pulsed drug delivery 
could be more attractive to deliver certain therapeutics. 2 For example, a pulsed release 
pattern could be advantageous for drugs that develop biological tolerance when they are 
constantly present at their target site or for drugs that require dosing at night. 3-6 Also, 
microparticles that could suddenly release antigens at well defined times after injection 
could show potential for ‘single-shot vaccination’. 7 For this purpose the injectable device 
should consist of different types of micro particles, each type of particle suddenly releasing 
its encapsulated antigen at a well defined time after injection. Devices which show pulsed 
release upon applying an external trigger such as pH, 8, 9 electric field, 10, 11 IR-light, 12-15 etc. 
have been described, however, the reported triggers might not always be applicable in vivo. 
Also implants for pulsed drug delivery 16, 17 have been reported but, for obvious reasons, 
injectable microparticles offer benefits.  
In the previous chapter we introduced a new type of microparticles which we termed 
‘self-exploding microcapsules’. 18 A self-exploding microcapsule consists of a biodegradable 
microgel core surrounded by a suitable membrane (Figure 1). It was shown that upon 
degradation of the microgels the swelling pressure of the degrading microgels was able to 
suddenly rupture the membrane. 19 In this system the membrane surrounding the microgels 
plays a major role as it has to be (i) permeable to water, (ii) impermeable to the degradation 
products of the microgels (upon degradation the gels turn into a polymer solution) and (iii) 
rupture when the swelling pressure reaches a critical value.  
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Figure 1. Schematic representation of a microgel coated by the LbL-technique. Before degradation the polymer 
chains (dextran chains in this study) are connected into a three-dimensional network by chemical cross-links (●). 
(I ), (II) and (III) show the coating of the microgels by sequential adsorption of oppositely charged polyelectrolytes. 
The microgels described in this chapter degrade by hydrolysis of the cross-links. As degradation proceeds, the 
cross-link density decreases and free polymer (dextran) chains arise. (IV) At the end of the degradation process 
the core of the particles consists of a dextran solution. When the swelling pressure of the core exceeds a critical 
value the membrane suddenly ruptures. (V) 
 
We applied a membrane at the surface of the microgels by layer-by-layer electrostatic 
self-assembly (LbL-ESA) which is a very promising technology for the coating of 
microparticles. 20-22 First developed by Decher et al. on planar substrates, 23, 24 this technique 
has been extended to the coating of colloidal particles by Sukhorukov et al. 25 Briefly 
explained, as illustrated in Figure 1, this approach is based on the alternate adsorption of 
oppositely charged polyelectrolytes (PE’s) on a charged surface, driven by the electrostatic 
interaction at each step of adsorption. It has been shown that a wide variety of colloidal 
particles can be coated by polyelectrolyte multilayer deposition: organic latex particles, 25, 26 
inorganic particles, 27 dye and drug nanocrystals, 28 protein aggregates 29 and biological cells. 
30 A major advantage of the LbL technique is the possibility to tune the layer thickness on the 
nanometer scale and thus control the mechanical properties and the permeability of the 
polyelectrolyte shell.   
 As the LbL membrane of the self-rupturing microcapsules has a major impact on the 
release features of this new type of microparticles, this chapter especially aims to 
characterize in detail the LbL films deposited on the surface of the microgels. We also aimed 
to show that choosing an optimal LbL-coating significantly reduces burst release and makes 
release to occur at the time the microcapsules rupture.   
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MATERIALS AND METHODS 
 
Materials.  
 
Dextran (Mw~19 kDa), fluorescein isothiocyanate-dextrans (FITC-dextran, Mw~ 
respectively 20 and 150 kDa), tetramethyl rhodamine B isothiocyanate-dextrans (TRITC-
dextran, Mw~158 kDa), N,N,N’,N’-tetramethylethylenediamine (TEMED), methacrylic acid 
(MAA) and dimethyl aminoethyl methacrylate (DMAEMA), rhodamine B isothiocyanate 
(RBITC), sodium poly(styrene sulfonate) (PSS, 70 kDa) and poly(allylamine hydrochloride) 
(PAH, 70 kDa) were purchased from Sigma-Aldrich-Fluka. Potassium peroxodisulphate 
(KPS) and poly(ethyleneglycol) (PEG; 20 kDa) were purchased from Merck. RBITC labelled 
PAH was synthesized as reported in literature. 31 
 
Synthesis of dex-HEMA.  
 
Dextran-hydroxyethyl methacrylate (dex-HEMA) was prepared and characterized 
according to a method described elsewhere. 32 Dextran with a number average molecular 
weight of 19 kDa was used. The degree of substitution (DS, the number of HEMA groups per 
100 glucopyranose residues of dextran) was determined by proton nuclear resonance 
spectroscopy (1H-NMR) in D2O with a Gemini 300 spectrometer (Varian). 33 The DS of the 
dex-HEMA used in this study was 2.5.  
 
Preparation of dex-HEMA microgels.  
 
Dex-HEMA microgels, with an initial water content of 70 % (w/w), were prepared 
according to Franssen et al. 34 In detail, 71 mg dex-HEMA was dissolved in 1.577 ml water 
and subsequently emulsified by vortexing with a 3.35 ml 24 % (v/v) aqueous PEG solution. 
Radical polymerisation of the aqueous dex-HEMA emulsion droplets was initiated by adding 
TEMED (100 µl pH neutralized with 4 N HCl) and KPS (9 mg). The reaction was carried out 
at room temperature for 1h. Afterwards the obtained microgels were washed three times with 
pure water to remove PEG, KPS and TEMED. Finally the microgels were suspended in 5 ml 
pure water and stored at -20 °C. To prepare negatively and positively charged dex-HEMA 
microgels, 35 respectively methacrylic acid (MAA; 25µl) or dimethyl aminoethyl methacrylate 
(DMAEMA; 35µl) was added to the dex-HEMA/PEG mixture just before vortexing it. In this 
chapter ‘dex-HEMA-MAA microgels’ and ‘dex-HEMA-DMAEMA microgels’ refer to negatively 
charged and positively charged microgels, respectively. FITC/TRITC-dextrans were 
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incorporated in the microgels by adding 100µl of a FITC/TRITC-dextran solution (50 mg/ml) 
to the dex-HEMA/PEG mixture just before the vortexing step. 
 
LbL coating of the dex-HEMA microgels.  
 
Dex-HEMA microgels were coated by the consecutive adsorption of oppositely 
charged polyelectrolytes using the centrifugation technique. 25 The microgels (500 µl from the 
original suspension) were dispersed in 1 ml of polyelectrolyte solution (2 mg/ml in 0.5M 
NaCl). The polyelectrolytes were allowed to adsorb for 15 min, under continuous shaking. 
The dispersion was then centrifuged at a speed of 300 g for 3 min. Subsequently the 
supernatant was removed and the microgels were redispersed in Milli-Q water to remove the 
non-adsorbed polyelectrolytes. This washing was repeated twice before the second 
polyelectrolyte solution was added. The process was repeated until the desired LbL coating 
was reached. 
 
Release experiments.  
 
TRITC-dextran containing dex-HEMA-DMAEMA microgels were prepared and LbL 
coated as described in the paragraphs above. However, the scale on which the LbL-coating 
was performed was 10 ml instead of 1 ml. After preparation, the uncoated and (PSS/PAH)3-
coated dex-HEMA-DMAEMA microgels were centrifuged, the supernatant was removed and 
the microgels/microcapsules were redispersed in centrifugation tubes containing 50 ml 0.1 M 
carbonate buffer (pH 9). The centrifugation tubes were thermostatisized at 37 ± 0.5 °C and 
the microgels/microcapsules were kept in suspension by mechanical agitation. 1 ml samples 
were withdrawn at 2.5 h time intervals (by a VenKel Industries 800 automatic sampling 
station) and filtered to remove the microcapsules. The fluorescence intensity of the samples 
was measured with a Wallac Victor 2 (Perkin Elmer) plate reader. The measured 
fluorescence values were normalized against the fluorescence values measured at the end 
of the release experiments. It was verified that the measured fluorescence values belonged 
to the range in which a linear relation exists between the concentration of the TRITC-dextran 
solutions and their fluorescence.  
 
Confocal laser scanning microscopy.  
 
Confocal micrographs of the LbL coated microgels were taken with a MRC1024 Bio-
Rad confocal laser scanning microscope (CLSM) equipped with a krypton-argon laser. An 
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inverted microscope (Eclipse TE300D, Nikon) was used which was equipped with a water 
immersion objective lens (Plan Apo 60X, NA 1.2, collar rim correction, Nikon).  
 
Electrophoretic mobility.  
 
The electrophoretic mobility of the LbL coated microgels was measured using a 
Malvern Zetasizer 2000 (Malvern Instruments). The ζ-potential was calculated from the 
electrophoretic mobility (μ) using the Smoluchowski relation: ζ=μη/ε where η and ε are the 
viscosity and permittivity of the solvent, respectively. Since the largest microgels did not 
allow ζ-potential measurements (they sedimented too quickly in the cuvette of the 
instrument), we measured the ζ-potential of the smallest microgels (approximately 1 µm). 
Therefore the dex-HEMA microgel dispersions were centrifuged (1 min at low speed (100 g)) 
and the ζ-potential measurements were done on dex-HEMA microgels which remained in the 
supernatant.  
 
Scanning electron microscopy (SEM).  
 
Scanning electron microscopy measurements on (LbL coated) microgels were carried 
out using a Zeiss DSM 40 instrument operating at an accelerating voltage of 3 kV.  
 
Atomic force microscopy (AFM).  
 
Experiments were performed on air-dried (LbL coated) microgels deposited onto 
microscope glass slides. Images were obtained in tapping mode under ambient conditions 
with an AutoProbe CP system (Park Scientific Instruments) using a 100 µm scanner. Si3N4 
cantilevers (spring constant about 0.1 Nm-1) with integrated pyramidal tips were used. The 
AFM-tip was positioned on top of rather large microgels (diameter of 15 µm) in order to avoid 
the effect of the curvature on the image.  
 
 
RESULTS AND DISCUSSION 
 
To synthesize biodegradable dextran hydrogels, 36 methacrylate moieties were linked 
to the dextran backbone by hydrolysable carbonate esters (Figure 2A). Radical 
polymerization of the methacrylate moieties cross-links the dextran chains. The fabrication of 
67
CHAPTER 3 - LAYER-BY-LAYER COATING OF DEGRADABLE MICROGELS FOR PULSED DRUG DELIVERY 
 
 
 
 
dex-HEMA microgels using the water-in-water emulsion technique is based on the 
immiscibility of the PEG and dex-HEMA solutions. Microgels with an average diameter of 7 
µm were obtained. It could be expected that charged dex-HEMA microgels would be more 
suitable for LbL coating than neutral ones. Van Tomme et al. recently reported that charged 
dex-HEMA microgels can be prepared by copolymerization of dex-HEMA with MAA (pKa 4,5) 
(Figure 2B) or DMAEMA (pKa 8,4) (Figure 2C). 35 The incorporation of these charged groups 
into the microgels was verified by measuring the ζ-potential of the dex-HEMA microgels. 
Indeed, a negative ζ-potential was measured in case MAA was used, while a positive 
ζ-potential was observed in case DMAEMA was used, indicating the successful charge 
loading of the dex-HEMA microgels.  
 
Figure 2. Chemical structure of (A) the monomer in dex-HEMA (A), which is glucopyranose substituted with 
HEMA, (B) MAA and (C) DMAEMA. 
 
We observed that the charge of the microgels strongly influences their degradation 
rate. While the positively charged  dex-HEMA-DMAEMA (70 %; DS 2.5) microgels were 
completely degraded within 5 days (at 37 °C and pH 7.4), it took up to 30 days to completely 
degrade the negatively charged dex-HEMA-MAA (70 %; DS 2.5) microgels.  It has been 
reported by van de Wetering et al. that the degradation rate of alkaline ester hydrolysis can 
be influenced by neighbouring ternary amine groups. 37 After nucleophilic attack of the 
hydroxyl ion on the ester group, the intermediate is stabilized by resonance stabilisation 
which promotes the alkaline hydrolysis of the ester group thus increasing the degradation 
rate of the dex-HEMA-DMAEMA microgels. On the other hand, in case of dex-HEMA-MAA 
microgels the presence of the carboxyl group of the MAA will destabilize the intermediate 
and thus defavourize the alkaline hydrolysis of the ester group, resulting in a slower 
degradation of the dex-HEMA-MAA microgels, which was indeed observed. 
  To perform the LbL-coating of the microgels we used poly(allylamine hydrochloride) 
(PAH) as polycation and sodium poly(styrene sulfonate) (PSS) as polyanion. This 
polyelectrolyte pair is well studied for the coating of both flat as well as colloidal 
templates.  28, 38-40 Initially we deposited 3 PSS/PAH bilayers onto the microgels. 
68
CHAPTER 3 - LAYER-BY-LAYER COATING OF DEGRADABLE MICROGELS FOR PULSED DRUG DELIVERY 
 
 
 
 
 
 
Figure 3. Evolution of the ζ-potential, as a function of layer number, during the LbL-coating of the microgels.  
 
Figures 3A-B show the results of ζ-potential measurements on uncoated and LbL 
coated dex-HEMA microgels. Before coating, the ζ-potential of neutral, dex-HEMA-MAA and 
dex-HEMA-DMAEMA microgels were respectively 0 mV, -30 mV and 28 mV; The ζ-potential 
values proved the successful incorporation of respectively MAA and DMAEMA. Figures 3A 
and B clearly show that the charge of the microgels changes upon submerging them in PSS 
and PAH solutions, indicating that multilayer build-up takes place. The ζ-potential profile 
observed upon exposure of the microgels to PSS/PAH solutions agrees well with literature 
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data on PSS/PAH coating of other types of particles. 25 Figure 3B shows that LbL coating of 
the neutral dex-HEMA microgels is also possible. The obtained ζ-potential profile is however 
quite irregular. For charged microgels (Figure 3A), electrostatic interactions between the 
microgels and the polyelectrolytes are the main driving force for polyelectrolyte adsorption. 
However, for neutral microgels other interactions probably play a role. 41-43 These interactions 
seem to be strong enough because otherwise the adsorbed layers would be removed upon 
adsorption of the next polyelectrolyte layer. Physical entanglements between the 
polyelectrolyte chains and the hydrogel matrix may considerably promote the adsorption of 
polyelectrolytes to the neutral gel surface. 
 
 
Figure 4. CLSM images of  dex-HEMA-DMAEMA microgels coated with (PSS/PAH)3 (A), dex-HEMA-MAA 
microgels coated with (PAH/PSS)3 (B) and  dex-HEMA microgels coated with (PSS/PAH)3 (C). The PAH was 
fluorescently labelled with RITC. 
 
The obtained microcapsules were visualized by confocal laser scanning microscopy 
(Figure 4 A-C). When fluorescently labelled PAH (PAH-RITC) was used in the LbL assembly 
on the dex-HEMA-DMAEMA microgels (Figure 4A) a sharp contour could be observed. 
When dex-HEMA-MAA microgels were coated using PAH-RITC (Figure 4B), inwards 
diffusion of PAH-RITC was observed. This indicates that besides a shell at the surface, also 
a polyelectrolyte matrix is formed inside the microcapsules. Figure 4C shows a confocal 
microscopy image of LbL coated neutral dex-HEMA microgels. In this case it becomes even 
impossible to distinguish a core-shell structure. Probably the absence of charges on the 
surface of the microgels is fatal to an adequate multilayer build-up and one can thus question 
the quality of the coating.  
70
CHAPTER 3 - LAYER-BY-LAYER COATING OF DEGRADABLE MICROGELS FOR PULSED DRUG DELIVERY 
 
 
 
 
 
 
Figure 5. SEM images of (A) uncoated and (B) coated microgels. 
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Figure 6. AFM images of uncoated (left) en PSS/PAH coated microgels (right) recorded in tapping mode. (A1) 
and (B1) show the topology of the surface. (A2) and (B2) show the roughness of the surface along the line 
marked on (A1) and (B1). (A3) and (B3) are the 3D images of the surface. 
 
Since confocal microscopy does not give any information about the morphology of the 
LbL-coated microgels, SEM and AFM were used. Figure 5 depicts SEM images of both 
uncoated and coated microgels. It reveals that the surface of the uncoated particles is rather 
smooth compared to the coated ones, which show a more granular structure. Especially 
when PAH was the outermost polyelectrolyte layer a remarkable ‘brain-like’ structure 
appeared. A similar morphology was observed using AFM by McAloney et al. 44, 45 when 
studying the deposition of PSS/PAH multilayers on planar substrates at high salt 
concentrations. The difference between uncoated and PSS/PAH coated dex-HEMA-
DMAEMA microgels was confirmed by AFM measurements. Uncoated microgels (Figure 6A) 
show irregularities ranging from 2 to 8 nm while PSS/PAH coated microgels (Figure 6B) 
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show irregularities ranging from 20 to 50 nm. The irregularities in the morphology of the LbL 
coating are highly likely due to the differential drying between the gel core and the LbL 
coating.  
As outlined in Figure 1, the rupturing of the microcapsules is triggered by the swelling 
pressure of the degrading microgels. To exert a sufficient pressure it is important that the 
degradation products of the microgels, i.e. 19 kDa dextran chains, do not diffuse through the 
coating during the degradation of the microgels. In the previous chapter we reported that the 
permeability of the (PSS/PAH)3 membrane seems to be pH dependent as self-rupturing 
microcapsules could only be obtained upon incubation of the microcapsules at pH 9 (thus 
suggesting that at pH 9 the coating is impermeable for 19 kDa dextran chains)  while upon  
incubation at pH 7 the microcapsules’ membrane remained intact (thus suggesting that at 
pH 7 the coating is permeable for 19 kDa dextran chains). 18 To further investigate the 
permeability of the (PSS/PAH)3 coating we used 20 kDa FITC-dextrans as its molecular 
weight corresponds well to the molecular weight of the dextran chains the microgels are 
composed of.  
 
Figure 7. Permeability of the LbL coating surrounding the dex-HEMA-DMAEMA microgels to 20 kDa FITC-
dextrans. The LbL coated microgels are immersed into a buffered solution containing 1 mg/ml FITC-dextrans and 
are visualized by confocal microscopy.    
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The (PSS/PAH)3 coated dex-HEMA-DMAEMA microgels were incubated in a 1 mg/ml 
FITC-dextran solution. The experiment was performed at pH 7 and pH 9. From the confocal 
images in Figure 7 it is clear that at pH 7 the microcapsules’ wall is permeable to the 20 kDa 
FITC-dextrans while at pH 9 it is impermeable. When the number of polyelectrolyte bilayers 
is increased from 3 to 6 we observed that also at pH 7 the coating becomes impermeable. As 
a control, when non-coated dex-HEMA-DMAEMA microgels were incubated in a FITC-
dextran solution they appeared to be permeable to the FITC-dextrans (data not shown). As 
PAH is a weak polyelectrolyte  (pKa 8.5 46) it is not surprising that the properties of PSS/PAH 
polyelectrolyte multilayers are pH-dependent. The pH dependent stability 47 and 
permeability 38 of PSS/PAH based polyelectrolyte microcapsules has indeed been shown. 
Antipov et al. reported that PSS/PAH based microcapsules become impermeable to high 
molecular weight species upon increasing the pH from 7 to above 8. 38 Apparently an 
analogue phenomenon is observed in our case.  
To evaluate the effect of the degradation of the microgel core on the integrity of the 
polyelectrolyte membrane, the microcapsules were incubated at 37 °C at pH 7 (for 10 days) 
and at pH 9 (overnight).  Optical microscopy on non-coated dex-HEMA-DMAEMA microgels 
showed that these degradation times ensure complete degradation of the microgel core. Two 
different types of microcapsules were used: dex-HEMA-DMAEMA microgels coated with 
(PSS/PAH)3 and dex-HEMA-DMAEMA microgels coated with (PSS/PAH)6. 
When the microcapsules were put under the confocal microscope after the 
degradation of the microgel core it was observed that only the (PSS/PAH)3-based 
microcapsules incubated at pH 9 were ruptured (data not shown),  in agreement with our 
previous observations. 18 In all other cases the polyelectrolyte membrane remained intact 
(Figure 8A). To prove that the membranes remained indeed intact the experiments were 
repeated with microgels which were initially loaded with 150 kDa FITC-dextrans. Upon 
degradation of the microgel core we observed that polyelectrolyte microcapsules filled with 
FITC-dextrans remained (Figure 8B). Figures 8C and 8D are SEM images corresponding to 
the microcapsules shown in respectively Figure 8A and 8B. In case 150 kDa FITC-dextrans 
were encapsulated the microcapsules showed a more granular structure due to the 
precipitation of the FITC-dextrans upon drying of the sample. A similar morphology of filled 
microcapsules after drying has been observed by Sukhorukov et al. 48 
To visualize the rupturing of the (PSS/PAH)3-coated dex-HEMA-DMAEMA microgels 
it was investigated up to which pH the (PSS/PAH)3 coating was stable. Déjugnat et al. have 
reported on the pH responsive properties of hollow PSS/PAH-based microcapsules and from 
these results it can be concluded that the PSS/PAH coating remains intact until a pH of 11 
whereas at a pH above 12 the multilayer membrane becomes irreversibly destroyed. 47 
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Therefore the (PSS/PAH)3 coated dex-HEMA-DMAEMA microgels were incubated in a 
solution buffered at pH 11 and the degradation process was monitored by confocal 
microscopy. Figure 9 shows snapshots of the microcapsules during the degradation. Initially 
they start to swell and at a certain moment they rupture leading to the release of the 
encapsulated material, which was 150 kDa FITC-dextran. 
In a next step the effect of the (PSS/PAH)3 coating on the release of 158 kDa TRITC-
dextrans from dex-HEMA-DMAEMA microgels, degrading at pH 9, was investigated. We 
expected to observe a pulsed release for the following reasons. First, at pH 9 the 
Figure 8. Confocal images of (PSS/PAH)3 coated empty dex-HEMA-DMAEMA microgels (A) and dex-HEMA-
DMAEMA microgels loaded with 150 kDa FITC-dextrans (B), after degradation at pH 7. The PAH was 
fluorescently labelled with RITC. Figures C and D show the SEM images corresponding to (A), respectively 
(B). 
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(PSS/PAH)3 coating surrounding dex-HEMA-DMAEMA microgels should not be permeable to 
158 kDa TRITC-dextrans as it is even impermeable to 20 kDa dextrans (Figure 7). In other 
words, the 158 kDa TRITC-dextrans should not leak through the membrane during 
degradation of the microgels. Second, at pH 9 the (PSS/PAH)3 microcapsules are self-
rupturing i.e. the membrane breaks due to the increase in swelling pressure of the microgels. 
 
 
Figure 9. CLSM images of (PSS/PAH)3 coated microgels during the degradation at pH 11.  
 
Figure 10 shows that the release of 158 kDa TRITC-dextrans from uncoated and 
(PSS/PAH)3 coated dex-HEMA-DMAEMA microgels differs significantly. Uncoated microgels 
show a substantial burst release followed by a continuous release until the microgels are 
completely degraded after 20 h. A burst release does not occur in case of (PSS/PAH)3 
coated dex-HEMA-DMAEMA microgels,  the 158 kDa TRITC-dextran release remains even 
low during the first 10 hours of degradation. After this initial phase  the majority of the 
encapsulated 158 kDa TRITC-dextran molecules are released in a couple of hours allowing 
to conclude that (PSS/PAH)3  coating of the dex-HEMA-DMAEMA microgels causes the 
release of the 158 kDa TRITC-dextrans to be much more pulsatile.  
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Figure 10. Cumulative release curves of 158 kDa TRITC-dextrans from uncoated dex-HEMA-DMAEMA (open 
symbols) and (PSS/PAH)3-coated dex-HEMA-DMAEMA microgel (closed symbols). The data points are 
interconnected with a cubic B-spline. The experiments were run in duplicate. 
 
One could, however, wonder why the observed release pulse is less steep than one 
would expect when all the microcapsules would simultaneously rupture. This may be partially 
explained by Laplace’s law: 
2p
r
γ=  
With p the pressure, γ  the membrane tension and r the radius. In other words, the internal 
pressure needed to destroy a given LbL membrane depends on the radius of the microgel; 
One needs a higher pressure for rupturing the membrane surrounding smaller microgels than 
for destroying the same membrane surrounding larger microgels. As the microgels reported 
in this chapter are polydisperse in size one could indeed expect that not all the 
microcapsules will self-rupture at the same time but the time of rupturing will show a 
distribution. Recently we reported on the fabrication of highly monodisperse dex-HEMA 
microgels using a microfluidic emulsification device. 49 Future work will focus on the use of 
these monodisperse microgels to produce a highly uniform population of microcapsules. 
Another aspect which should be addressed in future work is how to modify the properties of 
the LbL coating surrounding the microgels in order to render this coating sufficiently 
impermeable under physiological conditions without increasing the mechanical strength of 
this coating to a point where it can no longer be ruptured by the swelling pressure of the 
degrading microgel.  
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CONCLUSIONS 
 
Dextran based microgels, with different surface charges, were used as template for 
the LbL assembly of the polyelectrolytes PSS and PAH. ζ-potential measurements and 
CLSM proved that polyelectrolytes can be sequentially adsorbed onto the surface of neutral, 
positively as well as negatively charged dextran microgels leading to microcapsules. It was 
observed that the positively charged dex-HEMA-DMAEMA microgels were the most 
promising as template for LbL assembly. The permeability of PSS/PAH based LbL coatings 
surrounding dex-HEMA-DMAEMA microgels was investigated. It was found that 3 bilayers of 
PSS/PAH rendered the microcapsules impermeable to 20 kDa FITC-dextrans at pH 9 while 
they were still permeable at pH 7. Increasing the number of polyelectrolyte bilayers to 6 
rendered the microcapsules impermeable also at pH 7.  
We showed that upon degradation at pH 9 the dextran microgels were able to rupture 
their surrounding (PSS/PAH)3 coating, resulting in ‘self-rupturing microcapsules’, while when 
degraded at pH 7 the (PSS/PAH)3 coating did not rupture, leading to hollow (PSS/PAH)3 
microcapsules. This was explained by the pH dependent permeability of the (PSS/PAH)3 
coating to the degradation products of the microgels. When degraded at pH 9 the release of 
high molecular weight TRITC-dextran, encapsulated in (PSS/PAH)3 coated microcapsules, 
was significantly more pulsatile compared to the TRITC-dextran release from uncoated 
dextran microgels.  
The concept presented in this chapter may be promising towards biomedical 
applications, especially in the field of pulsed drug delivery, as the time of rupturing is 
determined by the degradation rate of the microgels, which can be tailored from days to 
several weeks by varying the cross-link density of the microgels. 36 Our further research will 
focus on LbL coating of degradable microgels making use of biocompatible polyelectrolytes 
with the aim to obtain microcapsules which are under physiological conditions impermeable 
to both the encapsulated drugs as well as the degradation products of the dextran gels, two 
major requirements to obtain pulsed delivery from this type of micromaterials.  
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ABSTRACT 
 
This chapter reports on microcapsules obtained by layer-by-layer deposition of bio-
polyelectrolyte multilayers at the surface of biodegradable dextran microgels. It shows that 
the behaviour of the layer-by-layer coating upon degradation of the microgel core strongly 
depends on the bio-polyelectrolytes used. Two types of microcapsules, ‘self-rupturing’ 
microcapsules and ‘hollow’ microcapsules are presented. Self-rupturing microcapsules were 
obtained when the swelling pressure of the degrading microgel core was sufficiently strong 
enough to rupture the surrounding bio-polyelectrolyte membrane. Self-rupturing 
microcapsules could be of interest as a pulsed drug delivery system. Hollow microcapsules 
were obtained after applying multiple layers of bio-polyelectrolyte that could withstand the 
swelling pressure of the degrading microgel core. It was observed that biomacromolecules 
(like albumin and dextran) spontaneously accumulate in the hollow microcapsules prepared 
from dex-HEMA microgels, which could be of interest for drug encapsulation purposes.  
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CHAPTER 4 
EXPLODING AND HOLLOW  
MICROCAPSULES FROM  
BIO-POLYELECTROLYTE  
COATED MICROGELS 
 
 
INTRODUCTION 
 
The advent of new biotechnological therapeutics has evoked novel challenges in drug 
delivery. 1 For several therapeutics such as vaccines 2 and hormones, 3-5 a pulsatile release 
pattern could be beneficial. For example, a vaccine delivery system able to release the 
antigen in multiple pulses after a single injection 6-8 could replace the multiple injections 
which are currently required to generate sufficient immunity. Also, for drugs that develop 
biological tolerance when they are constantly present in the bloodstream, pulsed drug 
release instead of sustained drug release could be attractive. A way to achieve pulsed drug 
delivery could be the encapsulation of the drug in micro- or nanoparticles which release their 
content at pre-programmed times after injection.  
In the chapters 2 and 3 we introduced microcapsules that are able to explode, and 
thus release their content, without the use of an external trigger. 9 As Figure 1A schematically 
represents, the so-called ‘self-exploding’ microcapsules consist of a biodegradable microgel 
surrounded by a semi-permeable membrane. The microgels are based on dextran-
hydroxyethyl methacrylate (dex-HEMA; Figure 1B). Dex-HEMA microgels are biodegradable 
through hydrolysis of the carbonate esters in the cross-links which connect the dextran 
chains. 10, 11 Upon cleavage of the cross-links the swelling pressure of the dex-HEMA 
microgels increases. 12, 13 This swelling pressure may rupture the surrounding membrane, 
depending on the properties of the membrane and the pH of the environment. In the chapters 
2 and 3 we reported that ‘self-exploding’ microcapsules could be obtained when the dex-
HEMA microgels were coated with (PSS/PAH)3, i.e. a membrane consisting of 3 
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polyelectrolyte bilayers, each bilayer composed of a sodium poly(styrene sulfonate) layer and 
a poly(allylamine hydrochloride). The (PSS/PAH)3 layer was applied by the layer-by-layer 
(LbL) technique. 14-17 LbL coating is the sequential adsorption of charged species, such as 
polyelectrolytes, 16 nanoparticles, 18-20 nanotubes, 21 lipids, 22 viruses, 23 etc. on an oppositely 
charged planar or colloidal substrate. An important observation was that the (PSS/PAH)3 
coated dex-HEMA microgels only exploded when they were incubated at pH 9. Rupturing of 
the (PSS/PAH)3 coating did not occur when the microcapsules were dispersed in buffer at a 
physiological pH (7.4). This was attributed to the pH dependent permeability of the 
(PSS/PAH)3 membrane. At pH 7 the (PSS/PAH)3 membrane was permeable to the 
degradation products of the dex-HEMA microgels while at pH 9 it was impermeable. 24 
Consequently, at pH 9 the degradation products remained inside the microcapsules during 
the degradation process of the microgels and thus increased the osmotic/swelling pressure 
of the core of the capsules, finally rupturing the (PSS/PAH)3 membrane.  
As self-exploding microcapsules may have great potential as a pulsed drug delivery 
system 6-8 we aimed to design self-rupturing microcapsules that (a) solely consist of 
biopolymers instead of synthetic polymers like PSS and PAH and (b) rupture upon incubation 
at a physiological pH. In this chapter we show that this is possible by carefully choosing the 
appropriate bio-polyelectrolytes for building the LbL membrane. Furthermore, we 
demonstrate that depending on the composition of the bio-polyelectrolyte membrane, self-
rupturing microcapsules as well as ‘hollow’ microcapsules can be fabricated using the 
degradable dex-HEMA microgels as sacrificial templates. Hollow bio-polyelectrolyte 
microcapsules, prepared by LbL coating of poly(lactic acid-co-glycolic acid), melamine 
formaldehyde and calcium carbonate microparticles as sacrificial template, have been 
 
Figure 1. (A) Schematic representation of a microcapsule. The inner core of the microcapsule is a microgel 
composed of dextran chains, which have been cross-linked (black dots). The microgel core has been coated with 
several polyelectrolyte bilayers of opposite charge (grey curves) using the LbL technique. (B) Molecular structure 
of dex-HEMA. Dex-HEMA are dextrans that have been derivatized with methacrylate groups connected to the 
dextran backbone by hydrolysable carbonate esters. The dextran chains can be cross-linked by radical 
polymerization of the methacrylate groups, forming a three dimensional network. Hydrolysis of the carbonate 
esters in the cross-links leads to the formation of the original dextran chains and polyHEMA fragments as 
degradation products. 
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reported before. However, the use of organic solvents to dissolve the core material may be 
disadvantageous, especially where the encapsulation of drug molecules is concerned. 25, 26  
Also, remnants of toxic melamine formaldehyde oligomers may remain in the capsules’ walls 
after dissolving the core. 27-29 Severe aggregation of the hollow microcapsules has also been 
reported. 30 In this study we show that dex-HEMA microgels can be dissolved under mild 
conditions yielding non-aggregated hollow microcapsules.  
 
 
EXPERIMENTAL 
 
Materials.  
 
Dextran (Mw~19 kDa), N,N,N’,N’-tetramethylethylenediamine (TEMED), dextran 
sulfate (DEXS; Mw~10 kDa), poly-L-arginine (PARG; Mw~100-200 kDa), chondroitin sulfate 
(CHON), poly-L-aspartic acid (PASP; M w~15-50 kDa), poly-L-glutamic acid (PGLUlow; 
Mw~15-50 kDa and PGLUhigh; Mw~50-100 kDa), FITC-bovine serum albumin (FITC-BSA), 
FITC-dextran (Mw~20, 40, 70, 150, 500 and 2000 kDa) and rhodamine B isothiocyanate 
(RITC) were purchased from Sigma-Aldrich-Fluka. Potassium persulfate (KPS), dimethyl 
aminoethyl methacrylate (DMAEMA), polyethylene glycol (PEG; Mw~20 kDa), citric acid, 
sodium hydroxide (NaOH) and hydrochloric acid were purchased from Merck. RITC-labelled 
PARG was synthesized by reacting RITC and poly-L-arginine in 0.1 M borate buffer at pH 8.5 
followed by dialysis with pure water for several days.  
 
Synthesis of dex-HEMA microgels.  
 
Dex-HEMA was synthesized as previously reported. 10, 11 The degree of substitution 
(DS; the number of HEMA groups per 100 glucopyranose units) was 2.5 as determined by 
1H-NMR spectroscopy. Fluorescent dex-HEMA microgels were fabricated according to 
Franssen et al. 31, 32 by dissolving 71 mg dex-HEMA, 20 µl FITC-dextran solution (50 mg/ml) 
and 35 µl DMAEMA in 1.577 ml water and subsequently emulsifying this solution with a 3.35 
ml aqueous PEG solution (24 % (v/v)). Radical polymerization of the aqueous dex-HEMA 
emulsion droplets was initiated by adding TEMED (100 µl pH neutralized with 4 N HCl) and 
KPS (180 µl, 41 mM). The reaction was carried out at room temperature for 1h. Afterwards 
the microgels obtained were washed three times with pure water to remove PEG, KPS and 
TEMED. Finally the microgels were suspended in 5 ml water and stored at -20 °C. The size 
distribution of the microgels was determined by laser diffraction (Malvern Mastersizer).  
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Polyelectrolyte coating of the microgels.  
 
Dex-HEMA microgels were coated by the consecutive adsorption of oppositely 
charged polyelectrolytes. 33 500 µl of dex-HEMA microgel dispersion was mixed with 1 ml of 
polyelectrolyte solution (1 mg/ml in 0.5 M NaCl). The polyelectrolytes were allowed to adsorb 
for 10 min, under continuous shaking. The dispersion was then centrifuged at a speed of 300 
g for 3 min. Subsequently the supernatant was removed and the microgels were redispersed 
in Milli-Q water to remove the non-adsorbed polyelectrolytes. This washing was repeated 
twice before the second polyelectrolyte solution was added. As the microgels were positively 
charged we started the LbL coating with the polyanion. In total 4 polyelectrolyte bilayers were 
deposited.  
 
Preparation of hollow microcapsules using dex-HEMA microgels as template.  
 
To obtain hollow microcapsules, dex-HEMA microgels coated with 4 bilayers 
DEXS/PARG were dispersed for 30 min in 0.1 M NaOH (to degrade the dex-HEMA microgel 
cores), followed by 3 washing steps with pure water to remove the degradation products of 
the microgels and the NaOH. Finally the hollow microcapsules were dispersed in 1 ml Milli-Q 
water. 
 
Preparation of hollow microcapsules using MnCO3 as template.  
 
Manganese carbonate (MnCO3) particles with an average diameter of 5 µm were 
prepared as reported by Zhu et al. 34 LbL coating of the MnCO3 particles occurred as 
described above for the LbL coating of dex-HEMA microgels. The MnCO3 cores were 
dissolved by adding 1 ml of 0.2 M citric acid in 0.1 M HCl to the coated MnCO3 particles, 
followed by several washing steps with pure water. 35 
 
Scanning electron microscopy measurements.  
 
Scanning electron microscopy (SEM) measurements were conducted on a Gemini 
Leo instrument operated at an acceleration voltage of 3 kV. For a sample preparation, a drop 
of microcapsules suspension was applied to a glass slide, dried overnight, and sputtered with 
gold. 
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Atomic force microscopy measurements.  
 
Atomic force microscopy (AFM) images were taken on a Nanoscope IIIa Multimode 
SFM (Digital Instruments Inc.) in air at room temperature using the tapping mode. Samples 
were prepared by applying a drop of microcapsules suspension onto a freshly cleaved mica 
substrate followed by drying under a gentle stream of nitrogen. 
 
 
Figure 2. (A) Size distribution of the dex-HEMA microgels as measured by laser diffraction. (B) Confocal 
microscopy image of dex-HEMA microgels which were fluorescently labelled with 150 kDa FITC-dextran (green 
colour).   
 
 
RESULTS AND DISCUSSION 
 
Biodegradable dex-HEMA microgels were fabricated according to Franssen et al. by 
a completely aqueous water-in-water emulsion technique based on the immiscibility of an 
aqueous polyethylene glycol phase and an aqueous dextran phase. 31, 32 Radical 
polymerization of the pending HEMA groups leads to the formation of a three-dimensional 
network. Positively charged microgels (as evidenced from electrophoreric mobility 
measurements) with an average diameter of 7 µm were obtained by copolymerizing dex-
HEMA with dimethyl aminoethyl methacrylate (DMAEMA), which is positively charged at 
neutral pH. 36 While Figure 2A shows the size distribution of the microgels, as determined by 
laser diffraction, Figure 2B is a confocal image of dex-HEMA microgels homogenously 
loaded with FITC-dextran. The FITC-dextrans stay encapsulated inside the dex-HEMA 
microgels and become slowly released during the degradation of the microgel core, during 
up to 7 days.  
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In the next step we tried to coat the dex-HEMA microgels with four bio-polyelectrolyte 
bilayers using the LbL technique. 37 The bio-polyelectrolyte coated dex-HEMA microgels are 
termed ‘microcapsules’ in the continuation of this chapter. Initially a large number of bio-
polyelectrolytes were attempted to coat the dex-HEMA microgels. Chitosan, poly-L-lysine, 
poly-L-ornithine, alginic acid and hyaluronic acid appeared to be unsuitable bio-
polyelectrolytes because severe aggregation of the microgels took place; mostly the dex-
HEMA microgels aggregated instantaneously upon dispersing in the bio-polyelectrolyte 
solution. The low charge density and relatively high viscosity (especially in case of chitosan, 
alginic acid and hyaluronic acid) of the bio-polyelectrolytes may explain their failure. The only 
bio-polycation that allowed coating the dex-HEMA microgels without aggregation seemed to 
be poly-L-arginine (PARG). Poly-L-arginine is the only polypeptide having side groups that 
are charged at almost every pH (the pKa of the side groups is 12.5) and is therefore a strong 
polyelectrolyte. Using PARG as polycation, chondroitin sulfate (CHON), poly-L-aspartic acid 
(PASP), low molecular weight poly-L-glutamic acid (PGLUlow), high molecular weight poly-L-
glutamic acid (PGLUhigh) and dextran sulfate (DEXS) seemed to be suitable polyanions for 
LbL coating of the dex-HEMA microgels. Figure 3 shows confocal microscopy images of dex-
HEMA microgels coated with different combinations of bio-polyelectrolytes. A clear ring of 
red fluorescence (due to the PARG which was fluorescently red labelled) surrounding the 
microgels can be observed indicating a successful LbL coating of the dex-HEMA microgels.  
 
 
Figure 3. Confocal microscopy images of the microcapsules obtained after LbL coating of the dex-HEMA 
microgels with 4 bio-polyelectrolyte bilayers. The microgels were fluorescently labelled with 150 kDa FITC-
dextrans (green colour) while the PARG in the LbL coating was fluorescently labelled with RITC (red colour). 
 
To investigate how the degradation of the dex-HEMA microgel core influences the 
bio-polyelectrolyte coating, the microcapsules were incubated in a 0.1 M phosphate buffer 
(pH 7.4) at 37 °C. After 5 days (being the time it takes to fully degrade the dex-HEMA 
microgel core at pH 7.4 and 37 °C) the microcapsules were investigated under the confocal 
microscope (Figure 4). The result was clearly dependent on the composition of the LbL 
membrane. In Figure 4A all microcapsules were ruptured; ‘self-rupturing’ capsules were thus 
obtained. In Figure 4B some microcapsules were ruptured while others remained intact and 
filled with FITC-dextran. In Figure 4C ‘hollow’ microcapsules were obtained i.e. the 
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microcapsules did not rupture but had released the 150 kDa FITC-dextran as no significant 
fluorescence could be detected within the microcapsules.  
 
 
Figure 4. Confocal images of dex-HEMA microgels (which were fluorescent labelled with 150 kDa FITC-dextrans; 
green colour) coated with respectively (A) (CHON/PARG)4, (B) (PGLUhigh/PARG)4 and (C) (DEXS/PARG)4 after 
degradation of the microgel core. In (A) all microcapsules were broken and had released their contents. In (B) 
both broken as well as intact (still filled with 150 kDa FITC-dextrans; green colour) were observed. The capsules 
in (C) remained intact but had released their content by diffusion through the bio-polyelectrolyte coating. In all 
cases the PARG was fluorescently labelled with RITC (red colour). 
 
Table 1. Depending on the membrane composition, degradation of the dex-HEMA microgel core results in self-
rupturing and/or hollow microcapsules.  
self-rupturing 
microcapsules 
hollow and self-rupturing 
microcapsules 
hollow 
microcapsules 
(PASP/PARG)4 (PGLUhigh/PARG) 4 (DEXS/PARG) 4 
(CHON/PARG) 4   
(PGLUlow/PARG) 4   
 
Table 1 shows which LbL membrane composition resulted in either self-rupturing or 
hollow microcapsules. The behaviour of the LbL membrane during degradation of the 
microgel core depends most likely on its mechanical strength and its permeability to the 
degradation products (i.e. 19 kDa dextran chains) of the microgel. (DEXS/PARG)4 
membranes remain intact probably due to the fact that they are permeable not only to the 
150 kDa FITC-dextrans but also to the degradation products of the microgels, which 
hampers the build-up of a significant osmotic pressure. The other bio-polyelectrolyte coatings 
are apparently less permeable to the degradation products of the microgels allowing the 
osmotic pressure to build-up and rupture the membrane.  It is also interesting to note that an 
increase in molecular weight of the PGLU clearly influences the (mechanical and/or 
permeability) behaviour of the microcapsules. Microcapsules fabricated with PGLUlow all 
rupture. The ones fabricated with PGLUhigh/PARG do not all explode, a percentage of them 
remains intact keeping the FITC-dextrans encapsulated. This indicates that the increase in 
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molecular weight of the PGLU changes the interplay between the mechanical properties and 
the permeability of the bio-polyelectrolyte coating. 
 
 
Figure 5. Confocal snapshots of (PGLUlow/PARG)4-coated microcapsules during degradation of the microgel core 
at alkaline pH. The microgels contained 150 kDa FITC-dextrans (green colour) and the PARG was fluorescently 
labelled with RITC (red colour). The time-interval between the successive snapshots is 20 s.  
 
We took a closer look at the behaviour of the (PGLUlow/PARG)4 microcapsules during 
degradation of the microgel core (Figure 5). The degradation was accelerated by increasing 
the pH of the dispersion (which accelerates the hydrolysis of the esters in dex-HEMA). Since 
PARG is a strong polyelectrolyte, its cationic groups are positively charged over a wide pH 
range. Therefore we could expect that the alkaline pH does not influence the properties of 
the polyelectrolyte membrane. This is crucial, as it has been reported that the properties of 
polyelectrolyte membranes containing one or more weak polyelectrolytes may change 
significantly as a function of the pH. 35, 38-40 Figure 5 shows confocal images taken at 20 s 
time intervals after the addition of 5 µl of 0.5 M NaOH to 5 µl of the (CHON/PARG)4 
microcapsule suspension. The microcapsules start to swell (Figure 5A-D) and at certain time 
(Figure 5F) all microcapsules rupture, most likely when the swelling pressure of the 
degrading microgels exceeds the tensile strength of the bio-polyelectrolyte membrane. After 
rupturing, only remnants of broken microcapsules are observed (Figure 5F) having 
completely released the encapsulated FITC-dextran.  
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Figure 6. Confocal microscopy images of (DEXS/PARG)4 coated dex-HEMA microgels before (A) and after (B) 
degradation of the microgel core. The PARG was red fluorescently labelled with RITC. The microgels were 
initially loaded with 150 kDa FITC-dextran (green colour) 
 
Figure 6 shows confocal microscopy images of (DEXS/PARG)4 microcapsules both 
before (A) and after (B) degradation of the microgel core. After degradation, the interior of the 
microcapsules is no longer (green) fluorescent which indicates the outward diffusion of the 
FITC-dextrans during the degradation process of the microcapsules. Figure 7 shows SEM 
images of the microcapsules (A) before, and (B) after degradation of the microgel core.  The 
rough surface in Figure 7A is probably due to the differential drying between the dex-HEMA 
microgel core and the (DEXS/PARG)4-coating upon sample preparation. In Figure 7B one 
can see a collapsed microcapsule, which confirms that the microgel core has indeed been 
degraded, yielding a hollow microcapsule. Using AFM, the thickness of the bio-
polyelectrolyte membrane could be estimated (Figure 8A-D) according to the method 
reported by Leporatti et al. 41 Taking into account that the measured height is twice the 
thickness of a single microcapsule wall, the thickness is estimated to be 45 ± 4 nm (as 
obtained from measurements on three different microcapsules). Compared to other LbL 
membranes, the (DEXS/PARG)4-coating seems to be rather thick. While Déjugnat et al. 35 
reported a mean bilayer thickness of 3.5 nm for poly(styrene sulfonate)/poly(allylamine 
hydrochloride) (PSS/PAH) we measured a mean thickness of 11 nm per DEXS/PARG 
bilayer. Bio-polyelectrolyte multilayers deposited on flat substrates have been studied by 
Picart et al. 42, 43 They reported that the thickness of the membranes increases exponentially 
as a function of the number of adsorbed layers. Also LbL multilayer films from 
polysaccharides and polypeptides seem to show an exponential growth, contrary to 
PSS/PAH multilayers which show a linear growth step as a function of layer number. 42, 43 It 
could also be possible that in Figure 4C not all of the degradation products of the microgel  
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were expelled from the microcapsules’ interiors (see below). These residual dextrans could 
result in a higher estimation of the shell thickness from AFM measurements. 
 
 
 
Figure 7. SEM images of (DEXS/PARG)4 coated dex-HEMA microgels before (A) and after (B) degradation of the 
microgel core. 
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Figure 8. AFM image of a hollow (DEXS/PARG)4 microcapsule fabricated from a dex-HEMA microgel as 
sacrificial template. (A) topology image, (B) error image, (C) Height profile along the line indicated in (A) and (D) 
3D image. 
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Hollow (DEXS/PARG)4 capsules, obtained after degradation of the dex-HEMA 
microgel cores, were incubated for 30 min in FITC-BSA or 40 kDa FITC-dextran solutions 
(0.5 mg/ml). Figures 9A and 9B show the FITC-BSA and FITC-dextran strongly accumulated 
inside the hollow microcapsules. Nearly no fluorescence remained in the solution 
surrounding the microcapsules. Similar results were obtained FITC-dextrans with a molecular 
weight ranging from 4 to 2000 kDa (data not shown). On the contrary, hollow (DEXS/PARG)4 
capsules fabricated from MnCO3 microparticles as sacrificial template did not become filled 
with FITC-BSA (Figure 9C), in agreement with earlier findings. 44, 45  
 
 
Figure 9. Confocal microscopy images of hollow (DEXS/PARG)4 microcapsules, fabricated from dex-HEMA 
microgels as sacrificial template, dispersed in (A) a FITC-BSA solution and (B) a 40 kDa FITC-dextran solution. 
(C) Confocal microscopy image of hollow (DEXS/PARG)4 microcapsules, fabricated from MnCO3 microparticles 
as sacrificial template, dispersed in a FITC-BSA solution.   
 
Currently, it remains speculative why hollow (DEXS/PARG)4 dex-HEMA microgel-
templated microcapsules so strongly absorb FITC-BSA while hollow (DEXS/PARG)4 
microcapsules templated on MnCO3 exclude FITC-BSA. It is known that the permeability of 
polyelectrolyte membranes not only greatly depends on external conditions, such as pH and 
ionic strength, but also on the type of sacrificial template from which they are fabricated. 46-49 
As 150 kDa FITC-dextrans are able to diffuse through the (DEXS/PARG)4 membrane during 
degradation of the dex-HEMA microgel core (Figure 6), it is very likely that most of the 19 
kDa dextran chains, from which the microgels were fabricated, are also able to permeate the 
(DEXS/PARG)4 membrane. It remains possible, however, that not all the dextran chains left 
the microcapsules. Indeed, when the hollow (DEXS/PARG)4 microcapsules were viewed with 
the confocal microscope at maximum laser intensity, traces of green fluorescence (due to 
remaining 150 kDa FITC-dextran) could still be observed inside the microcapsules (data not 
shown). It is known that many proteins show affinity for dextrans, 50 therefore remnants of 
dextran in the hollow capsules might explain the accumulation of FITC-BSA.   
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CONCLUSIONS 
 
This study reported on the successful fabrication of microcapsules consisting of a 
biodegradable dextran microgel core surrounded by a bio-polyelectrolyte multilayer coating 
applied to the microgels by layer-by-layer technology. Upon degradation of the microgel core, 
depending on the composition of the bio-polyelectrolyte coating, either ‘self-rupturing’ or 
‘hollow’ microcapsules were obtained.  
Self-rupturing microcapsules, being microcapsules that suddenly rupture due to the 
swelling pressure of the degrading microgel core, were obtained by LbL coating of dex-
HEMA microgels with 4 bio-polyelectrolyte bilayers of CHON/PARG, PGLUlow/PARG or 
PASP/PARG. The major difference between the self-rupturing microcapsules described in 
this chapter and those reported in chapter 2 is that the former explode at a physiological pH. 
Their exterior coating consists not of synthetic, but biological polyelectrolytes. Both the 
rupturing at a physiological pH and the use of bio-polyelectrolytes are promising features in 
the development of self-rupturing microcapsules for drug delivery purposes. 
Hollow capsules could be obtained by degrading dex-HEMA microgels after they 
were coated with 4 bio-polyelectrolyte bilayers of DEXS/PARG. It was shown that FITC-BSA 
and FITC-dextran spontaneously accumulate in the hollow capsules while they did not 
accumulate in (DEXS/PARG)4 hollow microcapsules prepared from MnCO3 microparticles as 
sacrificial template. Previously reported procedures to load hollow polyelectrolyte 
microcapsules with macromolecules often require the inclusion of oppositely charged 
species 51 or an additional step, such as a change in pH, 52, 53 ionic strength, 54 solvent 
polarity, 55 cross-linking, 56  to temporarily change the permeability of the microcapsule’s 
membrane. The spontaneous deposition of biomacromolecules in hollow microcapsules 
prepared from dex-HEMA microgels as sacrificial template could be of interest for drug 
encapsulation purposes.  
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ABSTRACT 
 
Self-exploding microparticles show potential for advanced delivery of certain 
therapeutics. This study evaluates (1) whether degrading biodegradable dextran 
hydroxyethyl methacrylate (dex-HEMA) microgels can be coated by a lipid membrane and 
(2) whether the surrounding membrane can be ruptured by the increasing swelling pressure 
of the degrading microgel. We found that adsorption of charged liposomes to oppositely 
charged dex-HEMA microgels provides efficient coating of the microgels whereby 
microparticles with a ‘core-shell’ structure were clearly obtained. Especially, we could confirm 
experimentally that the swelling pressure increase of degrading dex-HEMA microgels can 
destroy the lipid membrane surrounding the microgels. 
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INTRODUCTION 
 
Thanks to recent progress in biotechnology and medicine an increasing amount of 
macromolecular therapeutics (such as proteins and DNA) has become available. As these 
drugs have to be protected from threatening environments during administration, a lot of 
scientific effort has been focused on developing appropriate matrices. Due to their high 
biocompatibility and tuneable properties, hydrogel matrices are an attractive method to 
encapsulate such drugs. Our research group is focusing on ‘exploding microgels’ for pulsed 
drug delivery. 1 We envision micron-sized (bio)degradable gel particles surrounded by a 
membrane that is permeable to water but impermeable to both the entrapped drugs and the 
degradation products of the gel. As the microgel degrades its swelling pressure increases. 2,3 
At a critical value of the swelling pressure we foresee that the membrane will rupture and the 
entrapped drugs will be released.  
Clearly, to realize this concept, one requires a (water permeable) coating surrounding 
the microgels. Technology that allows coating the surface of hydrogels is very attractive for 
numerous applications in biomedicine and pharmacy, e.g. for tailoring the hydrophilicity or 
permeability. However, a general method for the coating of hydrogel surfaces does not yet 
exist. Obviously, coating microgels demands additional requirements when compared to 
coating planar supports, a main issue being that the microgels need to remain colloidally 
stable. Some strategies have been developed to coat microgels with lipids. Kiser et al. 4,5 
centrifuged drug loaded microgels into a lipid film deposited on a glass vial. Several groups 
modified the hydrogel surface by inserting lipid anchors at the microgel surface, which 
promote the self-assembly of lipid membranes. 6-9 Although attractive, these methods do 
show some limitations. For example, when we coated dextran-based microgels by the 
method of Kiser et al. we observed that only a marginal part of the microgels became lipid 
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coated. Also, the grafting of fatty acid chains on the microgels’ surface, requiring the use of 
organic solvents, may be hazardous to many biotechnological drugs.  
The aim of this chapter is twofold. In the first part we aim to demonstrate how dextran 
hydroxyethyl methacrylate (dex-HEMA) microgels can be coated with lipids, using 
electrostatic interactions as a driving force. In the second part we aim to show that the 
increase in swelling pressure, due to the degradation of the dex-HEMA microgels, can 
rupture the surrounding lipid membrane. 
 
Table 1. List of abbreviations of the polymers and lipids used in this study 
abbreviation full term net charge* 
dex-HEMA dextran-hydroxyethyl methacrylate 0 
dex-MA dextran-methacrylate 0 
dex-HEMA-MAA dextran-hydroxyethyl methacrylate-co-methacrylic acid - 
dex-HEMA-DMAEMA dextran-hydroxyethyl methacrylate-co-dimethyl aminoethyl 
methacrylate 
+ 
dex-MA-MAA dextran-methacrylate-co-methacrylic acid - 
PLGA poly(lactic-co-glycolic acid) - 
PAH poly(allylamine hydrochloride) + 
PSS poly(styrene sulfonate) - 
CHIT chitosan + 
DEXS dextran sulfate - 
SOPC stearoyl oleoyl phosphatidylcholine 0 
DOPA dioleoyl phosphatidic acid - 
DOTAP dioleoyl trimethylammoniumpropane + 
DOPE dioleoyl phosphatidylethanolamine 0 
*under physiological conditions 
 
 
MATERIALS AND METHODS 
 
Materials. 
 
 Sulfuric acid (98 %), hydrogen peroxide (H2O2) (30~%) and potassium persulfate 
(KPS) were purchased from Merck VWR. Dimethyl sulfoxide (DMSO), 4-N,N-
dimethylaminopyridine (DMAP), glycidyl methacrylate (GMA), N,N,N’,N’-
tetramethylethylenediamine (TEMED), methacrylic acid (MAA), dimethyl aminoethyl 
methacrylate (DMAEMA), chitosan (CHIT; low molecular weight), sodium 
poly(styrenesulfonate) (PSS, Mw~70 kDa), poly(allylamine hydrochloride) (PAH, Mw~70 
kDa) and poly(vinyl alcohol) (PVA, Mw~70 kDa) were obtained from Aldrich. Dextran (Mw~19 
104
Chapter 5 - Self-Exploding Lipid Coated Microgels 
 
 
 
kDa) and dextran sulfate (DEXS, Mw~500 kDa), were obtained from Fluka. Tetramethyl 
rhodamine isothiocyanate-dextrans (TRITC-dextran, Mw~158 kDa) and fluorescein 
isothiocyanate-polyallylamine hydrochloride (FITC-PAH, Mw~70 kDa) were purchased from 
Sigma. The lipids SOPC (stearoyl oleoyl phosphatidylcholine), DOPE (dioleoyl 
phosphatidylethanolamine), DOPA (dioleoyl phosphatidic acid) and DOTAP (dioleoyl 
trimethylammoniumpropane) were obtained from Avanti Polar Lipids. Cholesteryl BODIPY FL 
C12 was obtained from Molecular Probes. Poly(lactic-co-glycolic) acid (PLGA; 5050 DL 4A) 
was obtained from Alkermes. One-side polished 475 µm-thick silicon wafers were obtained 
from ACM (Applications Couches Minces, France) with (100) orientation. Table 1 gives an 
overview of the abbreviations of the polymers and lipids used in this chapter. 
 
Synthesis of dex-HEMA and dex-MA.  
 
Dex-HEMA with a DS of 2.5 and dex-MA with a DS of 5 were prepared and 
characterized as previously described. 10 The synthesis of dex-MA was as follows (Figure 1 
gives the reaction scheme for the synthesis of dex-MA). Dextran (50 g)and DMAP (10 g) 
were dissolved in 500 ml DMSO under a nitrogen atmosphere. GMA (14.5 mmol; 2 g) was 
added and the reaction mixture was stirred for 48h under a nitrogen atmosphere. Afterwards 
the reaction mixture was put in dialysis bags (Mw cut off of 14kDa). After 5 days of dialysis 
the solution is freeze dried and dex-HEMA us obtained as a white fluffy product. The DS of 
the dex-MA is determined by 1H-NMR in D2O. 
 
 
Figure 1. Reaction scheme for the synthesis of dex-MA. 
 
Preparation of dex-HEMA microgels.  
 
Dex-HEMA microgels were prepared according to Stenekes et al. 11 In detail, 
deoxygenated aqueous solutions of dex-HEMA (25 % w/w solution) and polyethylene glycol 
(PEG; 24 % w/w solution; 20 kDa) were prepared. The dex-HEMA and PEG solutions were 
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vigorously mixed with a vortex for 1 min under a nitrogen atmosphere to obtain a water-in-
water emulsion. A PEG/dex-HEMA ratio of 19 (v/v) was used; the total volume amounted to 5 
ml. The resulting emulsion was allowed to stabilize for 10-15 min. Subsequently TEMED 
(100 µl pH neutralized with 4 N HCl) and KPS (180 µl, 41 mM) were added to cross-link the 
dex-HEMA. After gentle mixing, the emulsion was incubated without stirring for 30 min at 
40°C yielding microgels with an estimated water content of approximately 70 % (w/w). 12 
Three washing and centrifugation steps with 50 ml Milli-Q water removed the residual KPS 
and TEMED. The remaining pellet was suspended in 5 ml Milli-Q water. To prepare 
negatively and positively charged dex-HEMA microgels, 13 respectively methacrylic acid 
(MAA; 25 µl) or dimethyl aminoethyl methacrylate (DMAEMA; 35 µl) were added to the 
mixture just before vortexing the dextran and PEG solutions as described in the paragraph 
above. In this chapter ‘dex-HEMA-MAA microgels’ and ‘dex-HEMA-DMAEMA microgels’ 
refer to negatively charged and positively charged microgels, respectively. Dex-MA microgels 
were fabricated in an identical way as dex-HEMA microgels. 
 
Preparation of PLGA microparticles.  
 
100 mg PLGA was dissolved in 10 ml dichloromethane. 100 mg PVA was dissolved in 
100 ml water. Both solutions were mixed by vortexing for 1 min yielding an emulsion of 
dichloromethane in water. 50 ml water was added and the emulsion was stirred for 3 hours at 
40 °C to evaporate the dichloromethane. The resulting PLGA microparticles were centrifuged 
and washed twice with Milli-Q water. Afterwards they were stored at 4 °C. 
 
Lipid coating of dex-HEMA microgels.  
 
The lipid vesicles were prepared as follows. The lipids were first dissolved in 
chloroform (2 mg/ml). Subsequently the chloroform was evaporated yielding a lipid film on a 
glass vial. To obtain lipid vesicles (liposomes), water was added up to a final lipid 
concentration of 1 mg/ml and sonicated (Bransonic 32, Branson Ultrasonics, 150 Watt) for 5 
min. To reduce the size of the liposomes, the liposomes were extruded through a 
polycarbonate membrane with a pore size of 100 nm. The (charged) liposomes (500 µl) were 
mixed with a suspension (200 µl) of (oppositely charged) microgels and shaken for 20 min to 
allow adsorption of the lipid vesicles to the surface of the microgels. Then the samples were 
centrifuged for 3 min at 500 g and the supernatant was removed. The centrifugation and 
resuspension procedure was repeated three times. Finally the microgels were redispersed in 
500 µl Milli-Q water and stored at 4 °C. 
106
Chapter 5 - Self-Exploding Lipid Coated Microgels 
 
 
 
Lipid coating of PLGA microparticles.  
 
The PLGA microparticles were first ‘pre-coated’ with 3 polyelectrolyte bilayers by 
alternating immersion in aqueous solutions of dextran sulfate (2 mg/ml) and chitosan (1 
mg/ml) in the presence of 0.5 M NaCl. The polyelectrolytes were allowed to adsorb for 15 
min, under continuous gentle shaking. The dispersion was then centrifuged and the 
supernatant was removed. Afterwards, the microparticles were redispersed in Milli-Q water to 
wash away the non-adsorbed polyelectrolytes. This washing was repeated twice before the 
second polyelectrolyte solution was added. The process was repeated until 3 bilayers were 
deposited. In a final step, the pre-coated PLGA particles were lipid coated, following the 
same procedure as for the lipid coating of microgels. 
 
Degradation experiments.  
 
In order to visualize the degradation behavior of the (lipid-coated) microgels a 10 µl 
drop of microgel suspension was put at room temperature on a coverslip under the confocal 
microscope. To accelerate the degradation rate of the (lipid coated) microgels 10 µl of a 1 M 
NaOH solution was added to the drop of microgel suspension and the behavior of the 
microgels was followed under the confocal microscope.  
 
Confocal laser scanning microscopy. 
 
 Confocal micrographs of the lipid coated microgels and PLGA microparticles were taken 
with a MRC1024 Bio-Rad confocal laser scanning microscope (CLSM) equipped with a 
krypton-argon laser (Biorad, Cheshire, UK). An inverted microscope (Eclipse TE300D, Nikon, 
Japan) was used which was equipped with a water immersion objective lens (Plan Apo 60X, 
NA 1.2, collar rim correction, Nikon, Japan). Dex-HEMA microgels were made fluorescent by 
adding 1 mg TRITC labelled dextrans to the dex-HEMA/PEG mixture before the cross-
linking. 
 
Electrophoretic mobility.  
 
The electrophoretic mobility of the layer-by-layer (LbL) coated microgels was 
measured using a Malvern Zetasizer 2000 (Malvern Instruments). The ζ-potential was 
calculated from the electrophoretic mobility (μ) using the Smoluchowski relation:  ζ=μη/ε 
where η and ε are the viscosity and permittivity of the solvent, respectively.  
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Scanning electron microscopy (SEM).  
 
Samples for Scanning electron microscopy (SEM) imaging were prepared by drying 
under vacuum followed by sputtering with chrome. SEM images were recorded using a 
Gemini Leo 982, operating at an accelerating voltage of 1 kV.  
 
Lipid coating of silicon wafers. 
 
 One-side-polished 475 µm-thick silicon wafers were cut into rectangles (2x3 cm). The 
wafers were cleaned for 20 min in freshly prepared piranha solutions (H2O2 (30 %): H2SO4 
(98 %); 1:1 v/v (Caution: piranha solutions react violently with organic materials and should 
not be stored in closed containers), then abundantly rinsed with Milli-Q water. Wafers were 
dried by spinning with a spin coater. Prior to adding the lipid coating to the silicon wafers, 
polyelectrolyte multilayers were first deposited by alternating dipping of the silicon wafers in 
aqueous solutions of dextran sulfate (2 mg/ml) and chitosan (1 mg/ml) in the presence of 
0.5 M NaCl for 5 min. Three rinsing steps in Milli-Q water and one drying step were applied 
in-between each adsorption step.  This process was repeated 3 times. Thereafter, the 
SOPC:DOTAP (9:1) lipid layer was deposited by dipping the polyelectrolyte coated silicon 
wafer in a lipid vesicle dispersion prepared as described above. 
 
Ellipsometry.  
 
The thickness of the film deposited on the silicon wafers was determined in air with a 
null ellipsometer (Multiskop from Optrel, Berlin, Germany) at a fixed incident angle of 70° and 
a fixed wavelength of 5320 Å. A refractive index of 1.48 was assumed to determine the film 
thickness. 
 
X-ray reflectometry (XRR). 
 
The experimental setup consists of a Siemens D5000 2-circles goniometer of 30 cm 
radius and 0.002° positioning accuracy. X-rays of 1.5418 Å wavelength (Cu Kα) were 
obtained from a Siemens rotating anode operated at 40 kV and 300 mA, fitted with a graphite 
secondary monochromator and a scintillation counter. The beam was defined by a 40 µm-
wide slit placed at 17.5 cm from the focal point. Parastatic scattering was decreased by a 
200 µm wide slit placed after the 40 µm slit. The sample was placed at the center of the 
goniometer with an automated procedure, using a vertical stage of 1 µm resolution. The 
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intensity was scaled to unit incident intensity, and then corrected for spill-over at very low 
angles of incidence. Data are reported as a function of kz0, the vertical component of the 
wave vector of the incident photons in a vacuum.  
XRR data were analyzed in two ways. First a Patterson function was computed from 
the data as described elsewhere,14 and the average thickness of the coating was obtained 
from the position of the subsidiary correlation peak in this function. Second, a model of 
electron density was fitted to the data. The electron density profile was discretized as a 
succession of flat slabs of width Δ=0.5 nm, approximately corresponding to the resolution of 
the experiments defined by kz0,max, the maximum value of kz0 for which the signal is not yet 
dominated by the background (Δ=π/(2.kz0,max)). The number of slabs required was initially 
selected from the known thickness of the coating determined by the Patterson function. It 
was progressively incremented to take into account the width of the interfaces, until the fit 
was deemed satisfactory as judged from the value of χ2 obtained. The fit parameters were 
the height (electron density) of each slab, a general scaling parameter, and a constant 
background value. The reflectivity was computed using Paratt’s formalism. 15,16 To ease 
interpretation, the electron density profiles are represented by dots placed at the centers of 
each slab; cubic spline interpolation of these profiles was used to draw a smooth line through 
the dots.  
 
 
RESULTS AND DISCUSSION 
 
Dex-HEMA and dex-MA were synthesized according to van Dijk-Wolthuis et al. 10 by 
grafting dextran with carbonyl imidazole activated HEMA (HEMA-CI) respectively glycidyl 
methacrylate (GMA). Microgels were synthesized using an all-aqueous water-in-water 
emulsion technique based on the immiscibility of a dex-(HE)MA and a polyethylene glycol 
(PEG) phase. 17 In a first approach we tried to coat the dex-HEMA microgels by centrifuging 
the microgels into a lipid film at the bottom of the test tube, following the procedure reported 
by Kiser et al. 4,5 However, in this way only a low percentage of the dex-HEMA microgels 
became lipid coated. Looking further for a more efficient way to coat the dex-HEMA 
microgels with a lipid membrane we thought to make charged microgels and coat them with 
oppositely charged lipids, using electrostatic attraction as the driving force. Addition of 
DMAEMA and MAA during synthesis of the dex-HEMA microgels allowed us to obtain 
positively and negatively charged dex-HEMA microgels, as evidenced from ζ-potential 
measurements (Figure 2A).  
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Figure 2.  (A) ζ-potential of dex-HEMA-MAA and dex-HEMA-DMAEMA microgels, respectively before and after 
coating with oppositely charged lipid vesicles. (B) CLSM images of dex-HEMA-DMAEMA microgels coated with 
SOPC:DOPA, the microgels themselves are fluorescently labelled with TRITC-dextrans while the lipids are 
labelled with BODIPY.   
 
In this study SOPC:DOPA, SOPC:DOTAP and DOPE:DOTAP  (all with a molar ratio 
of 9:1) liposomes were used. SOPC and DOPE are both neutral lipids while DOPA and 
DOTAP are respectively negatively and positively charged. For the formation of unilamellar 
liposomes it is important that the temperature at which the experiments are performed is 
above the phase transition temperature of the lipids. For all the lipids used in this study the 
phase transition temperature is below or equal to 0 °C, 18 allowing one to perform the 
experiments at room temperature. The combination of charged lipids with neutral lipids is 
necessary to avoid too much repulsion within the bilayers and thus allowing stable vesicles to 
form. CLSM clearly showed that upon exposure to the SOPC:DOPA lipid vesicles all the dex-
HEMA-DMAEMA microgels became lipid coated (Figure 2B). Microparticles with a core-shell 
structure were obtained with lipids only at the surface of the microgels and not in the interior, 
as schematically represented in Figure 3. We assume that the liposomes electrostatically 
interact with the charges at the microgel surface. Once the surface of a microgel is covered, 
the lipid vesicles probably spread open and form a lipid layer. Spreading of liposomes upon 
adsorption on a solid substrate has been observed by several other groups. 19-22 Recently 
Mornet et al. 22 reported on the coating of silica particles with a lipid bilayer. They observed 
with cryo electron microscopy that the lipid bilayer faithfully follows the contour of the solid 
support. Also they reported that to achieve spreading and fusing of the liposomes a ratio 
neutral to charged lipids of at least 3:1 was required. Liposomes with a higher net charge did 
not tend to spread, possibly due to electrostatic repulsion, this contributes to our choice of 
using liposomes with a ratio uncharged lipids to charged lipids of 9:1.  
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Figure 3. Proposed mechanism for lipid coating of microgels using the electrostatic interaction as driving force. 
The positively charged lipid vesicles adsorb onto the negatively charged microgels’ surface (A) and spread open, 
forming a continuous lipid layer surrounding the microgels (B). When the microgel degrades the number of 
crosslinks (•) decreases. This decreases the elasticity of the microgels thereby increasing the swelling pressure 
(C). When the swelling pressure reaches a critical value the lipid bilayer ruptures (D).  
 
Besides CSLM, electrophoretic mobility measurements also proved that the dex-
HEMA microgels became lipid coated.  Figure 2A shows that the ζ-potential of the microgels 
indeed inversed upon exposure to oppositely charged lipid vesicles. The morphology of both 
the lipid coated and uncoated microgels was further characterized by scanning electron 
microscopy (SEM). Figures 4C and 4D reveal that the surface of the uncoated microgels is 
smoother compared to the surface of the coated microgels. The observation of a rather 
rough surface of the lipid coated microgels can most likely be attributed to the differential 
drying of the microgel core and the lipid coating.  
To evaluate to what extent this way of lipid coating is broadly applicable on 
microparticles we performed experiments on neutral dex-HEMA microgels (Figure 5A and 
5B) and PLGA particles (Figures 5C). Both types of particles could be successfully coated 
with lipids if a polyelectrolyte film was first deposited onto the surface of the particles to 
introduce charges at the surface. Using the Layer-by-Layer (LbL) technique, as developed on 
colloidal particles by Sukhorukov et al., 23,24 we deposited 2 polyelectrolyte bilayers (using 
poly(styrenesulfonate) (PSS) and poly(allylamine) hydrochloride (PAH)) and one monolayer 
of PSS (denoted as (PSS/PAH)2PSS) on the neutral dex-HEMA microgels. On the PLGA 
particles a precursor film consisting of dextran sulfate (DEXS) and chitosan (CHIT) (denoted 
as (DEXS/CHIT)2DEXS) was applied. This 'pre-coating step' with polyelectrolytes was 
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performed by submerging the microgels for 15 min. in a 2 mg/ml polyelectrolyte solution 
containing 0.5 M NaCl, followed by two rinsing steps with pure water. The pre-coating step 
with polyelectrolytes was necessary, most likely to create a sufficient surface charge in order 
to electrostatically attract the liposomes, as a lipid coating could not be applied on PLGA 
particles or on neutral dex-HEMA microgels without a polyelectrolyte multilayer at their 
surface. Similarly it was not possible to coat microgels with only neutral charged lipids or with 
lipids bearing an equal charge as the microgels, indicating that electrostatic interactions play 
a major role in the lipid coating process we describe in this chapter.  
 
 
Figure 4. (A) SEM image of uncoated dex-HEMA-DMAEMA microgels. (B) SEM image of SOPC:DOPA coated 
dex-HEMA-DMAEMA microgels. 
 
 
Figure 5. (A) Green and (B) red fluorescence image of neutral dex-HEMA microgels first pre-coated with 
(PSS/PAH)2PSS and then coated with DOPE:DOTAP; PAH was FITC labelled and DOPE was rhodamine 
labelled. (C) PLGA microspheres first precoated with (CHIT/DEXS)3 and then coated with DOPE:DOTAP.  The 
lipids were labelled with BODIPY. 
 
Although the deposition of a lipid layer on the dex-HEMA microgels was evidenced 
we did not know whether one lipid bilayer or multiple lipid bilayers were formed. XRR is 
112
Chapter 5 - Self-Exploding Lipid Coated Microgels 
 
 
 
ideally suited to investigate the structure of ordered films. 14 As XRR should be performed in 
the dry state and on flat substrates it cannot be applied to microgels. To obtain some more 
insight into the deposition of charged lipids onto an oppositely charged surface we exposed 
liposomes to a silicon wafer onto which 3 bilayers CHIT/DEXS were deposited. Altough this 
surface probably differs largely from the microgels’ surface, it can serve as a model surface 
and will aid in understanding the lipid coating process. Figure 6 shows the X-ray 
reflectograms and the corresponding electron density profiles of (CHIT/DEXS)3 and 
(CHIT/DEXS)3/SOPC:DOTAP coated silicon wafers. From the number of Bragg peaks we 
estimated13 that the lipid coating obtained on the silicon wafers consists of approximately 20 
lipid bilayers, leading to a total thickness of 120 nm. As verification we measured the film 
thickness by ellipsometry and found a thickness of 119 nm which agrees with the XRR data. 
The absence of Kiessig fringes points towards a high roughness of the coating, most 
probably because the surface consists of steps of discrete height (integral multiples of the 
period), giving a cityscape profile to the surface.  Clearly, we cannot literally extend the 
observations made on the (flat) lipid coated silicon surface to the (spherical) lipid coated 
microgel surface. However, these observations allow speculating that the dex-HEMA 
microgels are probably covered with multiple lipid bilayers. From the XRR measurements it is 
most likely that upon adsorption the liposomes indeed fuse and spread resulting in a coating 
consisting of multiple lipid bilayers. In case the lipid coating would consist of intact non-fused 
liposomes it would be probably impossible to detect the 20 Bragg peaks, the width of each 
peak corresponding with a bilayer thickness of 6 nm which agrees well with literature data on 
the thickness of lipid bilayers.22 
As outlined in the introduction, the second aim of this work was to evaluate whether 
the swelling pressure of the degrading dex-HEMA microgels can rupture the surrounding lipid 
membrane. The degradation of dex-HEMA, by hydrolysis of the carbonate esters (indicated 
on Figure 1) that connect the methacrylate groups with the dextran backbone, results in high 
molecular weight dextran chains (19 kDa) and HEMA oligomers. 10 By hydrolysis of the 
carbonate esters, the cross links, which connect the dextran chains in the microgels, cleave. 
This lowers the elasticity of the microgels which, in turn, increases the swelling pressure of 
the dex-HEMA microgels. 2,3 In previous work, our group characterized how the swelling 
pressure of degrading dex-HEMA gels increases during degradation and showed that, when 
the gel becomes totally degraded, the swelling pressure at the end of the degradation equals 
the osmotic pressure of the obtained dextran solution. The swelling pressure of the 
completely degraded dex-HEMA hydrogels used in this study was previously determined to 
be around 150 kPa. 3 As lipids are known to have a limited permeability,25 we expected that 
the degradation products of the dex-HEMA microgels would not diffuse through the lipid 
membrane before the rupturing of the membrane. To accelerate the degradation of the lipid 
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coated dex-HEMA microgels, which ranges at neutral pH from days to weeks depending on 
the composition of the gel, 17 we added a sodium hydroxide solution (NaOH; 1 M) to the 
dispersion of lipid coated dex-HEMA microgels. Under these alkaline conditions hydrolysis of 
the dex-HEMA microgels occurs within minutes. Figure 7 shows CLSM snapshots, taken 
every 15 s, of the process.  Initially, during the first 75 s, the lipid membrane inflates and 
stretches, due to the increasing swelling pressure of the degrading dex-HEMA microgels. 
Finally, in the time interval between 75 and 90 s, this swelling pressure causes the rupture of 
the lipid membrane (as supporting information a movie is provided showing the explosion of 
a larger amount of lipid coated microgels, showing that all particles behaved in a similar way 
 
Figure 6. (A) X-ray reflectivity of silicon wafers coated with respectively (CHIT/DEXS)3 and 
(CHIT/DEXS)3/SOPC:DOTAP. Circles are experimental data. Lines are fits using the electron density profiles 
shown in part B. For clarity the curves have been displaced vertically. kz0 is the vertical component of the wave 
vector of the incident photons in vacuum. (B) Corresponding electron density profiles. Circles correspond to 
computed densities, and continuous lines were obtained by cubic spline interpolation.  
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during degradation) leading to a collapsed lipid membrane as is clearly shown in the image 
after 120 s. During the ‘stretch-phase’ of the lipid membrane we also observed the formation 
of ‘parachutes’ on the microgels preceding the complete explosion of the lipid membrane. 
The formation of these parachutes supports the hypothesis that the lipid film consists of 
multiple lipid bilayers which elongate, creating additional surface area, when subjected to the 
swelling pressure of the degrading microgel. As schematically outlined in Figure 8, at certain 
locations the lipid membrane may be weaker than at other locations due to discontinuities 
within single lipid bilayers. While the swelling pressure of the degrading microgel inflates the 
whole lipid membrane, at these weaker places in the membrane the increasing swelling 
pressure locally inflates the lipid membrane resulting in the formation of parachutes.  
 
 
Figure 7. CLSM snapshots of degrading dex-HEMA-MAA microgels, coated with SOPC:DOTAP. The first image 
(0 s) is obtained immediately after the addition of sodium hydroxide to the microgels. The subsequent images 
are taken each 15 s. The lipids are green labeled using BODIPY while the microgels are red labeled using 
TRITC-dextrans. Note that the fade out of the red color is not due to bleaching or leakage of the TRITC-dextrans 
from the microgels but due to the pH dependent fluorescence of TRITC. After explosion of the microgels (120 s) 
only remnants of the lipids can be observed 
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As the microgels immediately began to degrade upon exposure to NaOH it seems 
that the hydroxyl ions are able to diffuse through the lipid coating. On the other hand, the lipid 
coating appears to be impermeable to the degradation products of the microgels: they seem 
to remain in the lipid coated particles as an increase in osmotic pressure occurs which finally 
results in the rupturing of the lipid membrane. Several groups 18,26,27 have observed that 
supported lipid bilayers are permeable to small molecules whereas the corresponding 
liposomes seem impermeable to the same molecules. For example Pennefather et al. 
reported on lipid membranes supported on hydrogel beads which were impermeable to 
dextrans with a molecular weight ranging from 1.5 to 3 kDa whereas the membrane 
appeared to be permeable to calcium ions. 27 This permeability was attributed to the 
presence of small nanoscopic defects within the lipid bilayers allowing the diffusion of small 
molecules. Most likely a similar phenomenon occurs in case of lipid coating of dex-HEMA 
microgels. 
 
 
Figure 8.  ‘Parachute’ formation in the top bilayer during degradation of the dex-HEMA microgels. Discontinuities 
within a single lipid bilayer may allow the swelling pressure to inflate the top layer before complete rupturing of 
the lipid membrane.  
 
In the degradation experiment presented in Figure 7 the lipid-coated microgels were 
immersed in an alkaline solution. One could, however, wonder whether the alkaline medium 
did not damage the lipid coating, leading to desorption from the microgel surface. To 
elucidate this we prepared lipid coated (SOPC:DOTAP (9:1)) dextran-methacrylate (dex-MA) 
hydrogels containing MAA. While dex-HEMA hydrogels degrade through hydrolysis, dex-MA 
gels do not as no carbonate esters are present in the cross-links. 10 When 1 M sodium 
hydroxide was added to uncoated dex-MA-MAA microgels they remained intact (data not 
shown). A similar behaviour was observed when lipid coated dex-MA-MAA microgels were 
brought into contact with sodium hydroxide: the lipid film remained intact (lipid coated dex-
MA-MAA microgels were exposed to the NaOH during at least 1 h), parachute formation did 
not occur and the lipid coating did not desorb (Figure 9), all indicating that addition of NaOH 
did not influence the lipid bilayer itself within the observation period. This allowed us to 
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conclude that the rupture of the lipid membrane surrounding the dex-HEMA microgels upon 
addition of NaOH (Figure 7) is indeed attributed to the increase in swelling pressure of the 
degrading dex-HEMA core and not to NaOH-induced weakening of the lipid membrane.  
In the above sections we have shown that the swelling pressure of the degrading 
microgels can result in a rupturing of the surrounding lipid membranes. It can be argued that 
we were not able to deposit only a single lipid bilayer on the surface of the dex-HEMA 
microgels. However, multiple bilayers surrounding the microgels may provide us with a more 
robust system being more versatile for real applications. The use of 1 M NaOH to trigger the 
explosion of the lipid coating is clearly not a stimulus which can be provided by the human 
body in vivo. However, the only aim of adding NaOH was to accelerate the degradation of 
the lipid coated microgels in order to visualize their behavior in a reasonable time frame 
using confocal microscopy. To confirm that the explosion of the lipid coating also occurs at 
physiological conditions, the lipid coated dex-HEMA-DMAEMA microgels were incubated at 
37 °C in phosphate buffered saline. After 7 days lipid coated microgels could not be detected 
anymore indicating the degradation of the microgels and rupturing of the lipid coating. 
 
 
Figure 9. Lipid (SOPC:DOTAP) coated dex-MA-MAA microgels before and after the addition of sodium 
hydroxide. The lipid membrane remains intact. Note that the same fading of the red fluorescence occurs as 
observed in Figure 6, due to the pH dependent fluorescence of TRITC. 
  
 
CONCLUSIONS 
 
In this chapter we have demonstrated a new method for the lipid coating of microgels 
based on electrostatic interactions between the microgels’ charged surface and oppositely 
charged lipid vesicles. We have also demonstrated that this way of lipid coating is also 
applicable on non-charged microgels as well as PLGA particles, given that charges are 
introduced at their surface by applying a polyelectrolyte multilayer by the LbL approach. The 
lipid coating thus obtained very likely consists of multiple lipid bilayers and shows certain 
defects. We showed that the increase in swelling pressure, which occurs in degrading dex-
HEMA microgels, did indeed rupture the surrounding lipid membrane.  
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The prepared microgels may be promising for pulsed drug delivery applications. As 
the composition (i.e. cross link density) of the dex-HEMA microgels governs their 
degradation rate, and therefore how their swelling pressure increase 2,3, it may allow one to 
tailor the time of explosion of the lipid coated microgels by varying their composition. Using 
this concept one may be able to design a drug formulation which delivers the drug in a 
number of pulses after a single injection: a simultaneous injection of e.g. 3 populations of 
lipid coated dex-HEMA microgels, each population exploding at a well defined time after 
injection, may result in 3 drug pulses from a single injection. This clearly differs from other 
types of degradable microparticles that release the encapsulated drugs in a, more or less, 
constant rate. 28-30 
While others4,5 have reported on lipid coated microgels in which the lipid membrane is 
ruptured by an external trigger (e.g. electric field), the lipids surrounding the microgels 
presented in this chapter are ruptured by an internal trigger, namely at the moment the 
swelling pressure of the dex-HEMA reaches a critical value. To demonstrate the concept we 
used NaOH to trigger the rupturing of the coating. However, as the degradation of the 
microgels also occurs at physiological conditions the lipid-coated microgels presented in this 
study can be termed as ‘self-exploding microgels’. Our future research will focus on the 
release of macromolecules from such self-exploding microgels. 
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ABSTRACT  
 
Microgels are promising materials in drug delivery and biomedicine. Although 
monodisperse microgels would offer considerable advantages, most microgels investigated 
and used today are polydisperse in size. We report on the fabrication of 10 µm sized 
monodisperse microgels by emulsifying an aqueous dextran-hydroxyethylmethacrylate (dex-
HEMA) phase within an oil phase at the junction of microfluidic channels. Dex-HEMA 
microgels are biodegradable and are ideally suited for the controlled delivery of proteins.  
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INTRODUCTION 
 
Hydrogels are three dimensional polymer networks, connected chemically or 
physically, which are able to hold a large amount of water due to their hydrophilic nature. 
Spherical hydrogel microparticles, or microgels, have attracted large interest in drug delivery 
due to their biocompatibility and the possibility to package drug molecules within the polymer 
network.  When the microgels are fabricated from (bio)degradable polymers, the degradation 
of these hydrogels regulates the delivery of the encapsulated drug molecules when 
introduced into biological systems. 1 Stimuli responsive microgels may also be designed 
using physico-chemical motifs, which are able to respond to pH, 2 temperature, 3 electric field 
4 or glucose 5 changes, and provide an intelligent release of drugs. By tailoring the properties 
of the microgels, the release-rate and release-profile of the drug molecules can be optimized 
to suit the specific application. Until now, there is no general method available for the 
synthesis of monodisperse microgels. The use of monodisperse microgels for use in drug 
delivery systems or sensing applications should offer considerable advantages compared to 
polydisperse ones with respect to monitoring, predicting and modelling of their behaviour as 
they exhibit a constant and predictable response to external stimuli.  
‘Microparticles’ can be prepared in various ways. Microparticles have been prepared 
in bulk emulsions by mechanically shearing monomer into a continuous, immiscible phase, 
followed by subsequent polymerization of the emulsified droplets. However, the resulting 
particle size distribution is highly polydisperse. 6-9 Various approaches have been proposed 
to fabricate monodisperse microparticles. Recently, membrane emulsification techniques, in 
which the discontinuous phase is forced through a porous membrane into the continuous 
phase, have been reported to produce monodisperse droplets. 10 Sugiura et al. 11,12 
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synthesized monodisperse polymeric divinylbenzene beads (both large (> 50µm) as well as 
smaller (3-10 µm) ones) in micro channels. Thorsen et al. 13 used microfluidic devices to 
make monodisperse emulsion droplets, with the resulting droplet size controlled by the 
relative driving pressures of the two immiscible fluids and the geometry of the micro 
channels. Various groups used this approach to fabricate colloidal assemblies, 14,15 spherical 
and non-spherical microparticles 16,17 and photonic balls. 18 Nisisako et al. 19,20 reported on 
> 30µm sized monodisperse polymeric 1,6-hexanediol diacrylate microparticles obtained by 
emulsifying a monomer-containing phase in a non-solvent phase in a cross-flow set-up 
where the two liquid phases meet perpendicular in a T-shaped junction. The droplets were 
subsequently photochemically cured to form solid microspheres.  
 
Figure 1. Schematic representation of the (A) T-junction and (B) in-line microfluidic devices used in this study. (C) 
Image of the microfluidic device with the Tygon tubing attached to the PDMS-device with steel pins. (D) molecular 
structure of the dex-HEMA polymer (the Mw of the dex-HEMA is 19 kDa). 
 
The aim of the present research was to synthesize biodegradable monodisperse 
microgels by photopolymerisation of monodisperse pre-polymer droplets formed in a 
microfluidic device. The biodegradable monodisperse microgels were made from dextran-
hydroxyethyl methacrylate (dex-HEMA; Figure 1D). The synthesis and characterization of 
dex-HEMA were previously reported. 21,22 Unlike previously reported microfluidic devices in 
which the droplet formation is performed at a T-shaped junction, where water and oil phase 
meet perpendicular (Figure 1A), an in-line droplet generating channel geometry, were the 
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aqueous phase is flanked by the oil phase, is utilized (Figure 1B). The performance of the in-
line droplet generating geometry is compare to the T-shaped junctions and several distinct 
advantages of the in-line droplet generating geometry are pointed out. 
 
 
MATERIALS AND METHODS 
 
Materials.  
 
Dextran, chlorotrimethylsilane, mineral oil (low viscosity) and FITC-BSA was 
purchased from Sigma-Aldrich-Fluka. Irgacure 2959 was a gift from Ciba Chemicals. ABIL 
EM-90 was a gift from Degussa.  Photoresist AZ 4620 was purchased from Clariant. 
Polydimethyl siloxane (PDMS; Sylgard 184) was purchased from Dow Corning. Microscope 
glass slides (50x24 mm) were purchased from Esco. Air regulators were purchased from 
Control Air Inc. Digital Pressure gages were purchased from Dwyer Instruments, Inc). Tygon 
tubing with an internal diameter of 500 µm was purchased from Cole-Parmer. Steel 
connector pins were purchased from New England Small Tube Corp.  
 
Fabrication of silicon wafer moulds.  
 
The designs of the microfluidic channels was performed with Adobe Illustrator and 
imprinted on transparencies at a resolution of 5000 DPI. Silicon wafers were pre-treathed 
with Adhesion Promoter (Clariant), followed by spincoating (1 min, 1500 rpm) a 10 µm thick 
layer of AZ 4620 (Clariant) positive photoresist. The spincoated wafer was put for 5 min at 
90 °C. A next 10 µm layer AZ 4620 positive photoresist was spincoated onto the silicon wafer 
followed by 20 min incubation at 90 °C. The spincoated wafers were UV-irradiated through 
the transparencies for 1 min applying a 10 s on/off regime. The irradiated parts of the 
spincoated silicon wafers were washed off with 440 MIF Developer (Clariant) leaving 
rectangular positive relief mould profiles behind on the surface of the silicon wafers. The 
positive relief rectangular mould profiles were rounded by reflowing the photo-resist on a 
hotplate at 150 °C for 5 min. 
 
Fabrication of PDMS devices.  
 
The patterned silicon wafers were placed in Petri dishes and pre-treated with 5 drops 
clorotrimethylsilane. Sylgard 184 Base Silicon Elastomer was mixed with Sylgard 184 Curing 
125
CHAPTER 6 - MICROFLUIDIC FABRICATION OF MONODISPERSE BIODEGRADABLE MICROGELS  
 
 
 
Agent Silicon Elastomer in a 5:1 ratio and subsequently degassed. An approximately 5 mm 
thick layer of the mixture was cast onto the patterned silicon wafer in the Petri dish and cured 
in the oven for 20 min. Sylgard 184 Base Silicon Elastomer was mixed with Sylgard 184 
Curing Agent Silicon Elastomer in a 20:1 ratio, degassed and spincoated (1 min, 4000 rpm) 
on a microscope glass slide followed by curing in the oven for 20 min. The PDMS slabs are 
pealed off from the silicon wafers and holes for the connection pins are punched with a 
20 gauge blunt needle. The PDMS slabs were cleaned with isopropanol, dried with nitrogen 
and stuck onto the spincoated microscope glass slides. This construct was cured for another 
20 min at 80 °C in the oven.        
 
 
RESULTS AND DISCUSSION 
 
The microfluidic devices were fabricated by soft lithography. In soft lithography 
elastomeric materials such as poly(dimethyl siloxane) (PDMS) are used as building 
blocks. 23,24 PDMS are fluid polymers with a low glass transition temperature that form solid 
elastomers by cross-linking. Silicon wafer moulds containing the microfluidic channels in 
positive relief were fabricated by spin-coating a positive photo-resist on the silicon wafers 
followed by the UV-irradiation of the spin-coated wafer through the transparency printed with 
the microfluidic channels. After a development step, in order to remove the irradiated 
material, only the non-irradiated pattern of the microfluidic channels remained on the silicon 
wafer. By placing the patterned wafer on a hotplate at 150 °C for 5 minutes, the positive relief 
rectangular mould profiles were rounded by reflowing the photo-resist. While rectangular 
shaped walls caused the droplets to move along the walls of the channels, round shaped 
walls kept the droplets centred. The PDMS microfluidic chips were fabricated by casting a 
5 mm thick layer of PDMS on the moulds pre-treated with chlorotrimethylsilane. The chips 
were peeled from the moulds, interconnection ports punched, and sealed to glass coverslips 
pre-coated with a thin layer of partially cured PDMS. Finally, the microfluidic chips were 
sealed by overnight curing at 80 °C. The channels were approximately 100 µm wide x 20 µm 
high, tapering to 10 µm x 20 µm in the region where the oil and aqueous phase merged. 
Figure 1B shows a microscopy image of the microfluidic channels; Figure 1C shows the 
PDMS-device connected to the fluid reservoirs, containing respectively the dex-HEMA 
solution (30 % w/w; kinematic viscosity of 44 mm²/s at 25 °C) and the mineral oil (kinematic 
viscosity of 28 mm²/s at 25 °C), by 30 cm long Tygon tubing (500 µm internal diameter, 
~30 cm long) and steel pins (New England Small Tube Corp.). Compressed air was used to 
pressurize the reservoirs. Air pressure regulators equipped with digital pressure gages were 
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used to individually set the air pressure applied to the input reservoirs. In order to recover the 
droplets after manufacturing, a collection tube was connected to the outlet of the device. The 
inlet of the oil phases was split into two channels which met in the nozzle. The viscous oil 
stream impinged the flow of the aqueous dex-HEMA solution through the central cavity and 
created droplets via tip-streaming. Repeated contraction and expansion of the water-tip 
sheared a single droplet at each cycle and the stream was focused towards the outlet port for 
collection.  
 
 
Figure 2. Optical microscopy images of the production of monodisperse emulsion droplets in the in-line 
microfluidic device at (A) low production rate and (B) high production rate. C and D show close-ups of the 
corresponding nozzles.  
 
As mentioned above, our continuous phase was mineral oil while the emulsified 
phase was a 30 % (w/w) aqueous dex-HEMA solution. In the absence of a surfactant, a 
continuous aqueous stream was formed co-annular with the oil phase, as shown in 
Figure 2A. A non-ionic (cetyl dimethicone copolymer) surfactant, ABIL EM-90 (Degussa), 
was added to the oil phase at ~4 % (v/v) to reduce the surface tension between both phases 
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which facilitated emulsion formation and prevented subsequent coalescence prior to curing. 
In previous reports by our group 25 and the Hennink group, 6,7 dex-HEMA microgels were 
fabricated using a water-in-water emulsion technique based on the immiscibility of an 
aqueous dextran phase and an aqueous polyethylene glycol (PEG) phase.  Initially, we have 
also tried the use of a PEG solution as continuous phase but it was impossible to generate 
aqueous dex-HEMA droplets, due to the lack of shear between the two phases upon mixing. 
Figures 2B-D illustrate modes of droplet production in the microfluidic device at various 
pressure balances between the emulsified and continuous phases. Monodisperse droplets 
were formed at regular time intervals, at rates of ~101-102 Hz. Monodisperse droplets were 
formed at a low rate, when a low pressure was applied on the reservoirs and when the 
pressure on the dex-HEMA reservoir was low compared to the pressure on the oil reservoir 
(Figure 2B). Because the system remained at low Reynolds numbers, the droplets moved in 
an ordered way along the microfluidic channel without coalescence. By increasing the 
pressure on the dex-HEMA reservoir the droplets were individually sheared at a higher rate 
(Figures 2C-D). Figure 3A illustrates a single-file flow of droplets, while Figure 3B illustrates a 
self-assembled necklace pattern of droplets that results at higher relative pressures of the 
aqueous phase. Multiple droplets were formed at the nozzle when the instability generated at 
the droplet tip propagated faster than the liquid tread can retract. At a droplet frequency of 
~80 Hz, ~0.15 mg of monodisperse microgels was collected per hour. The size of the 
droplets can be slightly altered by changing the production rate, allowing tight control of final 
product size by modifying the relative operating pressures of the two inputs. 
 
 
Figure 3. Optical microscopy images of the emulsion droplets moving in an ordered fashion along the microfluidic 
channels.  
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As an alternative to the in-line droplet generating geometry also a T-junction 
geometry was used. This type of geometry was first reported by Thorsen et al., 13 producing 
water-in-oil emulsions inside microfluidic channels. Furthermore, T-shaped microfluidic 
junctions have been used by several other groups for the fabrication of monodisperse 
microparticles. 11, 20 In the T-junction, the aqueous and oil phase meet perpendicular and an 
aqueous tip is formed from which droplets are sheared off by the oil-phase at regular time 
intervals. Similar to the in-line droplet generating geometry, the formed droplets move along 
the microfluidic channels in an ordered way as shown in Figure 4. However, when the droplet 
generating process is observed more in detail one notices the formation of small droplets, so-
called satellites, sheared off simultaneously with the larger droplets. It was not possible to 
avoid the satellite formation through variation of the relative water/oil pressure as both at low 
as well as at high production speed satellite formation was observed (right images in Figure 
4). When the same experiment was repeated with pure water as aqueous phase instead of 
an aqueous dex-HEMA phase, no satellite formation was observed (data not shown). 
Apparently the failure of the T-shaped droplet generating geometry for the formation of 
monodisperse dex-HEMA droplets is due to the dex-HEMA phase itself. Moreover, also the 
production speed of this type of droplet generating geometry is limited compared to the in-
line droplet generating geometry. Whereas the in-line droplet generator can produce the 
‘self-assembled necklace’ structure of droplets moving parallel to each other, the T-shaped 
droplet generator is only able to produce one row of droplets thus limiting the droplet-
formation frequency. Therefore we proceeded further with the in-line droplet generating 
geometry for the production of monodisperse microgels. 
 
Figure 4. Optical microscopy images of the production of monodisperse emulsion droplets in the T-junction 
microfluidic device. The right images show enlarged images of the nozzle where the emulsion droplets are 
formed at low (upper right image) and high (lower right image) production speed. The red arrow points out the 
formation of satellites. 
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A photoinitiator, Irgacure 2959 (Ciba Chemicals), was added to the aqueous dex-
HEMA solution before the emulsification process to allow collected microspheres to be 
subsequently cured by UV irradiation. When the dex-HEMA droplets containing the 
photoinitiator left the microfluidic device they were collected in a separate vial and 
immediately polymerized by UV irradiation while still suspended within oil.  The cured dex-
HEMA microgels were then separated from the oil by centrifugation followed by several 
washing steps with deionised water. The removal of the oil from the surface of the microgels 
was verified by scanning electron microscopy. Figure 5A is an optical microscopy image of 
the dex-HEMA microgels suspended in water forming a hexagonal closely packed structure 
which is typical for microparticles exhibiting excellent size uniformity. Figure 5B shows the 
size distribution of a population of microspheres (n = 150), with an average diameter of 
9,9 µm ± 0,3 µm. In contrast to the uniform microgels prepared by microfluidic emulsification, 
Figure 5C illustrates the polydisperse microgels as synthesized by polymerizing droplets 
obtained by simply vortexing the same dex-HEMA and oil solutions. The main parameter 
determining the size of the microgels is the width of the channel in which the dex-HEMA 
phase is focused when leaving the nozzle. While very fine channels may be fabricated using 
soft lithography, with features on the order of a few microns, the operating pressures 
required to generate sufficient shear for emulsification becomes prohibitively large due to the 
increase in hydraulic resistance. When the applied pressure becomes too large, the bond 
between the PDMS and the coverslip loses integrity, resulting in the destruction of the 
device. This trade-off limits the size of the microgels produced by our soft microfluidic 
devices at a given operating point.  
 
 
Figure 5. Optical microscopy images of (A) monodisperse microgels synthesized using the microfluidic device, 
(B) the size of the monodisperse microgels (n = 150) and (C) polydisperse microgels synthesized by 
polymerization of dex-HEMA droplets obtained by ordinary emulsification of an aqueous dex-HEMA solution in 
mineral oil. 
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Dex-HEMA hydrogels are biocompatible 26,27 and degrade by hydrolysis of the 
carbonate ester groups which connect the polymerized methacrylate groups and the dextran 
chains, leading to the formation of both the original dextran chains and low molecular weight 
oligomethacrylates. This degradation process is schematically represented in step B of 
Figure 6. The degradation rate of dex-HEMA hydrogels depends on the cross-link density 
and can be tailored from days to months by varying (i) the number of methacrylate groups 
per dextran chain and (ii) the initial water content. 21,22 Dex-HEMA hydrogels are ideally 
suited for the encapsulation of proteins as the network structure is able to sterically entrap 
these proteins. 28 Once the hydrogels start to degrade, the size of the pores between the 
dextran chains increases due to the cleavage of the cross-links. This increase in porosity 
promotes the diffusion of the entrapped proteins out of the microgel into the bulk 
environment. To show that the microfluidic based method also allows loading of the 
microgels with proteins, we added fluorescein-labelled bovine serum albumin (FITC-BSA; 
 
Figure 6. Schematic representation of the polymerization of dex-HEMA (step A), leading to the formation of 
intra- and intermolecular cross-links which form the three dimensional hydrogel network, and (step B) the 
hydrolysis of the dex-HEMA hydrogels leading to the formation of dextran chains and oligomethacrylates as 
degradation products. 
 
 
Figure 7. Confocal images of dex-HEMA microgels containing FITC-BSA, respectively before (A), during (B) 
and after (C) degradation of the microgels.  
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0.1 mg per mg dex-HEMA) to the dex-HEMA phase. It was verified that the FITC-BSA was 
insoluble in the oil phase thus assuring total encapsulation efficiency. Moreover, it is 
known 29 that BSA tends to accumulate in a dextran rich phase. Figure 7A is a confocal 
microscopy image of a FITC-BSA loaded dex-HEMA microgel produced by microfluidic 
emulsification. Figures 7A-C show the FITC-BSA containing dex-HEMA microgels 
respectively during degradation (Figure 7B) and when completely degraded (Figure 7C). In 
this experiment we used sodium hydroxide to accelerate the degradation of the microgels, 
which normally takes several days to several weeks, depending on the cross-link density of 
the dex-HEMA microgels. 28 
 
 
CONCLUSIONS 
 
In conclusion, we have shown that monodisperse biodegradable dex-HEMA 
microgels can be prepared by the use of a PDMS microfluidic device. Aqueous dex-HEMA 
droplets were formed by periodic shearing of an aqueous dex-HEMA stream within a co-
flowing immiscible oil stream by an in-line nozzle geometry. The droplets were collected and 
polymerized by UV-irradiation with the formation of dex-HEMA microgels. A high production 
rate, by the simultaneous formation of monodisperse droplets, could be obtained by applying 
a high pressure on the dex-HEMA containing reservoir relative to the pressure on the 
reservoir containing the mineral oil. We also showed that the dex-HEMA microgels prepared 
by the microfluidic approach could be readily loaded with proteins. Microfluidic emulsification 
techniques such as those introduced in this chapter could be useful for rapid prototyping of 
drug delivery systems based on microgels with narrow size distributions. Further research 
will focus on the scale-up 30,31 of the process and on the evaluation of the monodisperse 
biodegradable microgels for specific applications in drug delivery.  
 
 
ACKNOWLEDGEMENTS 
 
B. G. D.G. gratefully acknowledges Ghent University for a BOF scholarship. J.P.U. 
was funded in part by the National Science and Engineering Research Council of Canada 
(PGSM Scholarship).  Degussa is thanked for the donation of the ABIL. 
 
 
 
132
CHAPTER 6 - MICROFLUIDIC FABRICATION OF MONODISPERSE BIODEGRADABLE MICROGELS  
 
 
 
REFERENCES 
 
1. Mathiowitz, E.; Jacob, J.S.; Jong, Y.S.; Carino, G.P.; Chickering, D.E.; Chaturvedi, P.; 
Santos, C.A.; Vijayaraghavan, K.; Montgomery, S.; Bassett, M.; Morrell, C., Nature 
1997, 386, 410-414. 
2. Chen, G.H.; Hoffman, A.S., Nature 1995, 373, 49-52.  
3. Yoshida, R.; Uchida, K.; Kaneko, Y.; Sakai, K.; Kikuchi, A.; Sakurai, Y.; Okano, T., 
Nature 1995, 374, 240-242.  
4. Kiser, P.F.; Wilson, G.; Needham, D., Nature 1998, 394, 459-462.  
5. Matsumoto, A.; Kurata, T.; Shiino, D.; Kataoka, K., Macromolecules 2004, 37, 1502-
1510. 
6. Franssen, O. Hennink, W.E., International Journal of Pharmaceutics 1998, 168, 1-7.  
7. Stenekes, R.J.H. Franssen, O. van Bommel, E.M.H. Crommelin, D.J.A. Hennink, 
W.E., Pharmaceutical Research 1998, 15, 557-561. 
8. Vladisavljevic, G.T. Williams, R.A., Advances in Colloid and Interface Science 2005, 
113, 1-20.  
9. Charcosset, C.; Fessi, H., Reviews in Chemical Engineering 2005, 21, 1-32. 
10. Nakashima, T.; Shimizu, M.; Kukizaki, M., Advanced Drug Delivery Reviews 2000, 45, 
47-56. 
11. Sugiura, S.; Nakajima, M.; Seki, M., Industrial and Engineering Chemistry Research 
2002, 41, 4043-4047. 
12. Sugiura, S.; Nakajima, M.; Itou, H.; Seki, M., Macromolecular Rapid Communications 
2001, 22, 773-778. 
13. Thorsen, T.; Roberts, R.W.; Arnold, F.H.; Quake, S.R., Physical Review Letters 2001, 
86, 4163-4166. 
14. Yi, G.R.; Thorsen, T.; Manoharan, V.N.; Hwang, M.J.; Jeon, S.J.; Pine, D.J.; Quake, 
S.R.;  Yang, S.M., Advanced Materials. 2003, 15, 1300-1304.  
15. Yi, G.R.; Manoharan, V.N.; Michel, E.; Elsesser, M.T.; Yang, S.M.; Pine, D.J., 
Advanced Materials 2004, 16, 1204-1208. 
16. Xu, S.; Nie, Z.; Seo, M.; Lewis, P.; Kumacheva, E.; Stone, H.A.; Garstecki, P.; Weibel, 
D.B.; Gitlin, I.; Whitesides, G.M., Angewandte Chemie International Edition 2005, 44, 
724-728.  
17. Dendukuri, D.; Tsoi, K.; Hatton, T.A.; Doyle, P.S., Langmuir 2005, 21, 2113-2116. 
18. Yi, G.R.; Jeon, S.J.; Thorsen, T.; Manoharan, V.N.; Quake, S.R.; Pine, D.J.; Yang, 
S.M., Synthetic Metals 2003, 139, 803-806. 
19. Nisisako, T.; Torii, T.; Higuchi, T., Chemical Engineering Journal 2004, 101, 23-29.  
133
CHAPTER 6 - MICROFLUIDIC FABRICATION OF MONODISPERSE BIODEGRADABLE MICROGELS  
 
 
 
20. Nisisako, T.; Torii, T.; Higuchi, T., Lab Chip 2002, 2, 24-26. 
21. van Dijk-Wolthuis, W.N.E.; Hoogeboom, J.A.M.; van Steenbergen, M.J.; Tsang, 
S.K.Y.; Hennink, W.E., Macromolecules 1997, 30, 4639-4645.  
22. van Dijk-Wolthuis, W.N.E.; Tsang, S.K.Y.; Kettenes-vanden Bosch, J.J.; Hennink, 
W.E., Polymer 1997, 38, 6235-6242. 
23 . Xia, Y.N.; Whitesides, G.M., Annual Review of Material Science. 1998, 28, 153-184.  
24. Whitesides, G.M.; Ostuni, E.; Takayama, S.; Jiang, X.Y.; Ingber, D.E., Annual Review 
of Biomedical Engineering 2001, 3, 335-373. 
25. De Geest, B.G.; Dejugnat, C.; Sukhorukov, G.B.; Braeckmans, K.; De Smedt, S.C.; 
Demeester, J. Advanced Materials 2005, 17, 2357-2361. 
26. De Groot, C.J.; Van Luyn, M.J.A.; Van Dijk-Wolthuis,W.N.E.; Cadee, J.A.; Plantinga, 
J.A.; Den Otter, W.; Hennink, W.E., Biomaterials 2001, 22, 1197-1203.  
27. Cadee, J.A.; Van Luyn, M.J.A.; Brouwer, L.A.; Plantinga, J.A.; Van Wachem, P.B.; De 
Groot, C.J.; Den Otter, W.; Hennink, W.E., Journal of Biomededical Mateials 
Research 2000, 50, 397-404. 
28. Franssen, O.; Vandervennet, L.; Roders, P.; Hennink, W.E., Journal of Controlled 
Release 1999, 60, 211-221. 
29. Albertsson, P.-A., 1986, Partition of Cell Particles and Macromolecules, 3rd edn. 
Wiley, New York. 
30. Thorsen, T.; Maerkl, S.J.; Quake, S.R., Science 2002, 298, 580-584.  
31. Leclerc, E. ; Sakai, Y. ; Fujii, T., Biotechnology Progess. 2004, 20, 750-755.  
 
 
 
 
134
CHAPTER 7 – GLUCOSE RESPONSIVE POLYELECTROLYTE MICROCAPSULES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 7 
GLUCOSE RESPONSIVE 
POLYELECTROLYTE MICROCAPSULES 
 
 
 
 
  
 
 
 
 
 
Parts of this chapter were published in: 
 
De Geest, B.G.;1 Jonas, A.M.;2 Demeester, J.;1 De Smedt, S.C.1 Langmuir 2006, 22, 5070-5074. 
 
1 Laboratory of General Biochemistry and Physical Pharmacy, Department of Pharmaceutics, 
Ghent University, Ghent, Belgium. 
2  Unité de Physique et de Chimie des hauts Polymères, Université catholique de Louvain, 
Louvain-la-Neuve, Belgium. 
135
CHAPTER 7 – GLUCOSE RESPONSIVE POLYELECTROLYTE MICROCAPSULES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
 
Phenylboronic acids are known to form covalent complexes with polyol compounds 
such as glucose. A novel polyelectrolyte, containing phenylboronic acid as glucose-sensitive 
moiety, has been synthesized and used for the fabrication of glucose-sensitive hollow 
polyelectrolyte capsules using the layer-by-layer technique. The response to glucose was 
observed as a rather fast dissolution of the capsules when brought into contact with a 
glucose-containing medium. These polyelectrolyte capsules are the first polyelectrolyte 
capsules able to respond to a stimulus that can be provided by the human body (i.e. an 
increase in glucose concentration). Therefore the concept we present has promising 
applications in the biomedical field for the controlled delivery of insulin. 
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INTRODUCTION 
 
Stimuli responsive capsules have gathered major scientific interest in different areas 
such as drug delivery, diagnostics and sensing. The layer-by-layer (LbL) technique 1-3 
provides an easy, low-cost and versatile method for the fabrication of hollow polyelectrolyte 
multilayer capsules. 4-6 Briefly, this technique is based on the alternating adsorption of 
oppositely charged polyelectrolytes onto a charged substrate. The major advantage of the 
layer-by-layer technique is its multifunctionality, allowing the incorporation of a broad variety 
of functional groups, 7 nanoparticles, 8-10 dyes, 11 enzymes, etc in the multilayers. Hollow 
polyelectrolyte capsules able to decompose as a consequence of an external stimulus such 
as pH, 12 salt, 13, 14 IR-laser 15-17 have been reported. However, the use of e.g. a change in pH 
as trigger is restricted to few locations in the body (e.g. upon transit from stomach to 
intestine). 
In this chapter we report on glucose-responsive hollow polyelectrolyte multilayer 
capsules using a novel synthesized polyelectrolyte containing phenylboronic acid as glucose-
sensitive moiety. Phenylboronic acids are known to form covalent complexes with 
polyolcompounds such as glucose. 18, 19 An important property of phenylboronic acid 
compounds in aqueous medium is that they are in equilibrium between an uncharged and a 
charged form as shown in Figure 1. Through complexation with glucose one is able to shift 
the equilibrium in the direction of increasing charged phenylborates because only charged 
borates can form a stable complex with glucose in aqueous media. Kataoka and co-workers 
have reported on phenylboronic acid containing poly(N-isopropylacrylamide) hydrogels. 20 
The addition of 5 mg/ml glucose, which increases the fraction of charged borate anions 
rendering the polymer more hydrophilic, shifts the lower critical solution temperature (LCST) 
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upwards from 22 °C to 35 °C. This results in a swelling and consequent release of the insulin 
loaded in the gels when the gels are incubated at a temperature between 22 °C and 35 °C. 
This is a very elegant system. However, its glucose-responsive capacity is limited to a 
narrow temperature window close to the LCST point. The concept we present in this chapter 
is not based on a change in LCST caused by glucose, but rather on a glucose-induced 
change in electrostatic interactions between a polyanion and a phenylboronic acid containing 
polycation.  
 
 
Figure 1. Equilibrium of phenylboronic acid compounds. 
 
 
EXPERIMENTAL 
 
Materials.  
 
4-Sodium polystyrene sulfonate (PSS; Mw~70 kDa), linear polyethylene imine (PEI; 
Mw~25 kDa), dimethyl aminoethyl acrylate (DMAEA; distilled under reduced pressure prior to 
use), N,N,N’,N’-tetramethylethylenediamine (TEMED), acrylic acid (AA), [1-ethyl-3-
(dimethylamino)propyl]carbo-diimide hydrochloride (EDC), hydrogen peroxide (35 %), FITC-
BSA and D-glucose were purchased from Sigma-Aldrich-Fluka. Aminophenylboronic acid 
(APBA) was purchased from Avocado Research Chemicals. Sodium chloride (NaCl), 
potassium peroxodisulphate (KPS), diethyl ether, sulfuric acid (98 %) and hydrochloric acid 
were purchased from Merck. Tetrahydrofuran (THF), methanol and diethyl ether were 
purchased from Acros Organics. Quartz slides were purchased from Hellma. Monodisperse 
polystyrene particles with a mean diameter of 10.25 µm were purchased from Microparticles 
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GmbH. Dialysis membranes (Mw cut off 25 kDa) were purchased from Spectra Por. Water 
used in all experiments was of Milli-Q grade. Rhodamine labeled PSS was synthesized as 
reported in literature. 21 
 
Synthesis of 3-acrylamidophenylboronic acid (AAPBA). 
 
AAPBA was synthesized according to Kitano et al.  In a 250 ml flask, placed in an ice 
bath, APBA (5.586 g, 30 mmol) was dissolved in distilled water (90 ml) followed by pH 
adjustment to 4.8 using 1 M NaOH. After dissolution of the APBA, EDC (6.903 g, 36 mmol) 
was added followed again by pH adjustment to 4.8 using 1 M NaOH. In a second 250 ml 
flask, AA (2.478 ml, 36 mmol) was dissolved in distilled water (30 ml), followed again by pH 
adjustment to 4.8 using 1 M NaOH. The acrylic acid solution was drop wise added to the 
other flask in the ice bath and allowed to stir for 1 h, followed by stirring overnight at room 
temperature. The reaction mixture was 4 times extracted with diethyl ether followed by the 
evaporation of the diethyl ether. The resulting product was recrystalized from water and 
obtained as a white solid. The yield was 33 % with respect to APBA.  1H-NMR in CD3OD 
using a Varian Mercury 300 NMR spectrometer: δ=5.75 (1H, dd, CH2=CH-), δ=6.35 (1H, dd, 
CHcisHtrans=CH-), δ=6.43 (1H, dd, CHcisHtrans=CH-) and δ=7.2-7.8 (4H, m, phenyl). The melting 
point of the AAPBA was 148 °C as determined by DSC (DSC 2920 Differential Scanning 
Calorimeter (TA Instruments)). 
 
Synthesis of the AAPBA-DMAEA copolymer (PAD).  
 
In a 200 ml two-necked flask 200 mg (= 1.047 mmol) AAPBA and 400 µl (= 2.794 
mmol) DMAEA were dissolved in 100 ml water. The mixture was deoxygenized by bubbling 
nitrogen for 30 min. To initiate the polymerization 20 mg KPS and 200 µl TEMED were added 
and the reaction mixture was stirred for 12 h at room temperature under a nitrogen 
atmosphere.  The mixture was subsequently dialyzed against water (pH adjusted to 3 using 
HCL) followed by dialysis against distilled water, leading to a partial precipitation of the 
polymer. After freeze-drying, the polymer was obtained as a white fluffy solid. Because the 
polymer appeared only soluble at a pH lower than 5 or higher than 11.5, and no organic 
solvent was suitable to dissolve the polymer, NMR and GPC analysis were not possible. The 
yield was 67 % with respect to AAPBA. The composition of the polymer was determined by 
elemental analysis (Vario EL; Elementar Analysensysteme, GmbH).  
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UV-VIS monitoring of the multilayer build-up.  
 
Quartz slides were cleaned and hydrophylized by treatment with freshly prepared 
piranha solution (H2O2 (35 %)/H2SO4 (98 %) 1:1 v/v (caution: piranha solution reacts violently 
with organic materials and should not be stored in closed containers) then abundantly rinsed 
with distilled water. The treated quartz slides were precoated with a PEI layer by immersion 
in a 2 mg/ml PEI solution containing 0.5 M NaCl. Multilayers of PSS/PAD were deposited on 
the PEI coated quartz slides starting with the negatively charged PSS by immersion in a 
2 mg/ml PSS solution (containing 0.5 M NaCl and 0.1 M HCl (pH 1)) during 15 min followed 
by rinsing with a 0.1 M HCl solution and pure water. Finally the quartz slides were dried 
under a nitrogen stream. After each deposition of a bilayer the absorbance of the film was 
measured with a Pharmacia Biochrom 4060 UV-VIS spectrophotometer. 
 
Fabrication of hollow capsules.  
 
Monodisperse polystyrene particles with a mean diameter of 10.25 µm served as a 
sacrificial template. Multilayer build-up was performed by the LbL technique from 1 mg/ml 
PAD and 2 mg/ml PSS solutions in 0.1 M HCl (pH 1) and 0.5 M NaCl. After each adsorption 
step, two washing steps with 0.1 M HCl were performed. When the desired amount of layers 
was deposited, the polystyrene core was dissolved overnight using THF followed by three 
washing steps with THF and four washing steps with distilled water.  
 
Electrophoretic mobility.  
 
The electrophoretic mobility of the LbL coated polystyrene particles was measured in 
pure water using a Malvern Zetasizer 2000 (Malvern Instruments). The ζ-potential was 
calculated from the electrophoretic mobility (μ) using the Smoluchowski relation: ζ=μη/ε 
where η and ε are the viscosity and permittivity of the solvent, respectively.  
 
Confocal microscopy.  
 
Confocal images of the hollow capsules were taken with a MRC1024 Bio-Rad 
confocal laser-scanning microscope (CLSM) equipped with a krypton-argon laser (Biorad). 
An inverted microscope (Eclipse TE300D, Nikon) was used which was equipped with a water 
immersion objective lens (Plan Apo 60X, NA 1.2, collar rim correction, Nikon). To visualize 
the microcapsules a 5 µL drop of capsule suspension was placed on a cover slip. To asses 
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the glucose responsive behavior of the microcapsules a second 5 µL drop, containing e.g. 
10 mg/ml glucose in a 0.2 M buffer (in order to obtain a total glucose concentration of 5 
mg/ml in a 0.1 M buffer), was gently added to the drop of capsule suspension avoiding 
capsule movement as much as possible.  
 
 
Figure 2. Polyelectrolytes used for the fabrication of the hollow capsules. PAD (A) serves as polycation and 
PSS (B) serves as polyanion.  
 
 
RESULTS AND DISCUSSION 
 
An acrylate having phenylboronic acid as a pending group, 3-acrylaminophenylboronic 
acid (AAPBA), was obtained by coupling acrylic acid with 3-aminophenylboronic acid 
hemisulphate using [1-ethyl-3-(dimethylamino)propyl]carbo-diimide hydrochloride as 
condensation reagent. AAPBA was copolymerized by radical polymerization in aqueous 
medium at room temperature with dimethyl aminoethyl acrylate (DMAEA) in a 1:2 (w/w) ratio 
AAPBA:DMAEA (corresponding with a monomer feed mixture of 40 mol% AAPBA and 
60 mol% DMAEA) using potassium peroxodisulphate as radical initiator and N,N,N’,N’-
tetramethyl ethylenediamine as catalyst.  After dialysis and freeze-drying, a white powder 
was obtained. This product will further on be denoted as PAD (structure A in Figure 2). The 
PAD seemed to be only soluble in water at a pH below 5 or above 11. At an intermediate pH, 
both the borate and amino groups are charged, which leads to complexation, resulting in the 
precipitation of the polymer. The exact composition of the copolymer, as determined from 
elemental analysis, was 44 mol% phenylboronic acid groups to 56 %mol amino groups, 
which is in agreement with the initial monomer ratio.  
UV-VIS spectrophotometry was used to determine whether the synthesized PAD and 
polystyrene sulfonate (PSS) could build-up a polyelectrolyte multilayer at the surface of 
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quartz slides. Quartz slides were first hydrophilyzed by treatment with piranha solution, 
inducing a negative surface charge.  Next, the quartz slides were pre-coated with a 
polyethylene imine monolayer, which is positively charged, to provide the quartz slides with a 
surface suitable for layer-by-layer deposition of polyelectrolytes. In total six bilayers 
PSS/PAD were deposited onto the quartz slides. The coating of the quartz slides with a PSS 
or PAD layer was performed as described earlier from polyelectrolyte solutions containing 
0.5 M NaCl and 0.1 M HCl (pH 1). The high salt concentration is required to keep the 
polyelectrolytes in a coiled conformation and to allow the deposition of a sufficient amount of 
polyelectrolyte.8 The low pH of the polyelectrolyte solutions was used in order to keep the 
boronic acid moieties uncharged during the layer-by-layer build-up. Figure 3A shows the 
absorbance spectra of the coated quartz slides recorded after the deposition of each bilayer. 
The absorbance increases after each deposition cycle, indicating a successful multilayer 
build-up. Figures 3B and C show the increase in absorbance at 225 nm and 250 nm 
(attributed to the aromatic groups in PSS and AAPBA) as a function of bilayer number. A 
nearly ‘linear growth’ of the multilayer can be observed.   
 
Figure 3. UV-VIS spectra of a quartz slide coated with PSS/PAD.’n’ denotes the number of PSS/PAD bilayers 
deposited on the surface of the quartz slide. The insets show the increase in absorbance at (B) 250 nm and (C) at 
225 nm as a function of the number of PSS/PAD bilayers. 
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Figure 4. (A) ζ-potential as a function of layer number during the multilayer build-up on the polystyrene particles. 
The measurements were performed in pure water (n=5). (B) Confocal microscopy image of hollow capsules 
consisting of 6 PAD/PSS bilayers. Note that the PSS was fluorescently labeled with RITC. 
 
As the PAD copolymer has shown to be suitable for multilayer formation in 
combination with PSS, the PAD/PSS polyelectrolyte pair was further used for the fabrication 
of hollow polyelectrolyte capsules. The fabrication of these hollow polyelectrolyte capsules 
was carried out in two consecutive steps. First the core material (being monodisperse weakly 
cross-linked polystyrene particles with a diameter of 10.25 µm) was coated with six PAD/PSS 
bilayers. The deposition conditions were identical to those used for the coating of the quartz 
slides except that no pre-coating step with PEI was required. In order to separate the 
polystyrene particles from non-adsorbed polyelectrolytes two washing steps with 0.1 M HCl 
(using the centrifugation procedure9) were carried out followed by the addition of the next 
polyelectrolyte solution. To monitor the multilayer build-up the ζ-potential of the particles was 
measured after each adsorption step (Figure 4A). The ζ-potential of the bare (non-coated) 
polystyrene particles was -21 mV and changed regularly between +45 and -52 mV upon 
adsorption of PAD, respectively PSS. The second step in the fabrication of the hollow 
capsules was the removal of the core material. Therefore THF was added to dissolve the 
polystyrene. Several washing steps with THF were carried out to remove the polystyrene 
followed by several washing steps with pure water in order to remove the THF.  In this way 
hollow polyelectrolyte capsules were obtained which were stored in pure water. The hollow 
capsules could be visualized by confocal microscopy when rhodamine labeled PSS was 
used during the multilayer build-up (Figure 4B). 
When the hollow capsules were placed into a buffered solution at pH 9 (0.1 M 
carbonate buffer) they remained stable, even after several days (data not shown). Note that 
upon polymerization and complexation with oppositely charged polyelectrolytes the apparent 
pKa of the amino groups in DMAEA (i.e. 8.4)  will  increase.  This explains  why the  capsules  
A B 
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Figure 5. Confocal microscopy images (recorded at fixed exposure) of hollow (PAD/PSS)6 capsules gradually 
disassembling in a 5 mg/ml glucose solution at pH 9. Note that the PSS was fluorescently labeled with RITC. The 
inset in the upper right corner shows the transmission light image of a capsule.  
 
 
Figure 6. Confocal microscopy images of the gradual filling and disassembling of hollow (PAD/PSS)6 capsules in 
a 5 mg/ml glucose solution at pH 9 containing FITC-BSA. Note that the PSS was fluorescently labeled with RITC. 
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remain intact at pH 9.  However, when the capsules were suspended in a solution containing 
5 mg/ml glucose at pH 9 they disappeared gradually. As Figure 5 shows, the capsules 
gradually faded out in time, accompanied by a small degree of swelling, and completely 
disappeared after 250 s, indicating a rather fast response to the external stimulus. Identical 
observations were performed on different batches of capsules. Note that the disappearance 
of the capsules shown in the confocal images was not due to bleaching by the laser. To 
prove this we added, in the top right corner, the transmission light microscopy image of a 
disassembling capsule. After 1 min the capsules are barely visible with transmission light 
microscopy and therefore we opted to visualize the dissolution of the capsules by confocal 
microscopy. We repeated the same experiment at pH 7 (0.1 M phosphate buffer) and 
observed that the capsules remained stable in the presence of glucose (data not shown). 
Also the permeability of the capsules to fluorescently labeled bovine serum albumin (FITC-
BSA) was investigated. When the capsules were incubated in a solution containing 
0.1 mg/ml FITC-BSA buffered at pH 9 the capsule interior remained dark for at least 30 min 
(data not shown). When the capsules were incubated in solution of 0.1 mg/ml FITC-BSA and 
5 mg/ml glucose, buffered at pH 9, a gradual filling of the capsules with FITC-BSA was 
observed (Figure 6). Apparently, before complete disassembly of the capsules the wall 
becomes permeable allowing the inwards diffusion of FITC-BSA. The behavior of the 
PAD/PSS capsules at glucose concentrations lower than 5 mg/ml was also tested. At a 
glucose concentration of 2.5 mg/ml (buffered at pH 9) the capsules still decomposed 
whereas at lower glucose concentrations the capsules remained intact. 
 
 
Figure 7. Proposed mechanism of the glucose induced decomplexation of a polyelectrolyte bilayer. The red 
circles represent the sulfonates, the blue circles represent the amino groups. The green circles represent the 
uncharged phenylboronic acid groups that become anionic (orange circles) after addition of glucose. 
 
It is known that the pH of the environment strongly affects the sensitivity of 
phenylboronic acid compounds to glucose. The glucose sensitive properties of phenylboronic 
acid are greatly enhanced when the system is operated near the pKa of the phenylboronic 
acid derivatives which is generally situated between 8 and 9. Springsteen et al. have 
reported that the apparent pKa of phenylboronic acid/polyol-complexes drops 2 - 4 pKa units 
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upon complexation. 10 This drop in pKa is due to the fact that the polyol complex itself is a 
stronger acid than the phenylboronic acid derivative. The presence of both the amino groups 
of the DMAEA and the sulfonate groups of the PSS will influence the apparent pKa of the 
phenylboronic acid, thus severely complicating the system. Therefore we will only attempt to 
give a qualitative interpretation of the experimental observations. When the suspension 
containing the capsules is buffered at pH 9, which is near the pKa of phenylboronic acid, the 
downward shift of the apparent pKa upon addition of glucose leads to a strong increase in 
borate anions. From our experimental results this increase in borate anions seems to be 
sufficient to cause the disassembly of the polyelectrolyte multilayers. When the suspension is 
buffered at pH 7, the increase in borate anions upon addition of glucose is less pronounced 
and apparently incapable of causing the disassembly of the polyelectrolyte multilayers. 
Overall one can state that the addition of glucose at a pH of 9 leads to a situation with an 
excess of negative charges that are no longer compensated by the positive charges of the 
DMAEA groups. 
The exact mechanism responsible for the disassembly of the capsules is most likely 
quite complex and not fully understood at this moment. A possible, simplified, explanation is 
presented in Figure 7. The layer-by-layer build-up is based on the complexation between the 
anionic sulfonate groups of the PSS and the ternary amino groups of the PAD. Since the 
multilayer build-up was performed at an acidic pH, the phenylboronic acid moieties are 
uncharged and did not contribute to the electrostatic complexation during the layer-by-layer 
build-up. When placed in a buffer at pH 9 already some of the borate groups become 
charged due to intramolecular complexation, which is likely to occur between amino and 
boronic acid groups. Upon addition of glucose, an increased amount of phenylboronic acid 
moieties become negatively charged and start to interfere strongly with the polyelectrolyte 
multilayers. We expect two phenomena to occur simultaneously. First there is an 
intermolecular repulsion between the sulfonate groups of the PSS and the 
glucose/phenylboronic acid complex leading to repulsion between the successive layers. 
Secondly, there is an intramolecular complexation due the electrostatic interactions between 
the cationic ternary amino groups and the anionic glucose/phenylboronic acid.  Both 
phenomena contribute to the disassembly of the capsules, indicating that the change in 
electrostatic interaction between the oppositely charged polyelectrolytes in the multilayer 
assembly plays a major role in the dissolution of the capsules.  
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CONCLUSIONS 
 
In conclusion, a novel glucose-sensitive polyelectrolyte, bearing phenylboronic acid 
moieties, was synthesized and used for the fabrication of hollow polyelectrolyte capsules 
using the layer-by-layer technique. When exposed to glucose the capsules disassembled in 
less than 5 minutes. It is well known that phenylboronic acids do not bind specific to only 
glucose but form a complex with a wide variety of vicinal diol containing compounds. 5 
However, the concentration of non-glucose carbohydrates in the human blood (like 
galactose) is several orders of magnitude lower than the concentration of glucose 13 and 
should therefore not be able to cause the disassembly of the capsules (which we indeed 
observed – data not shown). For healthy human beings the glucose concentration in the 
bloodstream does not exceed 1.5 mg/ml. 13 As the capsules reported in this chapter only 
decompose at glucose concentrations above 2.5 mg/ml they will remain intact at normal (i.e. 
healthy) glucose levels. Capsule decomposition would only occur in those cases where 
threatening glucose levels are reached. The proposed system can be applied in a broad 
temperature range and may have significant benefits compared to earlier reported glucose 
responsive systems which comprise the use of proteins (concanavalin A) or enzymes 
(glucose oxidase) which may easily denature. Further research aims to design LbL capsules 
which disassemble at elevated glucose concentrations at more physiological pH (i.e. 7.4) 
using polymerizable phenylboronic acid derivatives having a pKa situated near the 
physiological pH. 
 
 
ACKNOWLEDGEMENTS 
  
Jan Heyl is gratefully thanked for helpful discussions and practical assistance. Prof. J. 
Delanghe is thanked for helpful discussions. Ghent University is thanked for a BOF 
scholarship. 
 
 
REFERENCES 
 
1. Arys, X.; Jonas, A.M.; Laschewsky, A.; Legras, R., Supramolecular polyelectrolyte 
assemblies. Marcel Dekker: New York, 2000. 
2. Decher, G., Science 1997, 277, 1232-1237. 
147
CHAPTER 7 – GLUCOSE RESPONSIVE POLYELECTROLYTE MICROCAPSULES 
 
 
 
3. Decher, G.; Schlenoff, J., Multilayer Thin Films. Wiley-VCH: Weinheim, 2002. 
4. Donath, E.; Sukhorukov, G. B.; Caruso, F.; Davis, S. A.; Mohwald, H., Angewandte 
Chemie-International Edition 1998, 37, 2202-2205. 
5. Peyratout, C. S.; Dahne, L., Angewandte Chemie-International Edition 2004, 43, 
3762-3783. 
6. Sukhorukov, G. B.; Rogach, A. L.; Zebli, B.; Liedl, T.; Skirtach, A. G.; Kohler, K.; 
Antipov, A. A.; Gaponik, N.; Susha, A. S.; Winterhalter, M.; Parak, W. J., Small 2005, 
1, 194-200. 
7. Mauser, T.; Dejugnat, C.; Sukhorukov, G. B., Macromolecular Rapid Communications 
2004, 25, 1781-1785. 
8. Caruso, F.; Caruso, R. A.; Mohwald, H., Science 1998, 282, 1111-1114. 
9. Shchukin, D. G.; Sukhorukov, G. B., Advanced Materials 2004, 16, 671-682. 
10. Shchukin, D. G.; Sukhorukov, G. B.; Mohwald, H., Angewandte Chemie-International 
Edition 2003, 42, 4472-4475. 
11. Dai, Z. F.; Voigt, A.; Leporatti, S.; Donath, E.; Dahne, L.; Mohwald, H., Advanced 
Materials 2001, 13, 1339-1342. 
12. Dejugnat, C.; Sukhorukov, G. B., Langmuir 2004, 20, 7265-7269. 
13. Ibarz, G.; Dahne, L.; Donath, E.; Mohwald, H., Advanced Materials 2001, 13, 1324-
1327. 
14. Schuler, C.; Caruso, F., Biomacromolecules 2001, 2, 921-926. 
15. Radt, B.; Smith, T. A.; Caruso, F., Advanced Materials 2004, 16, 2184-+. 
16. Skirtach, A. G.; Antipov, A. A.; Shchukin, D. G.; Sukhorukov, G. B., Langmuir 2004, 
20, 6988-6992. 
17. Skirtach, A. G.; Dejugnat, C.; Braun, D.; Susha, A. S.; Rogach, A. L.; Parak, W. J.; 
Mohwald, H.; Sukhorukov, G. B., Nano Letters 2005, 5, 1371-1377. 
18. Aronoff, S.; Chen, T. C.; Cheveldayoff, M., Carbohydrate Research 1975, 40, 299-
309. 
19. Barker, S. A.; Chopra, A. K.; Hatt, B. W.; Somers, P. J., Carbohydrate Research 
1973, 26, 33-40. 
20. Kataoka, K.; Miyazaki, H.; Bunya, M.; Okano, T.; Sakurai, Y., Journal of the American 
Chemical Society 1998, 120, 12694-12695. 
21. Dahne, L.; Leporatti, S.; Donath, E.; Mohwald, H., Journal of the American Chemical 
Society 2001, 123, 5431-5436. 
 
 
148
CHAPTER 8 – INTRACELLULARLY DEGRADABLE POLYELECTROLYTE MICROCAPSULES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 8 
INTRACELLULARLY DEGRADABLE 
POLYELECTROLYTE MICROCAPSULES 
 
 
 
 
 
 
 
 
Parts of this chapter were published in: 
 
De Geest, B.G.;1 Vandenbroucke, R.E.;1 Guenther, A.M.;2 Sukhorukov, G.B.;3 Hennink, W.E.;4 
Sanders, N.N.;1 Demeester, J.;1 De Smedt, S.C.1 Advanced Materials 2006, 18, 1005-1009. 
 
 
1 Laboratory of General Biochemistry and Physical Pharmacy, Department of Pharmaceutics, 
Ghent University, Ghent, Belgium. 
2 Max Planck Institute of Colloids & Interfaces, Potsdam, Germany. 
3 IRC/Materials, Queen Mary University of London, London, United Kingdom. 
4 Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands. 
149
CHAPTER 8 – INTRACELLULARLY DEGRADABLE POLYELECTROLYTE MICROCAPSULES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
 
Polyelectrolyte capsules are very promising for biomedical applications. However, 
until now there are few techniques available for the release of macromolecules from these 
capsules. In this communication we are the first to report on the fabrication of polyelectrolyte 
capsules which can be degraded intracellular after internalization. Both enzymatic as well as 
hydrolytic degrading capsules are presented. These types of capsules might be promising for 
the intracellular delivery of peptides and genetic material. 
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CHAPTER 8 
INTRACELLULARLY DEGRADABLE  
POLYELECTROLYTE 
 MICROCAPSULES 
 
 
INTRODUCTION 
 
‘Hollow’ polyelectrolyte capsules, 1, 2 fabricated by coating colloidal templates using 
the layer-by-layer (LbL) technique 3-6 followed by the dissolution of the core material, have 
recently emerged as attractive materials in the field of controlled drug delivery and catalysis. 
They can carry high amounts of active compounds in a non-complexed state (i.e. in free form 
within the cavity of the capsule) 7, 8 and they exhibit the tremendous potential that their 
physicochemical and mechanical properties can easily be tailored leading to microcapsules 
with an unmet functionality. The LbL technique is based on the sequential adsorption of 
oppositely charged substances (polyelectrolytes, 9 nanoparticles, 10 nanotubes, 11 proteins 12 
and lipids 13) onto a charged template, being a flat surface 9 or a colloidal core. 14 A wide 
variety of organic1 and inorganic 15 materials have been used as colloidal templates for the 
preparation of hollow polyelectrolyte microcapsules. Major concerns, however, are both the 
incomplete removal of the core material (which is often toxic) and the hazardous conditions 
required for removing the core. 16, 17 Recently, calcium carbonate (CaCO3) based colloidal 
templates have shown to be promising for the synthesis of hollow polyelectrolyte capsules as 
CaCO3 is non-toxic and as the CaCO3 core can be easily removed by complexation with 
EDTA (Scheme 1). 18 Moreover, CaCO3 particles are easy to synthesize and to load up with 
macromolecules up to a size of about 40 nm due to their high porosity. 19, 20 
There are, to the best of our knowledge, no studies reporting on polyelectrolyte 
capsules which degrade at physiological pH or which can be destroyed by endogenous 
enzymes. Especially, although cellular uptake of polyelectrolyte capsules has been recently 
demonstrated, 21-23 intracellularly degradable polyelectrolyte capsules have not been 
reported. Such microcapsules could be attractive for the delivery of drugs with an intracellular 
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target (like e.g. nucleic acids and various proteins). This study aims to design hollow 
polyelectrolyte capsules which, after cellular entry, degrade intracellularly.  
 
 
Scheme 1. Schematic representation of the synthesis of polyelectrolyte capsules filled with FITC-dextran using 
CaCO3 particles as a template. (A) co-precipitation of FITC-dextran (yellow) in calcium carbonate particles (grey) 
during the mixing of calcium chloride and sodium carbonate solutions, (B) LbL coating of the calcium carbonate 
particles (red=polyanion , blue= polycation), and (C) polyelectrolyte capsules filled with FITC-dextran obtained 
after dissolution of the CaCO3. 
 
 
Scheme 2. Chemical structure of the polyelectrolytes used for the fabrication of the polyelectrolyte 
microcapsules. The arrow indicates the cleavable carbonate ester of the P(HPMA-DMAE) that links the cationic 
side chain to the backbone of the polymer. 
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 EXPERIMENTAL 
 
Materials.  
 
Chlorpromazine, filipin III, genistein, FITC-dextran (Mw~2000 kDa), dextran sulphate 
(DEXS; Mw~10kDa), poly-L-arginine hydrochloride (PARG; Mw>70 kDa), sodium 
polystyrene sulfonate (PSS; Mw~70 kDa) and polyallylamine hydrochloride (PAH; Mw~70 
kDa) were purchased form Sigma-Aldrich-Fluka. Calcium chloride (CaCl2) and sodium 
carbonate (Na2CO3) were purchased from Merck. LysoTracker® Red was purchased from 
Molecular Probes. Dulbecco's modified Eagle's medium (DMEM), L-glutamine, heat-
inactivated FBS and penicillin/streptomycin were purchased from GibcoBRL. P(HPMA-
DMAE) was synthesized according to Funhoff et al. 24 
 
Fabrication of (FITC-dextran filled) CaCO3 particles.  
 
CaCO3 particles were fabricated according to Volodkin et al. 18 Briefly, CaCl2 and 
Na2CO3 solutions (0.33 M) were mixed under vigorous stirring for 30 s leading to the 
precipitation of CaCO3 particles. Subsequently 4 centrifugation and washing steps with pure 
water were performed in order to remove the unreacted species.  In a last step the particles 
were washed with acetone and subsequently air-dried. 
 FITC-dextrans were incorporated in the CaCO3 particles by co-precipitation. 20 
Therefore 5 mg of FITC-dextran was dissolved in the CaCl2 solution (3.5 ml) before mixing 
with the Na2CO3 solution. 
 
Fabrication of FITC-dextran filled capsules.  
 
FITC-dextran filled capsules were fabricated in a two step procedure. In a first step 
the CaCO3 particles containing the FITC-dextrans were coated using the layer-by-layer (LbL) 
technique. Therefore 20 mg of FITC-dextran containing CaCO3 particles were dispersed in a 
0.5 M NaCl solution containing the polyanion (1 mg/ml). The dispersion was continuously 
shaken during 10 min. The excess of polyanion was removed by three 
centrifugation/washing steps with deionized water. Thereafter, 1 ml of a 0.5 M NaCl solution 
containing the polycation (1 mg/ml) was added and the dispersion was continuously shaken 
during 10 min followed again by three centrifugation/washing steps. This procedure was 
repeated three times for each polyelectrolyte resulting in the deposition of eight 
polyelectrolyte layers on the FITC-dextran filled CaCO3 particles. In a second step the 
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CaCO3 core was removed by complexation with EDTA. Therefore the coated CaCO3 
particles were shaken during 30 min with 1 ml EDTA-solution (0.2 M, pH 7.5) followed by 
centrifugation and redispersion in 1 ml fresh EDTA-solution. This procedure was repeated 4 
times to assure complete removal of the CaCO3 core as previously reported by 
Volodkin et al. 18 Finally the thus obtained hollow microcapsules filled with FITC-dextran were 
washed 4 times with deionised water. 
 
Electrophoretic mobility.  
 
The electrophoretic mobility of the LbL coated microcapsules was measured using a 
Malvern Zetasizer 2000 (Malvern Instruments). The zeta-potential (ζ-potential) was 
calculated from the electrophoretic mobility (μ) using the Smoluchowski relation 
(ζ=μη/ε) where η and ε are the viscosity and permittivity of the solvent, respectively.  
 
Scanning electron microscopy (SEM).  
 
A drop of particle or capsule suspension was deposited onto a silicon wafer and dried 
under a nitrogen stream followed by sputtering with gold. SEM images were recored with a 
Quanta 200 FEG FEI scanning electron microscope operated at an acceleration voltage of 
5 kV. 
 
Cell culture experiments.  
 
Vero-1 (African green monkey kidney cells; ATCC number CCL-81) were cultured in 
Dulbecco's modified Eagle's medium (DMEM) containing 2 mM glutamine, 10 % heat-
inactivated FBS, 100 U/ml penicilline/streptomycine (culture medium) and grown at 37 °C in 
a humidified atmosphere containing 5 % CO2. To determine the cellular uptake of the 
microcapsule we seeded 2.5 x 104 cells per cm2 in sterile glass-bottomed culture dishes 
(MatTek Corporation, MA, USA). Subsequently, 12 h after seeding the cells, they were 
incubated with 20 µl of the microcapsule dispersions (containing approximately 106 per ml in 
deionized water; the concentration of capsules was determined by haemocytometry). After 
30 min of incubation the culture medium was removed and replaced with fresh culture 
medium. To visualize the microcapsules in the cells a confocal laser scanning microscope 
was used (MRC1024 Bio-Rad) equipped with a 60x water immersion objective. To elucidate 
through which pathway the microcapsules were taken up by the cells we again seeded 
2.5 x 104 cells in sterile glass-bottomed culture dishes (MatTek Corporation). Twelve hours 
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after seeding, the cells were incubated for 1 h at 37 °C in DMEM with respectively 
chlorpromazine (10 mg/ml), filipin III (1 mg/ml) or genistein (200 µM). Subsequently, the 
microcapsules were added and the cells were further incubated at 37 °C. Before imaging the 
cells were washed twice with 0.1 M citrate buffer (pH 4) and twice with DMEM to remove all 
membrane-associated particles. For lysosome staining the cells were incubated during 
30 min at 37 °C with 50 pM of the lysosomal marker LysoTracker® Red before visualization 
under the confocal microscope. 
 
 
Figure 1. Transmission (A) and confocal (B image) of FITC-dextran (green fluorescence) filled PSS/P(HPMA-
DMAE) capsules.  
 
 
RESULTS AND DISCUSSION 
 
Two types of degradable capsules were fabricated using CaCO3 microparticles as 
template. The first type of capsules should be susceptible to enzymatic degradation and 
were made of poly-L-arginine (PARG; Scheme 2) as polycation and dextran sulfate (DEXS; 
Scheme 2) as polyanion. In the second type of capsules poly(hydroxypropyl methacrylamide 
- dimethyl aminoethyl) (P(HPMA-DMAE); Scheme 2) and polystyrene sulfonate (PSS; 
Scheme 2) were used respectively as polycation and polyanion. As Scheme 2 shows, 
P(HPMA-DMAE) is a polymethacrylamide bearing cationic side chains which can be cleaved 
by hydrolysis of the carbonate ester. 24 Besides degradable capsules we also prepared non-
degradable ‘control capsules’ by coating CaCO3 particles with PSS and polyallylamine 
hydrochloride (PAH; Scheme 2).  
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Figure 2. SEM images of (PSS/PAH)4 (A1 & B1) and (DEXS/PARG)4 (lA2 & B2) capsules at different 
magnification.  
 
CaCO3 particles were prepared by a precipitation reaction between calcium chloride 
and sodium carbonate under vigorous stirring as reported previously.18 The average 
diameter of the CaCO3 particles was 3 µm (as measured by optical microscopy and image 
analysis software). CaCO3 particles, containing FITC-dextran (Mw~2000 kDa), were obtained 
via co-precipitation (step A in Scheme 1) and washing away the unincorporated FITC-
dextran. 20 The thus obtained FITC-dextran loaded CaCO3 particles were coated by 
sequential incubation of the particles in the polyanion and polycation solutions (1 mg/ml; 
starting with the polyanion) containing 0.5 M of NaCl. After each adsorption step, two 
washing steps were performed in order to remove the non-adsorbed polyelectrolytes. In total 
four polyelectrolyte bilayers were deposited (step B in Scheme 1). We preferred to have a 
polycation as outermost layer as a positive surface charge should enhance the cellular 
uptake of the capsules considering that most cell types exhibit a negative surface charge. 
The multilayer build-up was followed by measuring the ζ-potential) of the particles after each 
adsorption step. The ζ-potential of the DEXS/ARG-, PSS/P(HPMA-DMAE)- and PSS/PAH 
156
CHAPTER 8 – INTRACELLULARLY DEGRADABLE POLYELECTROLYTE MICROCAPSULES 
 
 
 
microcapsules changed regularly between -40 and +30 mV upon adsorption of respectively a 
polyanion and a polycation (data not shown). The CaCO3 templates were dissolved by 
adding a 0.2 M EDTA solution (buffered at pH 7.5) to the coated CaCO3 particles (step C in 
Scheme 1) leading to the complexation of the Ca2+ ions which easily diffuse through the 
polyelectrolyte coating. 18 Figure 1 shows FITC-dextran filled P(HPMA-DMAE)/PSS 
polyelectrolyte capsules obtained in this way. SEM images of (PSS/PAH)4 and 
(DEXS/PARG)4 polyelectrolyte capsules are shown in Figure 2. Upon drying of the sample 
collapsed capsules can be observed. Apparently the (PSS/PAH)4 capsules exhibit a higher 
thickness compared to the (DEXS/PAH)4 capsules which exhibit a flatter morphology. 
 
 
Figure 3. Transmission (A) and confocal (B) image of FITC-dextran filled DEXS/PARG capsules taken up by 
VERO-1 cells after 20h incubation. The transmission image clearly shows the presence of (still) intact capsules 
(of a few micrometer in size) in the cells. The red arrows stress the presence of intact capsules. In the confocal 
image LysoTracker® Red, which stains the lysosomes in the cytosol red, was used. The green structures are 
FITC-dextran filled DEXS/PARG capsules present in the cells.  
 
First we studied whether the DEXS/PARG microcapsules degrade when incubated at 
37 °C in a Tris buffer (pH 7.4) containing 1 mg/ml pronase (which is a mixture of proteases). 
Optical microscopy revealed that after 2 hours of incubation all the microcapsules were 
disintegrated (data not shown), remnants of capsules could even not be found, indicating that 
the DEXS/PARG microcapsules are susceptible to degradation by proteases. Consequently 
we studied whether the PSS/P(HPMA-DMAE) microcapsules degrade when incubated in a 
phosphate buffer (pH 7.4) at 37 °C (without pronase). After approximately 48 h all the 
microcapsules had disappeared (data not shown), indicating the disassembling of the 
multilayers due to the hydrolysis of the cationic side-groups on P(HPMA-DMAE). The 
degradation period of 48 h is consistent with the report of Funhoff et al. who studied the 
degradation kinetics of HPMA-DMAE solutions. 24 As expected, the PSS/PAH coated 
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(control) microcapsules did not degrade nor in the pronase solution neither in the phosphate 
buffer, even after being incubated for several days. 
 
 
Figure 4. Transmission (A1,B1,C1) and confocal (green fluorescence (A2,B2,C2) and fluorescence overlay 
(A3,B3,C3)) images of VERO-1 cells 60h after incubation with FITC-dextran filled (A) PSS/PAH, (B) 
PSS/P(HPMA-DMAE) and (C) DEXS/PARG microcapsules. LysoTracker® Red was used to stain the 
lysosomes. The red arrows in A1 stress the presence of intact capsules.  
 
In a next step the DEXS/PARG-, PSS/P(HPMA-DMAE)- and PSS/PAH- 
microcapsules, loaded with FITC-dextran, were brought into contact with African green 
monkey kidney cells (VERO-1 cells). Initially, the microcapsules adhered on the surface of 
the cells and during the first hour of incubation no uptake of capsules by the cells could be 
observed (data not shown). However, 20 h later microcapsules were clearly present in most 
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of the cells, as illustrated for DEXS/PARG microcapsules in Figure 3. At this time point the 
capsules seemed to be intact. Figure 4 (A1, A2 and A3) shows that after 60 h of incubation 
the (control) PSS/PAH microcapsules were still present in the cells; they remained clearly 
filled with FITC-dextran and were thus still intact. However, DEXS/PARG and PSS/pHPMA-
DMAE microcapsules could no longer be detected in the cells by transmission imaging 
(Figure 4 B1 and C1). Also, intact FITC-dextran filled capsules could not be detected 
anymore in the fluorescence images (Figure 4 B2, B3, C2 and C3) all indicating that the 
DEXS/PARG and PSS/pHPMA-DMAE capsules degraded intracellularly. As Figure 4 B2, B3, 
 
Figure 5. Transmission and confocal images of VERO-1 cells 20h after incubation with FITC-dextran filled 
DEXS/PARG capsules. A and B are images of VERO-1 cells which have been incubated with microcapsules 
plus chlorpormazine; C and D are images of VERO-1 cells which have been incubated with microcapsules 
plus filipin III. The red fluorescence is from LysoTracker® Red.  
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C2 and C3 show, after intracellular degradation of the capsules green fluorescent spots 
(much smaller than the original intact capsules) could be observed which are most likely 
endosomal/lysosomal vesicles containing FITC-dextran. Note that FITC-dextran was not 
observed in the nucleus, as expected since it is, highly likely, too large to cross the nuclear 
pores. 25 
To determine in more detail the mechanism by which the microcapsules were taken 
up by the cells we exposed the microcapsules to the cells for 20 h in the presence of 
selective uptake inhibitors. Chlorpromazine 26 was used to inhibit clathrin mediated uptake 
while filipin III 27, 28 and genistein 29, 30 were used to inhibit lipid raft mediated uptake. Before 
imaging, the cells were washed with fresh culture medium to remove non-adsorbed 
capsules. Figure 5 shows transmission and confocal images of cells which were incubated 
during 20 h with microcapsules in the presence of respectively chlorpromazine (Figure 5 A 
and B) and filipin III (Figure 5 C and D). Clearly, only the cells co-incubated with 
chlorpromazine were able to internalize microcapsules while the cells co-incubated with filipin 
III failed. Co-incubation with genistein yielded identical results as co-incubation with filipin III 
(data not shown). Therefore one can assume that lipid raft mediated uptake is most probably 
the mechanism through which the microcapsules enter the cells. 31 Our observations are in 
accordance to the data reported by Hoekstra et al. who studied the cellular uptake 
mechanism of polystyrene beads as a function of their size and found that the cellular uptake 
of micron sized particles (> 1 µm) is mostly caveolae mediated (a subtype of raft lipid 
mediated uptake) and not clathrin mediated. 31 
  
 
CONCLUSIONS 
 
In conclusion, we have shown that polyelectrolyte capules which contain an 
enzymatically or hydrolytically degradable polycation, after lipid raft mediated uptake, 
spontaneously degrade in Vero-1 cells. However stimuli responsive capsules have already 
been reported, 7, 32, 33 the capsules presented in this chapter have the distinct advantage that 
no external trigger is required for their decomposition. The in vivo conditions appear to be 
able to induce this decomposition. These capsules may have high potential for the 
intracellular delivery of therapeutic nucleic acids (DNA, siRNA) and proteins. 
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ABSTRACT  
 
Gold nanoparticles with carboxyl groups on their surface were used in combination 
with poly(allylamine hydrochloride) for the layer-by-layer coating of calcium carbonate 
microparticles, followed by the dissolution of the calcium carbonate core. Scanning electron 
microscopy, transmission electron microscopy and confocal microscopy were used to 
characterize the hybrid nanoparticle/polyelectrolyte microcapsules. As the gold nanoparticles 
have carboxyl groups on their surface their charge density is pH dependent, therefore the 
microcapsules exhibit a pH dependent swelling and can be deconstructed both at low and 
high pH. Covalent cross-linking between the carboxyl groups of the gold nanoparticles and 
the amino groups of the poly(allylamine hydrochloride) made it possible to suppress the pH-
responsive behavior. The gold nanoparticles incorporated in the microcapsules’ wall 
rendered the microcapsules responsive to IR-light, which can be used at high intensity to 
destroy the microcapsules and at low intensity to perform imaging by raman 
microspectroscopy. 
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INTRODUCTION 
 
Nanoparticles have become the subject of intensive research during the past decade. 
Their potential to be used in different fields such as optoelectronics, 1 catalysis, 2 
diagnostics, 3 drug delivery, 4, 5 … has stimulated scientists in different fields such as physics, 
chemistry, biotechnology to become involved with nanoparticle research. The incorporation 
of nanoparticles (like e.g. gold nanoparticles) into supramolecular structures is of great 
interest to a broad field as it allows adding extra functionalities to supramolecular structures. 
The layer-by-layer (LbL) technique is a highly versatile method to fabricate multifunctional 
supramolecular entities with tunable properties. 6 The LbL technique is based on the 
sequential adsorption of charged species (like e.g. polyelectrolytes) onto an oppositely 
charged surface. By consecutive adsorption steps one is able to build-up multilayers which 
are stabilized through electrostatic interactions. Rather recently, so called polyelectrolyte 
microcapsules have been designed by LbL coating of a sacrificial template followed by the 
dissolution of this template. 7, 8 Due to the multifunctionality of the LbL technique it is possible 
to fabricate polyelectrolyte microcapsules with functionalized 9, 10 or stimuli responsive 11, 12 
walls which could be promising for e.g. drug delivery. 13, 14 Polyelectrolyte microcapsules 
containing nanoparticles within the capsule wall have already been reported, although in all 
cases only a single layer of nanoparticle was applied. 15 In one study the nanoparticles were 
introduced in the capsule wall after the fabrication of the microcapsules. 16 Up to our 
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knowledge multilayered microcapsules consisting of alternating nanoparticle/polyelectrolyte 
layers have not been reported before.   
In this paper we report on the fabrication of pH sensitive gold nanoparticles, 1 to 5 nm 
in size, and their use for the fabrication of ‘hybrid’ microcapsules from alternating gold 
nanoparticle/poly(allylamine hydrochloride) layers. As both the gold nanoparticles and the 
poly(allylamine hydrochloride) have a pH dependent charge density the obtained 
microcapsules are pH responsive. Further, as gold nanoparticles absorb light, irradiation of 
the microcapsules destroys the microcapsules and results in the release of the encapsulated 
material. Clearly, IR-laser sensitive microcapsules could have potential as drug delivery 
system, e.g. for remote release after subcutaneous injection of microcapsules.  
 
 
MATERIALS AND METHODS 
 
Materials.  
 
Poly(allylamine hydrochloride) (PAH; Mw~70 kDa), FITC-dextran (Mw~2000 kDa), 
hydrogen tetrachloroaureate trihydrate (HAuCl4.3H2O), mercaptosuccinic acid (MSA) and 
sodium borohydride (NaBH4) were purchased from Sigma-Aldrich-Fluka. Methanol, sodium 
chloride (NaCl), ethylenediaminetetraacetic acid (EDTA), calcium chloride (CaCl2) and 
sodium carbonate (Na2CO3) were purchased from Merck. Quartz slides were purchased from 
Hellma Optics. All water used in the experiments was of Milli-Q grade. 
 
Synthesis of gold nanoparticles (AuNP).  
 
425 mg (1.25 10-3 mol) HAuCl4.3H2O was dissolved in 5 ml water. 188 mg 
(1.25 10-3 mol) MSA was dissolved in 245 ml methanol. Both solutions were mixed and 
stirred during 30 min at room temperature. 473 mg (12.5 10-3 mol) NaBH4 was dissolved in 
25 ml water and drop wise added to the HAuCl4.3H2O/MSA mixture under vigorous stirring. 
During the addition of the NaBH4 the solutions gradually turned dark and the AuNP’s were 
formed as a dark precipitate. The reaction mixture was further stirred during 1 h at room 
temperature. Afterwards the reaction mixture was centrifuged at 4000 rpm during 5 min and 
the supernatant was discarded. Three washing/centrifugation steps with methanol were 
performed and finally the AuNP’s were dried under vacuum. 
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UV-VIS monitoring of the multilayer build-up.  
 
Quartz slides were cleaned and hydrophylized by treatment with freshly prepared 
piranha solution (H2O2 (35 %)/H2SO4 (98 %) 1:1 v/v (caution: piranha solution reacts violently 
with organic materials and should not be stored in closed containers) then abundantly rinsed 
with distilled water. The treated quartz slides were precoated with a PEI layer by immersion 
in a 2 mg/ml PEI solution containing 0.5 M NaCl. Multilayers of AuNP/PAH were deposited on 
the PEI coated quartz slides starting with the negatively charged AuNP’s by immersion in a 
1 mg/ml AuNP solution (containing 0.5 M NaCl) during 10 min followed by rinsing with pure 
water. Finally the quartz slides were dried under a nitrogen stream. Then the PAH layer was 
deposited from a 2 mg/ml PAH solution (containing 0.5 M NaCl). This was repeated until the 
desired amount of bilayers was deposited. After each deposition of a bilayer the absorbance 
of the film was measured with a Pharmacia Biochrom 4060 UV-VIS spectrophotometer 
 
Fabrication of calcium carbonate (CaCO3) microparticles.  
 
CaCO3 particles were fabricated according to Volodkin et al. 17, 18 Briefly, CaCl2 and 
Na2CO3 solutions (0.33 M) were mixed under vigorous stirring for 30 s leading to the 
precipitation of CaCO3 particles. Subsequently four centrifugation and washing steps with 
pure water were performed in order to remove the unreacted species. In a last step the 
particles were washed with acetone and subsequently air-dried. FITC-dextrans were 
incorporated in the CaCO3 particles by co-precipitation. 19 Therefore, 5 mg of FITC-dextran 
was dissolved in the CaCl2 solution (3.5 ml) before mixing with the Na2CO3 solution.  
 
Fabrication of multilayered microcapsules.  
 
Capsules were fabricated in a two step procedure. In a first step the CaCO3 
microparticles were coated using the layer-by-layer (LbL) technique. Therefore, 20 mg of 
FITC-dextran containing CaCO3 microparticles were dispersed in a 0.5 M NaCl solution 
containing the AuNP’s (1 mg/ml). The dispersion was continuously shaken during 10 min. The 
excess of AuNP’s was removed by three centrifugation/washing steps with deionised water. 
Thereafter, 1 ml of a 0.5 M NaCl solution containing PAH (2 mg/ml) was added and the 
dispersion was continuously shaken during 10 min followed again by three 
centrifugation/washing steps. This procedure was repeated four times until four AuNP/PAH 
bilayers were deposited on the surface of the CaCO3 microparticles. In a second step the 
CaCO3 core was removed by complexation with EDTA. Therefore the coated CaCO3 particles 
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were shaken during 30 min with 1 ml EDTA-solution (0.2 M, pH 7.5) followed by 
centrifugation and redispersion in 1 ml fresh EDTA-solution. This procedure was repeated 4 
times to assure complete removal of the CaCO3 core as previously reported by 
Volodkin et al. 17, 18 Finally the thus obtained hollow microcapsules filled with FITC-dextran 
were washed four times with water. 
 
Electrophoretic mobility.  
 
The electrophoretic mobility of the AuNP’s was measured using a Malvern Zetasizer 
2000 (Malvern Instruments). The ζ-potential was calculated from the electrophoretic mobility 
(μ) using the Smoluchowski relation: ζ=μη/ε where η and ε are the viscosity and permittivity 
of the solvent, respectively. 
 
Scanning electron microscopy (SEM).  
 
A drop of  AuNP or capsule suspension was deposited onto a silicon wafer and dried 
under a nitrogen stream followed by sputtering with gold. SEM images were recorded with a 
Quanta 200 FEG FEI scanning electron microscope operated at an acceleration voltage of 
5 kV. 
 
Transmission electron microscopy (TEM).  
 
A drop of AuNP or capsule suspension was deposited and dried onto a Cu-grid 
modified with amorphous carbon. TEM images were recorded with a CM-200 FEG Philips 
transmission electron microscope operated at an acceleration voltage of 120 kV. 
 
Confocal Microscopy.  
 
Confocal microscopy and transmission light microscopy images were recorded with a 
Biorad MRC 1024 confocal system. An inverted microscope (Eclipse TE300D, Nikon) 
equipped with a 60x water immersion objective lens was used.  
 
Confocal Raman Microscopy.  
 
A RamanRxn1 spectrometer (Kaiser Optical Systems), equipped with an air cooled 
CCD Detector (back-illuminated deep depletion design) was used in combination with a 
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Leica DMLP Raman microprobe equipped with a 100x objective. The laser wavelength 
during the experiments was the 785 nm line from a 785 nm Invictus NIR diode laser. All 
spectra were recorded at a laser power of 400 mW. 
 
IR-laser irradiation of microcapsules 
 
A drop of microcapsule suspension was deposited onto a microscope slide and 
positioned under a 100x microscope objective. The collimated IR laser beam of a CW laser 
diode at 830 nm, with optical power up to 80 mW, was focused on the sample through the 
objective. A more detailed description of the set-up can be found elsewhere. 20 Visualisation 
of the microcapsules was performed by a 150 W white light source and a fluorescence lamp. 
Images were recorded by a charge coupled device (CCD) camera connected to a computer.  
 
 
Figure 1. (A) TEM image of AuNP’s. (B) UV-VIS spectrum of the AuNP suspension. 
 
 
RESULTS AND DISCUSSION 
 
Gold nanoparticles were synthesized, following the method reported by 
Kimura et al .21, by reduction of hydrogen tetrachloroaureate (HAuCl4.3H2O) with sodium 
borohydride (NaBH4) in methanol. Mercaptosuccinic acid (MSA) was used to cap the formed 
gold nanopartciles with a monolayer of carboxyl groups. The ζ-potential of the AuNP ’s  
equaled 32 ± 8 mV, indicating that the carboxyl groups of the MSA indeed provide the AuNP’s 
with a negative surface charge. Figure 1 represents schematically the structure of the 
obtained AuNP’s in their ionized form. Transmission electron microscopy (TEM) (Figure 2A) 
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revealed that the AuNP’s are in a non-aggregated state and have a size distribution ranging 
from approximately 1 to 5 nm. The UV-VIS spectrum of the AuNP’s in concentrated dispersion 
is shown in Figure 1B, exhibiting the characteristic surface plasmon resonance absorption 
peak around 560 nm. 22 
 
 
Figure 2. Schematic representation of the molecular structure of the AuNP’s and molecular structure of PAH.  
 
As the AuNP’s exhibit a negative surface charge they should be suitable to build 
multilayered films, using the LbL technique, in combination with poly(allylamine 
hydrochloride) (Figure 1B), which is a positively charged polyelectrolyte (at neutral pH). As 
AuNP’s absorb, UV-VIS spectrophotometry can be used to monitor the build-up of AuNP/PAH 
multilayers onto a quartz slide. As shown in Figure 3A, the absorbance of the film increases 
after every deposited AuNP/PAH bilayer, indicating that multilayer build-up takes place. The 
absorbance spectrum of the deposited film does not show the characteristic plasmon peak at 
560 nm due to the fact that the optical absorbance of extremely thin films is hardly detectable 
with conventional UV-VIS measurements. 22 Figure 3B shows that the absorbance at 450 nm 
of the films increases linearly as a function of the number of AuNP/PAH bilayers.   
 
 
Figure 3. (A) UV-VIS spectra of a quartz slide coated with an increasing number of AuNP/PAH bilayers. 
(B) Absorbance at 450 nm as a function of the number of AuNP/PAH bilayers.  
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Figure 4. SEM images of (A) CaCO3 microparticles containing FITC-dextrans before LbL-coating and (B) after 
coating with 4 bilayers AuNP/PAH. (C) SEM image of hollow (AuNP/PAH)4 microcapsules obtained after dissolution 
of the CaCO3 core. (D) Confocal microscopy image of FITC-dextran filled (AuNP/PAH)4 microcapsules.  
 
Subsequently AuNP/PAH microcapsules were fabricated using CaCO3 microparticles 
as sacrificial templates. 17, 18, 23 FITC-dextran filled CaCO3 particles were synthesized by 
reacting calcium chloride and sodium carbonate solutions in the presence of FITC-dextran 
(2000 kDa). 23 Immediately after mixing of the components the precipitation of 4 µm sized 
CaCO3 microparticles, filled with FITC-dextrans in their pores, took place. The FITC-
dextran/CaCO3 microparticles were subsequently coated with AuNP’s and PAH. In total 4 
AuNP/PAH bilayers were deposited onto the surface of the CaCO3 microparticles. After the 
deposition of the (AuNP/PAH)4 coating, the CaCO3 microparticles were dissolved in EDTA 
solutions. After several washing steps with water, removing the dissolved ions, hollow 
microcapsules filled with a FITC-dextran solution were obtained. Figure 4 shows SEM 
images of FITC-dextran filled CaCO3 microparticles (A) before and (B) after coating with 4 
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AuNP/PAH bilayers. Clearly, the uncoated CaCO3 microparticles exhibit a smooth surface, 
whereas after coating the CaCO3 microparticles exhibit a rather rough surface. Figure 4C 
shows SEM images of the microcapsules obtained after dissolution of the CaCO3 core. 
Collapsed microcapsules, with a rough surface are observed. The collapsed state, which is 
due to the drying upon preparation of the sample prior to SEM imaging, indicates that hollow 
microcapsules were present before drying. Figure 4D shows a confocal microscopy image of 
the microcapsules depicting homogeneous filling of the microcapsules with FITC-dextrans. 
Figure 5 shows TEM images of a (AuNP/PAH)4 capsule at low (Figure 5A) and high 
(Figure 5B) magnification. A very dense network of AuNP’s which are ‘glued’ together by 
electrostatic interactions with the PAH can be observed. In Figure 5B one can clearly 
distinguish the individual AuNP’s which are closely packed to each other. The TEM images of 
the (AuNP/PAH)4 microcapsules are substantially different from those reported by Skirtach et 
al. 15 where only one layer of AuNP’s was intercalated within the capsule wall. TEM images 
from such microcapsules show AuNP’s which are sparsely spread within the capsule wall, 
whereas the AuNP’s in the (AuNP/PAH)4 microcapsules reported in  this paper form a tight 
network. 
 
 
Figure 5. (A) TEM image of a hollow (AuNP/PAH)4 capsule. (B) TEM image of the periphery of a hollow 
(AuNP/PAH)4 capsule (at high magnification). 
 
PAH is a weak polyelectrolyte, meaning that its charge density is dependent on the 
pH of the environment. 24 Whereas the amino groups of the PAH are protonated, and thus 
positively charged, at a pH below 10.7 (the pKa of PAH when it is complexed to a polyanion 
was estimated to be 10.7 by Petrov et al.), 23 they become uncharged when the pH is above 
10.7. Several papers have been published describing the swelling and dissolution behavior 
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of polyelectrolyte multilayers made from weak polyelectrolytes. 25-27 As the (AuNP/PAH)4 
microcapsules were fabricated by electrostatic build-up between a weak polyacid, as the 
AuNP’s have carboxyl acid groups on their surface, and a weak polybase (i.e. PAH), we were 
interested to know how the (AuNP/PAH)4 microcapsules behave both at low and high pH. 
Figure 6 shows transmission light microscopy images of the (AuNP/PAH)4 microcapsules 
before and after addition of respectively 0.5 M HCl (Figure 6A) and 0.5 M NaOH (Figure 6B). 
The microcapsules swell approximately twice in diameter and then gradually dissolve. 
Clearly, at high pH the PAH amino groups become uncharged and no longer complex with 
the carboxyl groups of the AuNP, leading to a loosening of the electrostatic interactions within 
the multilayers. As the negatively charged carboxyl groups are no longer neutralized by the 
amino groups repulsion between the carboxyl groups occurs, the microcapsules start to 
swell, and finally dissolve. At low pH (Figure 6B) the inverse phenomenon occurs as the 
carboxyl groups of the AuNP’s become uncharged and no longer repel the positively charged 
amino groups of the PAH, again leading to a swelling followed by the dissolution of the 
microcapsules. 
 
 
Figure 6. Transmission light microscopy images of (AuNP/PAH)4 microcapsules suspended in pure water (A1 & 
B1), immediately after addition of 0.5 M NaOH (A2) respectively 0.5 M HCl (B2) and  1 min after the addition of 
0.5 M NaOH (A3) respectively 0.5 M HCl (B3). 
 
173
CHAPTER 9 – STIMULI RESPONSIVE MULTILAYERED HYBRID NANOPARTICLE/ POLYELECTROLYTE MICROCAPSULES 
 
 
 
 
We were further interested to examine whether it was possible to covalently cross-link 
the multilayer membrane in order to make microcapsules which remain to exist in a broad pH 
range. Following the work of Mauser et al. 25 we tried to introduce amide bonds between the 
carboxyl groups on the AuNP‘s and the amino groups on the PAH using carbodiimide 
chemistry. When such cross-linked (FITC-dextran filled) (AuNP/PAH)4 microcapsules  were 
dispersed in respectively 0.5 M HCl and 0.5 M NaOH they did not swell and remained intact 
(data not shown). Moreover, the core of the microcapsules remained fluorescent (both in acid 
and alkaline media) indicating that the cross-linking also prevented the escape of the 
encapsulated FITC-dextrans. Apparently, the cross-linked (AuNP/PAH)4 microcapsules were 
able to encapsulate the FITC-dextrans even when the electrostatic interactions were no 
longer contributing to the integrity of the microcapsules.  
 
 
Figure 7. Fluorescence microscopy images of a cluster of FITC-dextran filled (AuNP/PAH)4 microcapsules upon 
irradiation with IR-laser light. The time interval between the successive images is 2 s. 
 
It has been reported that polyelectrolyte microcapsules containing gold nanoparticles 
in their shell can be destroyed when irradiated with an IR-laser. 4, 15 The AuNP’s absorb IR-
light which locally heats the nanoparticles. 15 As IR-light is not harmful to living tissue,28 IR-
light could be an attractive method to open microcapsules which are injected 
subcutaneously. The IR-responsive properties of the (AuNP/PAH)4 microcapsules were 
assessed by irradiating them with a focused laser beam of 30 mW. Figure 7 shows the 
impact of the irradiation on a cluster of (AuNP/PAH)4 microcapsules. Clearly, shortly after the 
exposure the microcapsules explode and only debris of broken microcapsules remains. Also 
the green fluorescence of the encapsulated FITC-dextrans has disappeared. The 
advantages of the (AuNP/PAH)4 microcapsules described in this paper, which are fabricated 
from CaCO3 microparticles as sacrificial template, compared to previously reported IR-
sensitive microcapsules, which were made using melamine formaldehyde (MF) or 
polystyrene (PS) microparticles as sacrificial template, are threefold. (1) Whereas the 
dissolution of MF and PS microparticles occurs under harsh conditions (such as extreme low 
pH7 and the use of organic solvents) 26 CaCO3 templates can be easily dissolved at 
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physiological pH using EDTA. 18 (2) When MF or PS microparticles are used, MF or PS 
oligomers/polymers main remain inside the capsule wall, 29, 30 making the microcapsules 
unsuited as drug delivery system. In contrast, the Ca2+ and CO33- ions can easily permeate 
through the multilayer wall, moreover they are non-toxic. (3) Polyelectrolyte microcapsules 
prepared from MF or PS templates need to be post-loaded after the dissolution of the 
sacrificial template. This requires that the microcapsules’ wall can be temporarily reversibly 
opened, allowing filling of the microcapsules. 31, 32 CaCO3 microparticles can easily be filled 
with macromolecules by coprecipitation of the macromolecules during the fabrication of the 
CaCO3. 19 After LbL coating and dissolution of the CaCO3 one obtains already filled 
microcapsules.  
 
 
Figure 8. (A) Confocal raman microscopy image of a (AuNP/PAH)4 capsule, (B) the interpolated image and (C) 
raman spectra taken inside a capsule (gray line) and outside a microcapsules (red line).  
 
We wondered whether the (AuNP/PAH)4 microcapsules could be detected by raman 
microspectroscopy. Raman spectroscopy is based on the shift in wave number of 
monochromatic IR-light upon inelastic scattering by a substance. 33 Raman 
microspectroscopy allows one to collect data from a well defined microscopic area. The 
(AuNP/PAH)4 microcapsules were dried onto a quartz slide and put under the confocal raman 
microscope. Figure 8A shows a raman mapping image of a (AuNP/PAH)4 capsule while 
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Figure 8B shows the interpolated image. The raman spectra inside and outside the capsule 
are shown in Figure 8C. The raman spectrum in Figure 8C was found to be similar to the one 
observed in an AuNP’s suspension (in water), proving that the measured raman shifts are due 
to the AuNP’s in the multilayer of the microcapsules. Therefore, the response of the 
(AuNP/PAH)4 microcapsules to IR-light is interesting for both release purposes (upon 
destruction of the microcapsules by highly intense IR light) as well as applications in the 
diagnostic field.  
  
CONCLUSIONS 
 
We reported on the fabrication of hybrid nanoparticle/polyelectrolyte microcapsules by 
multilayer formation of carboxylic acid functionalized gold nanoparticles and poly(allylamine 
hydrochloride). Confocal microscopy showed a homogenous filling of the microcapsules with 
FITC-dextran while electron microscopy clearly revealed the presence of the AuNP’s within 
the capsule wall. As the gold nanoparticles and the poly(allylamine hydrochloride) contain 
respectively weak carboxyl and weak amino groups it was possible to deconstruct the 
microcapsules at both low and high pH. Further it was shown that covalent cross-linking of 
the capsule wall was an effective method to render the microcapsules invariant to changes in 
pH. The gold nanoparticles incorporated in the microcapsules’ wall rendered the 
microcapsules responsive to IR-light, which can be used at high intensity to destroy the 
microcapsules and at low intensity to perform imaging. The use of CaCO3 as sacrificial 
template for capsule fabrication makes the microcapsules ideally suited for applications in 
the drug delivery field. In our ongoing research the microcapsules are currently evaluated for 
IR induced transdermal drug release.  
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ABSTRACT 
 
Multilayered microcapsules fabricated using the Layer-by-Layer (LbL) technology are 
promising vehicles for the delivery of drug molecules. In this chapter we report on the use of 
ultrasound for release of encapsulated species from such multilayered microcapsules. It was 
found that ultrasound has a dramatic effect on the integrity of the capsule membrane leading 
to destruction of the entire capsule and release of encapsulated material.  
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INTRODUCTION 
 
The growing needs for drug delivery systems releasing their content in a desired 
fashion have intensified research for ‘smart carriers’ with unique properties. 1-3 Among other 
pharmaceutical carriers, such as polymeric micelles, 4 liposomes, 5 and small colloidal 
particles, 6 polymeric polyelectrolyte multilayered 7 microcapsules 8, 9 are novel materials 
holding promise due to their loading capacity and the possibility to precisely tailor their 
properties by choosing the microcapsules’ components. Recently these microcapsules have 
gathered attention as drug delivery system. 10-12 Once their target site is reached it is of 
utmost importance to have a mechanism causing release of encapsulated species from 
these microcapsules. Externally triggered release has recently been shown to be possible by 
laser light illumination. 13-15 The principle is based on heating of metal nanoparticles causing 
changes in permeability of the outer shell and even total disruption of the shell, finally 
resulting in the release of encapsulated materials. 15 These laser light sensitive 
microcapsules could e.g. be activated after cellular uptake 16 or could be activated after 
subcutaneous injection. 
In this chapter we report on the use of ultrasound to trigger release from 
polyelectrolyte microcapsules. Ultrasound has widely been investigated for biomedical 
applications, 17 improving drug uptake, anti-inflammatory treatment and imaging. Upon 
propagation, an ultrasound wave undergoes both viscous and thermal absorption as well as 
scattering. 18, 19 At low frequency the temperature difference between the particle and the 
medium will be in equilibrium, whereas at high frequency only a small portion of the surface 
will be affected by thermal wave.  Similar frequency dependence is applicable to viscous 
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losses, wherein extensive particle motion occurs at low frequency while little movement takes 
place at high frequencies.  
Figure 1 shows schematically which effect ultrasound may have on a polyelectrolyte 
capsule. When the microcapsules are subjected to ultrasound a morphological change of the 
capsule wall may occur due to the creation of shear forces between the successive fluid 
layers, resulting in the disruption of the capsule membrane and release of encapsulated 
species.  
 
 
MATERIALS AND METHODS 
 
Materials. 
 
Poly(allylamine hydrochloride) (PAH; Mw~70 kDa), sodium poly(styrene sulfonate) 
(PSS, Mw~70 kDa) and FITC-dextran (Mw~2000 kDa) were purchased from Sigma-Aldrich-
Fluka. Sodium chloride (NaCl), ethylenediaminetetraacetic acid (EDTA), calcium chloride 
(CaCl2) and sodium carbonate (Na2CO3) were purchased from Merck. Gold nanoparticles 
(AuNP) were synthesized according to Kimura et al. 20 All water used in the experiments was 
of Milli-Q grade. 
 
Fabrication of calcium carbonate (CaCO3) microparticles.  
 
CaCO3 particles were fabricated according to Volodkin et al. 21, 22 Briefly, CaCl2 and 
Na2CO3 solutions (0.33 M) were mixed under vigorous stirring for 30 s leading to the 
precipitation of CaCO3 particles. Subsequently four centrifugation and washing steps with 
 
Figure 1.  Schematic representation of the release of encapsulated materials by ultrasound. Before ultrasound 
irradiation, the microcapsules, consisting of polyelectrolytes (red and blue lines) and nanoparticles (black dots) 
form a closed structure keeping high molecular weight species encapsulated. After ultrasound irradiation the 
membrane should rupture, leading to the release of encapsulated species. 
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pure water were performed in order to remove the unreacted species. In a last step the 
particles were washed with acetone and subsequently air-dried. FITC-dextrans were 
incorporated in the CaCO3 particles by co-precipitation. 23 Therefore, 5 mg of FITC-dextran 
was dissolved in the CaCl2 solution (3.5 ml) before mixing with the Na2CO3 solution. 
 
Fabrication of multilayered microcapsules.  
 
Capsules were fabricated in a two step procedure. In a first, step the CaCO3 
microparticles were coated using the layer-by-layer (LbL) technique. Therefore, 20 mg of 
FITC-dextran containing CaCO3 microparticles were dispersed in a 0.5 M NaCl solution 
containing PSS (2 mg/ml) or AuNP’s (1 mg/ml). The dispersion was continuously shaken 
during 10 min. The excess PSS or AuNP’s was removed by three centrifugation/washing 
steps with deionised water. Thereafter, 1 ml of a 0.5 M NaCl solution containing PAH 
(2 mg/ml) was added and the dispersion was continuously shaken during 10 min followed 
again by three centrifugation/washing steps. This procedure was repeated four times until 
four bilayers were deposited on the surface of the CaCO3 microparticles. In a second step 
the CaCO3 core was removed by complexation with EDTA. Therefore the coated CaCO3 
particles were shaken during 30 min with 1 ml EDTA-solution (0.2 M, pH 5) followed by 
centrifugation and redispersion in 1 ml fresh EDTA-solution. This procedure was repeated 4 
times to assure complete removal of the CaCO3 core as previously reported by Volodkin et 
al.21 Finally the thus obtained hollow microcapsules filled with FITC-dextran were washed 
four times with water. 
 
Ultrasonic treatment.  
 
The experiments were performed with a Branson Sonifier 250 equipped with a 
titanium microtip, operating at a constant output frequency of 20 kHz. The microtip was 
positioned in 250 µl of microcapsule suspension in a 500 µl Eppendorf microtube. 
Subsequently ultrasound was applied at different output power and for different times.  
 
Scanning electron microscopy (SEM).  
 
A drop of particle or microcapsule suspension was deposited onto a silicon wafer and 
dried under a nitrogen stream followed by sputtering with gold. SEM images were recorded 
with a Quanta 200 FEG FEI scanning electron microscope operated at an acceleration 
voltage of 5 kV. 
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Confocal Microscopy.  
 
Confocal microscopy and transmission light microscopy images were recorded with a 
Biorad MRC 1024 confocal system. An inverted microscope (Eclipse TE300D, Nikon) 
equipped with a 60x water immersion objective lens was used. 
 
 
Atomic Force Microscopy (AFM). 
 
AFM images were recorded on a Nanoscope IIIa Multimode SFM (Digital Instruments 
Inc.) in air at room temperature using taping mode. Samples were prepared by applying a 
drop of microcapsule suspension on a freshly cleaved mica substrate followed by drying 
under a gentle stream of nitrogen.  
 
 
RESULTS AND DISCUSSION 
 
Multilayered microcapsules were fabricated using the LbL technique by successive 
coating of CaCO3 microparticles with different layers of polyelectrolytes and gold 
nanoparticles. During fabrication, the CaCO3 microparticles were filled with 2000 kDa FITC 
dextran by co-precipitation of the CaCO3 with the FITC-dextrans. This is an elegant method, 
allowing a high degree of loading and avoiding a post-filling step of the microcapsules. Two 
different types of microcapsules were fabricated; type 1 consisted solely of polyelectrolytes 
while type 2 were ‘hybrid’ microcapsules consisting of polyelectrolytes and gold nanoparticles 
(AuNP). Sodium poly(styrene sulfonate) (PSS) was used as polyanion while poly(allylamine 
hydrochloride) (PAH) was used as polycation. AuNP’s were fabricated according to the 
method reported by Kimura et al., 20 resulting in AuNP’s with a diameter ranging from 1 to 5 
nm (as verified by transmission electron microscopy (data not shown)) and a negative 
surface charge (as verified by measuring the electrophoretic mobility) due to the presence of 
carboxyl groups on the surface of the AuNP’s. Multilayer build-up between the PSS/PAH (in 
case of type 1 microcapsules) and AuNP/PAH (in case of type 2 microcapsules) was driven by 
the electrostatic interactions between the cationic amino groups of the PAH and the anionic 
sulfonate, respectively carboxyl groups of the PSS, respectively AuNP’s. For each type of 
microcapsules in total 4 bilayers were deposited onto the surface of the CaCO3 
microparticles followed by the dissolution of the CaCO3 by EDTA treatment. EDTA 
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complexes the calcium and permeates easily through the multilayer membrane, resulting in 
hollow microcapsules with an average diameter of 4 µm. The FITC-dextrans, initially 
entrapped inside the pores of the CaCO3 microparticles, are too large to permeate through 
the multilayered membrane and stay encapsulated inside the hollow microcapsules. Figure 2 
shows optical transmission, confocal and scanning electron microscopy images of the thus 
obtained (PSS/PAH)4 microcapsules while Figure 3 shows the corresponding microscopy 
images of the (AuNP/PAH)4 microcapsules. On the transmission image both types of 
microcapsules appear transparent. However, whereas the (PSS/PAH)4 microcapsules are 
hardly visible on the transmission image, the (AuNP/PAH)4 microcapsules appear significantly 
darker. These observations are consistent with the appearance of the microcapsules in 
suspension, being a slightly turbid but clear suspension in case of (PSS/PAH)4 
Figure 2. Optical transmission (A), confocal (B) and scanning electron (C & D – at different magnifications) 
microscopy images of (PSS/PAH)4  microcapsules. The green colour in image B is due to the FITC-dextrans 
encapsulated inside the microcapsules.  
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microcapsules and a dark brown suspension in case of (AuNP/PAH)4 microcapsules. The dark 
appearance of the (AuNP/PAH)4 microcapsules is due to the absorption of light by the AuNP’s. 
On the confocal images in Figures 2B and 3B a homogeneous filling of the microcapsules 
with green fluorescence in observed, indicating no preferential accumulation of fluorescence 
in particular parts of the microcapsules. The scanning electron microscopy images in Figures 
2C&D and 3C&D show in detail the morphology of the microcapsules. Apparently the 
(PSS/PAH)4 microcapsules have a much smoother morphology compared to the (AuNP/PAH)4 
microcapsules. This is most likely due to the presence of the AuNP’s within the multilayer 
membrane, offering it a more rigid structure which appears rather rough upon drying.     
 
Figure 3. Optical transmission (A), confocal (B) and scanning electron (C & D – at different magnifications) 
microscopy images of (AuNP/PAH)4  microcapsules. The green colour in image B is due to the FITC-dextrans 
encapsulated inside the microcapsules.  
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To evaluate the effect of ultrasound on the integrity of the microcapsules’ wall, the 
microcapsules, in suspension, were subjected to ultrasonic treatment with an ultrasonic 
probe operating at a frequency of 20 kHz and a power output of respectively 20, 40 and 
100 W during respectively 1, 5 and 10 seconds. Initially both the (PSS/PAH)4 as well as the 
(AuNP/PAH)4 microcapsules are nearly monodisperse spherically shaped and homogenously 
filled with FITC-dextrans, as shown in Figures 2A&B and 3A&B. However, after 1 s 
sonication at 20 W a large amount of microcapsules are broken and much debris of broken 
microcapsules can be detected. When the microcapsules are subjected to ultrasound at an 
output power of 100 W almost no intact microcapsules can be observed and nothing is left 
but unidentifiably debris of broken microcapsules. The ultrasonic shockwaves originating 
 
Figure 4. Optical transmission (A), confocal (B) and scanning electron (C & D – at different magnifications) 
microscopy images of (PSS/PAH)4  microcapsules after ultrasonic treatment (10 s – 20 W). The green colour 
in image B is due to residual FITC-dextrans sticking on the wall of broken microcapsules. 
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from the ultrasound probe propagate through the liquid and probably cause high shear forces 
between the successive liquid layers. When such shear forces cleave through the membrane 
of the microcapsules, the membrane is torn apart and the microcapsules are destroyed. 
Figures 4 and 5 show optical transmission, confocal and scanning microscopy images of the 
microcapsules after ultrasonic treatment. The microcapsules are clearly destroyed and 
empty, the only fluorescence being detected is on the walls of broken microcapsules due to 
electrostatic or hydrophobic interactions between the florescent dye and the remaining 
polyelectrolytes. Whereas before ultrasonic treatment the microcapsules had a round shape 
on the electron microscopy images, the microcapsules are extremely deformed after 
ultrasonic treatment and individual microcapsules can hardly be detected. Figures 4D and 5D 
 
Figure 5. Optical transmission (A), confocal (B) and scanning electron (C & D – at different magnifications) 
microscopy images of (AuNP/PAH)4  microcapsules after ultrasonic treatment (10 s – 20 W). The green colour 
in image B is due to residual FITC-dextrans sticking on the wall of broken microcapsules. 
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show scanning electron microscopy images at higher magnification of most likely a destroyed 
capsule. From the irregularities of the surface one can clearly see the impact of the 
ultrasound on the integrity of the capsule wall as large holes and cracks are present. Figure 
6A1 shows an AFM image of a (AuNP/PAH)4 capsule before ultrasonic treatment. The 
capsule exhibits a round shape and a double wall thickness of 447 nm as observed from the 
height profile (Figure 6A2). When an AFM image is recorded of the debris after ultrasonic 
treatment (Figure 6B1) a height of 261 nm (Figure 6B2) is measured. Most likely this 
corresponds to the thickness of a piece of a single capsule wall which was torn of the 
capsule due to the sonication. 
 
 
Figure 6. AFM images of a (AuNP/PAH)4 microcapsules before (A) and after (B) ultrasonic treatment. A2 and B2 
show the corresponding height profiles along the green line indicated on, A1 and B1. Images A3 and B3 show the 
corresponding 3D images. 
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Figure 7. Percentage of broken (A) (PSS/PAH)4 and (B) (AuNP/PAH)4 microcapsules after ultrasound irradiation 
as function of irradiation time and output power. For each bar 50 microcapsules were counted. 
 
To quantify the effect of ultrasonic treatment on the microcapsules’ integrity the 
amount of intact and destroyed microcapsules after ultrasonic treatment was determined for 
the different parameters, being treatment time and power output. Logically, before ultrasonic 
treatment, no broken microcapsules are observed. After 1 s ultrasonic treatment already a 
considerable amount of microcapsules are broken and increasing the treatment time results 
in an increasing amount of broken microcapsules. Also an increase in power input results in 
an increase of the amount of broken microcapsules. These trends are graphically presented 
in Figure 7. Remarkably also an influence of the presence of gold nanoparticles can be 
observed. In case ultrasonic treatment is performed during 10 s, virtually all microcapsules 
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are destroyed, irrespective of the presence of nanoparticles in the microcapsules’ shell. 
However, for shorter treatment times, the microcapsules appear mechanically more stable 
when nanoparticles are included in the shell. When comparing Figure 7A and 7B one 
observes that after 1 and 5 s of ultrasonic treatment almost the double amount of 
(PSS/PAH)4 microcapsules are broken compared to the amount of broken (AuNP/PAH)4 
microcapsules. The high density of carboxyl groups on the surface of the AuNP’s 20 offers 
good binding sites with the PAH, making the multilayer structure more rigid than in case of 
PSS/PAH multilayers. Therefore such hybrid multilayers, consisting of nanoparticles and 
polyelectrolytes, are most likely more stable towards ultrasound than multilayers consisting 
solely of polyelectrolytes. 
 
 
CONCLUSIONS 
 
In conclusion, remote release of encapsulated materials from multilayered 
microcapsules has been performed by ultrasound irradiation. It was shown that ultrasonic 
irradiation has a dramatic effect on the integrity of multilayered microcapsules leading to their 
destruction and the release of encapsulated material. Ultrasound offers and easy and fast 
way of inducing release from multilayered microcapsules and may be of interest to the 
biomedical field, e.g. for topological application of ultrasound after subcutaneous injection of 
microcapsules . 
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Novel biotechnological macromolecular drugs, such as certain peptides and proteins, 
require special formulations preventing them from degradation before reaching their target. 
Moreover, besides protection against enzymatic degradation, also the release pattern plays 
an important role. For example, in some cases, like the administration of antigens, it could be 
of interest to release the drug molecules in a pulsatile manner i.e. at different pre-determined 
time intervals. In other cases the therapeutics should only be released at a specific target 
site, as a response to a specific local or external trigger. As an example, an appropriate 
insulin dose should only be delivered to diabetic patients when the glucose concentration in 
the blood exceeds a critical value.     
In this thesis several types of microcapsules are engineered which disassemble, and 
thus release their content, (1) after a certain incubation time and (2) in response to a specific 
physicochemical trigger. For the fabrication of these microcapsules we used the Layer-by-
Layer (LbL) technique. This technique, based on the sequential adsorption of charged 
species onto an oppositely charged surface, is highly attractive due to its multifunctionality 
and ease of use. 
In CHAPTER 1 the LbL technique was introduced. The most widespread techniques to 
characterize LbL films were described. Especially the use of the LbL technique for the 
fabrication of polyelectrolyte microcapsules has been reviewed in detail. We described in 
detail the approaches so far reported in literature to induce release from polyelectrolyte 
microcapsules. On top, the strengths and weaknesses of polyelectrolyte microcapsules 
towards drug delivery were discussed and compared with the pro’s and con’s of other drug 
delivery systems under investigation.   
In the CHAPTERs 2-5 ‘self-exploding’ microcapsules were presented. These 
microcapsules can ‘explode’ without the use of an external trigger. The microcapsules 
consist of a biodegradable dextran-based (dex-HEMA) microgel core surrounded by a semi 
permeable membrane which is permeable to water but impermeable to the encapsulated 
drugs and the degradation products of the microgels. When the microgel core degrades, the 
swelling pressure increases and at a certain moment, when the swelling pressure exceeds 
the tensile strength of the membrane, the membrane ruptures, releasing of encapsulated 
material.   
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In CHAPTER 2 the ‘proof of principle’ of self-exploding microcapsules, i.e. the fact that 
the swelling pressure of a degrading microscopic gel particle can rupture a surrounding 
membrane, was reported. For this purpose positively charged dex-HEMA microgels were 
coated with 3 bilayers of the synthetic polyelectrolytes poly(sodium styrene sulfonate) and 
poly(allylamine hydrochloride) (PSS/PAH). We showed that the resulting microcapsules 
indeed exploded when incubated (during a certain time) at pH 9. However, at physiological 
pH (i.e. pH 7.4) the (PSS/PAH)3 membrane seemed permeable to the degradation products 
of the microgels, thus preventing the osmotic pressure to build-up. Consequently, the 
polyelectrolyte microcapsules were not self-exploding at pH 7.4. In CHAPTER 3 we 
investigated the (PSS/PAH)3 microcapsules physicochemically in more detail by different 
methods. 
In CHAPTER 4 bio-polyelectrolytes, in stead of synthetic polymers, were used for the 
LbL coating of the dex-HEMA microgels. The main advantage of the bio-polyelectrolytes is 
their biocompatibility. We showed that the behaviour of the bio-polyelectrolyte microcapsules 
upon degradation of the microgel core strongly depended on the choice of the bio-
polyelectrolyte pair used for the LbL coating. Microcapsules consisting of 4 bilayers of poly-L-
glutamic acid / poly-L-arginine exploded and released their content upon incubation under 
physiological conditions. Microcapsules consisting of 4 bilayers of dextran sulfate/poly-L-
arginine did not explode upon incubation under physiological conditions, nor did they explode 
at non-physiological conditions. ‘Hollow’ microcapsules were obtained. The hollow nature of 
the resulting microcapsules was proven by scanning electron microscopy and atomic force 
microscopy.  
In CHAPTER 5 self-exploding lipid (in stead of polyelectrolytes) coated microgels were 
introduced. We took advantage of the unique structure of lipids, having a polar hydrophilic 
head group and a hydrophobic hydrocarbon tail. When dispersed in aqueous medium these 
lipids self-assemble spontaneously and form spherical structures, so called liposomes. Some 
types of lipids bear a net charge and can be attracted to an oppositely charged surface by 
electrostatic interactions. Once adsorbed on that surface, the liposomes spread and form a 
continuous bilayer. This concept was used in CHAPTER 5 to coat the microgels with lipid 
bilayers. The deposition of a lipid layer on the surface of dex-HEMA microgels was proven by 
ζ-potential measurements, confocal microscopy and scanning electron microscopy. When 
the lipid coated microgels were immersed in a solution at high pH, the lipid layer initially 
inflated and finally ruptured due to the swelling pressure of the degrading microgel. During 
the inflation of the lipid membrane so-called ‘parachutes’ were observed on the lipid surface, 
indicating that the lipid consists of multiple bilayers rather than a single bilayer. This 
hypothesis was confirmed by X-ray reflectivity studies.  
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The microgels prepared and investigated in the CHAPTERS 2 – 5 showed a broad size 
distribution. According to Laplace’s law, larger microcapsules (as obtained by LbL or lipid 
coating of larger dex-HEMA microgels) will explode easier than smaller microcapsules as 
less pressure is required for the elongation of the membrane. Therefore, coating of 
‘monodisperse’ microgels would be beneficial in order to narrow the timeframe during which 
capsule explosion occurs. In CHAPTER 6 we described the use of a microfluidic device for the 
fabrication of such monodisperse microgels. By impingement of an aqueous dex-HEMA 
stream, by a flanking oil stream in a microfluidic nozzle, monodisperse dex-HEMA droplets 
(in the oil phase) were formed in a continuous way. UV irradiation of the monodisperse dex-
HEMA droplets resulted in monodisperse microgels.   
The CHAPTERS 7 to 10 dealt with the fabrication of polyelectrolyte microcapsules 
which decompose under influence of a natural or external trigger. In CHAPTER 7 
polyelectrolyte microcapsules which dissolve in the presence of glucose were reported. 
Phenylboronic acid forms a covalent anionic complex with glucose at alkaline pH, leading to 
a decrease in the apparent pKa. A phenylboronic acid containing acrylate was synthesized by 
coupling aminophenylboronic acid to acrylic acid. This acrylate was copolymerised with 
dimethyl aminoethyl acrylate, yielding a copolymer containing both amino and phenylboronic 
acid groups. At low pH this copolymer was used as polycation for multilayer build-up in 
conjunction with the polyanion poly(styrene sulfonate) (PSS), as evidenced by UV-VIS 
spectroscopy. Hollow microcapsules were fabricated by LbL coating of polystyrene particles 
with 6 copolymer/PSS bilayers followed by the decomposition of the polystyrene core in 
tetrahydrofuran. Upon addition of glucose under buffered alkaline (i.e. pH 9) conditions, the 
phenylboronic acid moieties change from their uncharged form into their anionic form as their 
pKa shifts, causing repulsion with the sulfonate groups of the poly(sodium styrene sulfonate) 
and attraction with the amino groups of the dimethyl aminoethyl acrylate. These phenomena 
of intermolecular repulsion and intramolecular attraction destabilised the multilayer wall of the 
microcapsules, leading to their dissolution, as shown by confocal microscopy. 
In CHAPTER 8 bio-degradable polyelectrolyte microcapsules were fabricated and 
investigated in the context of intracellular delivery of molecules. Two types of degradable 
microcapsules were synthesized. The first type contained a polycation bearing hydrolysable 
cationic side chains. The second type was fabricated using the bio-polyelectrolytes dextran 
sulfate and poly-L-arginine. Calcium carbonate (CaCO3) microparticles were used as 
sacrificial template for the LbL coating. After LbL coating the CaCO3 templates were 
dissolved in an EDTA solution. When the thus obtained polyelectrolyte microcapsules were 
incubated in a cell culture, the microcapsules were taken up by the cells and degraded 
intracellularly. Contrary, microcapsules fabricated from the synthetic, non-degradable, 
polyelectrolytes PSS/PAH did not degrade but stayed intact in the cells. The bio-degradable 
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polyelectrolyte microcapsules might be promising carriers for the delivery of antigens and 
genetic material (e.g. DNA, siRNA…) which have an intracellular target. 
In CHAPTERS 9 and 10 we reported on hybrid microcapsules fabricated by consecutive 
adsorption of negatively charged gold nanoparticles and the polycation PAH onto CaCO3 
microparticles as sacrificial template. Confocal microscopy and electron microscopy were 
used to reveal the structure of the microcapsules. As the gold nanoparticle had weak acid 
groups, i.e. carboxyl groups, on their surface and PAH has weak basic groups, i.e. primary 
amino groups, the microcapsules dissolved respectively at low and high pH as the carboxyl, 
respectively amino groups, were no longer charged. Covalent cross-linking of the carboxyl 
and amino groups stabilized the microcapsules. They remained stable in the whole pH 
range. Further we showed that the microcapsules were remotely activated by IR-laser 
irradiation by conversion of light energy into thermal energy, heating the gold nanoparticles 
resulting in the destruction of the microcapsules. In CHAPTER 10 we evaluated the effect of 
ultrasound on the integrity of polyelectrolyte and hybrid polyelectrolyte/nanoparticle 
microcapsules. The shear forces, resulting from the propagating ultrasonic shockwaves in 
the fluid medium of the microcapsules, completely destroyed the microcapsules. Confocal 
and scanning electron microscopy could only reveal debris of broken microcapsules after 
ultrasonic treatment. Both types of microcapsules completely released their content after 
exposure to ultrasound. 
Polyelectrolyte microcapsules are, since their advent in 1998, of interest to both 
fundamental as well as application oriented researchers. The concepts developed in this 
thesis may be promising towards biomedical applications of polyelectrolyte microcapsules. 
However, polyelectrolyte microcapsules are only in their earliest stage and further research is 
required both to fully understand them as well as to optimise them towards real applications. 
Indeed, it remains a huge challenge to further develop such microcapsules and to show that, 
compared to other more established delivery systems such as liposomes and ordinary 
polymeric particles, they have important benefits. 
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Recente biotechnologische macromoleculaire geneesmiddelen, zoals bepaalde 
peptiden en eiwitten, vereisen een speciale formulatie om hen te beschermen tegen 
degradatie alvorens ze hun doel bereiken.  Naast bescherming tegen enzymatische afbraak 
is echter ook het vrijstellingsprofiel van belang. Zo zou het voor het vrijstellen van antigenen 
interessant zijn een gepulseerd vrijstellingspatroon te bekomen, waarbij de antigenen 
vrijgesteld worden na vooraf bepaalde tijdsintervallen. In andere gevallen daarentegen moet 
het geneesmiddel enkel vrijgegeven worden op een specifieke plaats, volgend op een 
specifieke lokale of externe stimulus. Bijvoorbeeld, een geschikte dosis insuline zou enkel 
moeten vrijgegeven worden wanneer de glucoseconcentratie in het bloed een kritische 
waarde overschrijdt. 
In deze doctoraatsthesis werden verschillende types microcapsules ontwikkeld die 
hun inhoud kunnen vrijstellen na (1) een bepaalde incubatietijd en (2) ten gevolge van een 
specifieke fysicochemische stimulus. Deze microcapsules werden aangemaakt via de Layer-
by-Layer (LbL)-techniek. Deze techniek is gebaseerd op de alternerende adsorptie van 
geladen species op een tegengesteld geladen oppervlak. Grote voordelen van deze techniek 
zijn de multifunctionaliteit en de eenvoud van gebruik. 
In HOOFDSTUK 1 werd de LbL-techniek geïntroduceerd en werden de meest 
aangewende karakterisatietechnieken besproken. Er werd bijzondere aandacht besteed aan 
het gebruik van de LbL-techniek voor de aanmaak van polyelektroliet-microcapsules. 
Daarnaast werden ook de benaderingen gerapporteerd in de literatuur om vrijstelling uit 
dergelijke microcapsules te bewerkstelligen gedetailleerd beschreven. Tevens werden de 
sterktes en zwaktes van polyelektroliet-microcapsules met betrekking tot 
geneesmiddelafgifte besproken en vergeleken met andere geneesmiddelafgiftesystemen.  
In de HOOFSTUKKEN 2 – 5 werden ‘zelf-exploderende’ microcapsulesontwikkeld. Deze 
microcapsules kunnen ‘exploderen’ zonder dat ze een externe stimulus nodig hebben. De 
microcapsules zijn opgebouwd uit een biodegradeerbare, dextraan gebaseerde (dex-HEMA) 
microgelkern omgeven door een semi-permeabel membraan dat permeabel is voor water 
maar impermeabel voor het geëncapsuleerde geneesmiddel en de degradatieproducten van 
de microgels. Wanneer de microgelkern degradeert, neemt de zweldruk toe en op een 
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bepaald ogenblik, wanneer de zweldruk de treksterkte van het membraan overschrijdt, 
scheurt het membraan en wordt het geëncapsuleerde materiaal vrijgesteld.  
In HOOFDSTUK 2 werd de ‘proof of principle’ aangetoond, namelijk dat de zweldruk 
van een degraderende microgel in staat is een omgevend membraan te doen scheuren. 
Hiertoe werden positief geladen dex-HEMA microgels gecoat met 3 dubbellagen van de 
synthetische polyelektrolyten poly(styreen sulfonaat) en poly(allylamine hydrochloride) 
(PSS/PAH). We toonden aan de verkregen microcapsules explodeerden wanneer ze 
gedurende een bepaalde tijd geïncubeerd werden bij pH 9. Onder fysiologische 
omstandigheden (pH 7.4) echter bleek het (PSS/PAH)3-membraan permeabel voor de 
degradatieproducten van de microgelkern, waardoor er onvoldoende osmotische druk kon 
opgebouwd worden en  de microcapsules niet zelf-exploderend waren bij pH 7.4. In 
HOOFDSTUK 3 werden de eigenschappen van de (PSS/PAH)3 coating in detail onderzocht 
met behulp van verschillende fysicochemische technieken.   
In HOOFDSTUK 4 werden voor de LbL-coating van dex-HEMA microgels bio-
polyelektrolieten gebruikt in plaats van synthetische polymeren. Het voornaamste voordeel 
van deze bio-polyelektrolieten is dat ze biocompatibel zijn. We toonden aan dat het gedrag 
van de bio-polyelektroliet microcapsules tijdens degradatie van de microgelkern sterk 
afhankelijk is van het gekozen bio-polyelektrolietpaar voor LbL-coating. Microcapsules 
bestaande uit 4 dubbellagen poly-L-glutaminezuur/poly-L-arginine explodeerden en gaven 
hun inhoud vrij bij incubatie onder fysiologische condities. Microcapsules bestaande uit 4 
dubbellagen dextraansulfaat / poly-L-arginine explodeerden noch onder fysiologische 
condities, noch onder niet-fysiologische condities, resulterend in holle microcapsules. Het hol 
zijn van de microcapsules werd aangetoond met elektronenmicroscopie en atoomkracht-
microscopie. 
In HOOFDSTUK 5 werden zelf-exploderende  met lipiden (in plaats van met 
polyelektrolieten) gecoate  microgels voorgesteld. We maakten gebruik van de unieke 
structuur van lipiden, die een polaire hydrofiele kop en een hydrofobe koolwaterstofstaart 
hebben. Gedispergeerd in waterig midden gaan lipiden zich spontaan ordenen en sferische 
structuren, zogenaamde liposomen, vormen. Bepaalde types lipiden hebben een netto lading 
en kunnen door middel van elektrostatische interactie aangetrokken worden tot een 
tegengesteld geladen oppervlak. Eénmaal geadsorbeerd op het oppervlak spreiden de 
liposomen zich en vormen ze een continue dubbellaag. In HOOFDSTUK 5 werd dit concept 
gebruikt om de microgels met lipiden te coaten. De adsorptie van een lipidenlaag op het 
oppervlak van de microgels werd aangetoond met ζ-potentiaal metingen, confocale 
microscopie en elektronenmicroscopie. Wanneer de lipiden-gecoate microgels in een 
oplossing met hoge pH gebracht werden, begon de lipidenlaag op te blazen ten gevolge van 
de zweldruk van de degraderende microgels en op een bepaald ogenblik scheurde het 
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volledige membraan. Gedurende het opblazen van de lipidenlaag observeerden we de 
vorming van zogenaamde ‘parachutes’ op het lipidenoppervlak. Dit was een aanwijzing dat 
het lipiden-membraan eerder bestond uit meerdere dubbellagen in plaats van één enkele 
dubbellaag. Deze hypothese werd  ondersteund door X-straal reflectiviteitsmetingen. 
De microgels aangemaakt en bestudeerd in de HOOFDSTUKKEN 2 – 5 vertoonden een 
brede deeltjesgrootte-distributie. Volgens de wet van Laplace zullen grotere microcapsules 
(verkregen door LbL- of lipiden-coating van grotere dex-HEMA microgels) makkelijker 
exploderen dan kleinere microcapsules aangezien er minder druk vereist is om het 
membraan te doen uitrekken. Bijgevolg zou het coaten van ‘monodisperse’ microgels 
voordelen bieden door het tijdsinterval waarin explosie optreedt te vernauwen. In 
HOOFDSTUK 6 beschreven we het gebruik van een microfluidic apparaat voor de aanmaak 
van monodisperse microgels.  
De HOOFDSTUKKEN 7 – 10 handelden over de aanmaak van polyelektroliet- 
microcapsules die konden ontbinden onder invloed van een natuurlijke of externe stimulus. 
In HOOFDSTUK 7 werden capsules beschreven die konden oplossen in de aanwezigheid van 
glucose. Fenylboronzuur vormt een covalent anionisch complex met glucose bij alkalische 
pH, waarbij een daling van de apparente pKa optreedt. Een fenylboronzuur bevattend 
acrylaat werd gesynthetiseerd door aminofenylboronzuur te koppelen aan acrylzuur. Dit 
acrylaat werd gecopolymeriseerd met dimethyl-aminoethyl-acrylaat, resulterend in een 
copolymeer dat zowel amine- als fenylboronzuurgroepen bevat. Dit copolymeer werd bij lage 
pH gebruikt als polykation voor LbL-opbouw in combinatie met PSS als polyanion. UV-VIS 
spectroscopie werd gebruikt om de LbL-opbouw aan te tonen. Holle microcapsules werden 
aangemaakt door LbL-coating van polystyreenbolletjes met 6 dubbellagen copolymeer/PSS, 
waarna de polystyreenbolletjes opgelost werden in tetrahydrofuraan. Wanneer glucose 
toegevoegd werd onder gebufferde alkalische (pH 9) omstandigheden, veranderden de 
fenylboronzuurgroepen van een neutrale naar een anionische vorm, ten gevolge van de 
verschuiving in pKa. Hierdoor treedt er afstoting op tussen de fenylboronzuurgroepen en de 
sulfonaatgroepen van het PSS en treedt er tevens aantrekking op tussen de 
fenylboronzuurgroepen en de aminegroepen op hetzelfde copolymeer. Door deze 
intermoleculaire afstoting en aantrekking destabiliseerde het LbL-membraan van de 
microcapsules en losten deze op, zoals aangetoond met confocale microscopie.  
In HOOFDSTUK 8 werden degradeerbare polyelektroliet-microcapsules beschreven en 
onderzocht met het oog op intracellulaire afgifte van moleculen. Er werden twee types 
degradeerbare microcapsules. Het eerste type bevatte een polyelektroliet met 
hydrolyseerbare kationische zijketens. Het tweede type werd aangemaakt gebruik makend 
van de biopolymeren dextraansulfaat en poly-L-arginine. Calcium-carbonaat (CaCO3) 
micropartikels werden  gebruikt als sacrificiële kern voor LbL-coating. Na LbL-coating werden 
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de CaCO3 micropartikels opgelost met behulp van een EDTA-oplossing. Wanneer de 
verkregen polyelektroliet-microcapsules toegevoegd werden aan een celcultuur werden de 
microcapsules opgenomen door de cellen en intracellulair afgebroken. Dit in tegenstelling tot 
microcapsules bestaande uit de synthetische polyelektrolieten PSS/PAH die niet 
degradeerden en intact in de cellen bleven. De bio-degradeerbare polyelektroliet 
microcapsules  lijken beloftevol voor de afgifte van antigenen en genetisch materiaal 
(bijvoorbeeld DNA, siRNA ...), die een intracellulair doel hebben.   
HOOFDSTUK 9 en 10 beschreven de aanmaak van hybride microcapsules door 
alternerende adsorptie van negatief geladen goud-nanopartikels en PAH op CaCO3 
micropartikels als sacrificiële kern. Confocale en elektronenmicroscopie werden gebruikt om 
de structuur van de microcapsules te onderzoeken. Aangezien de goud-nanopartikels zwak 
zure groepen (carboxyl) op hun oppervlak hebben en PAH zwak basische groepen (primair 
amine) heeft, konden de microcapsules zowel bij lage als bij hoge pH opgelost worden, 
aangezien de carboxyl-, respectievelijk amine groepen niet langer geladen waren. Door 
covalente vernetting tussen de carboxyl- en amine groepen konden de microcapsules 
gestabiliseerd worden waardoor ze stabiel bleven over de hele pH-schaal. Verder toonden 
we aan dat de microcapsules konden geactiveerd worden door IR-laser-bestraling waarbij 
lichtenergie omgezet wordt in thermische energie en de microcapsules uiteindelijk scheurden 
en hun inhoud vrijgaven. In HOOFDSTUK 10 onderzochten we het effect van ultrasone golven 
op de integriteit van polyelektroliet- en hybride nanopartikel/polyelektroliet microcapsules. De 
afschuifkrachten, veroorzaakt door de propagerende ultrasone schokgolven, in de vloeistof 
rond de microcapsules vernielden de microcapsules volledig. Met behulp van confocale en 
elektronenmicroscopie konden na ultrasone behandeling enkel nog restanten van gebroken 
microcapsules gedetecteerd worden. Beide types microcapsules stelden hun volledige 
inhoud vrij na ultrasone behandeling. 
Polyelektroliet-microcapsules wekken, sinds hun uitvinding in 1998, de interesse van 
zowel fundamentele als toepassingsgerichte wetenschappers. De concepten ontwikkeld in 
deze doctoraatsthesis zijn een beloftevolle stap in de richting van farmaceutische 
toepassingen van polyelektroliet-microcapsules. Echter, deze microcapsules zijn nog in het 
vroegste stadium van ontwikkeling  en verder onderzoek is noodzakelijk om volledig inzicht 
te verwerven en hen te optimaliseren tot echte toepassingen. Inderdaad, het blijft een 
enorme uitdaging om deze microcapsules verder te ontwikkelen en hun voordeel aan te 
tonen tegenover meer gevestigde afgiftesystemen zoals liposomen en klassieke 
polymeerpartikels. 
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